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Chapter 1 
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1 Background 
1.1 Intestinal epithelial cell differentiation and development is a dynamic, continuous process 
During ontogenesis and throughout the lifespan of mammals, the small intestine 
undergoes an integrated pattern of differentiation (128,141). The complex structure of the mature 
epithelium occurs as a result of a series of developmental transitions beginning in the embryo 
and terminating after weaning (95,128,141 ). Beginning on embryonic day 8 (E8) in mice, 
interactions betvveen visceral endoderm and mesoderm produce an undifferentiated stratified 
epithelium and, by E9, a primitive gut tube is formed. The cells lllldergo rapid cytodifferentiation 
beginning on El5, and by E19, an epithelial monolayer overlies nascent villi. It is during this 
important transition that the expression of certain intestine-specific genes is first detected 
(96,97). Villi are separated at their bases by a proliferative compartment which is converted to a 
mature crypt ofLieberklihn during the first two weeks of postnatal life. The intestine undergoes 
final differentiation at weaning whereby the panel of genes expressed establishes the protein 
patterns that are responsible for digestion and absorption of nutrients. The mechanisms 
underlying intestinal development are unknown, but an understanding of the developmental 
history of transcriptional events of specific genes will provide insight into the combined effects 
of temporally regulated transcription factors. 
The columnar intestinal epithelium of the mature intestine is a highly dynamic system in 
which the cells are continuously renewed by a process involving cell generation and migration 
from the stem cell population located near the base of the crypt to differentiated cells of the 
villus (56,79,141). From stem cells, four major terminally differentiated cell types arise: 
absorptive enterocytes, goblet cells, enteroendocrine cells and Paneth cells ( 41 ). Absorptive 
enterocytes, comprising approximately 95% of epithelial cells on villi, are polarized cells with an 
apical brush border that contains transporters, receptors, and membrane-anchored hydro lases, 
including lactase-phlorizin hydrolase (LPH) and sucrase-isomaltase (SI). Goblet cells synthesize 
mucins, which protect the epithelium and produce a medium in which terminal digestion and 
absorption can occur optimally (25). Enteroendocrine cells produce a variety of hormones 
necessary for regulation of intestinal processes (116). Paneth cells produce a number of proteins 
including those of the innate immune system such as, lysozyme and defensins (115). An 
additional cell type that is derived form the enterocyte lineage are the M-cells, which are also 
produced in crypts adjacent to the Peyer's patches (95,155). Precursor cells undergo several 
rounds of cell division while they reside in the crypt compartment and, with the exception of 
Paneth cells which migrate to the base of crypts, migrate from crypts toward the tip of the villi. 
As the precursor cells approach the crypt-villus junction, the proliferating phase ends and the 
cells then acquire a functionally differentiated phenotype. The cells continue to migrate up the 
villi, undergo apoptosis (95), and are shed (83) into the intestinal lumen three to five days 
(depending on species) after their initial appearance on villi (17,40). This continuous process is a 
model for cellular differentiation. In addition to differentiation-specific regulation along the 
crypt/villus (vertical) axis, intestinal gene expression is also controlled along the proximal-to-
distal (horizontal) axis resulting in distinct functions in different regions of intestine as well as by 
the developmental gradient. The molecular mechanisms underlying the dynamic processes of 
intestine-specific gene expression, cell fate determination, cellular differentiation, and intestinal 
development are poorly understood at present 
The critical mechanisms for the determination of specific cell lineages remains unclear, 
but the influence of specific early transcription factors are beginning to be discovered. Recent 
investigations in intestinal stem cells by Yang et. al. (161) have shown that Mathl, a basic helix-
loop-helix transcription factor, is required for secretory cell lineage commitment in the mouse 
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intestine. Loss of Mathl results in depletion of goblet, enteroendocrine, and Paneth cells without 
affecting absorptive enterocytes. These results suggest that the secretory cells (goblet, 
enteroendocrine, and Paneth cells) arise from a common progenitor that expresses Mathl, 
whereas absorptive cells ( enterocytes) arise from a progenitor that is Mathl-independent. These 
discoveries are relevant because the downstream signaling from these early specification genes 
dictates the eventual hierarchy of differentiative transcription factors present in specified 
intestinal cells. By delineating the overlapping expression of transcription factors and target 
genes during fetal and postnatal development, along vertical axis, and along the horizontal 
gradient, the critical modulators that regulate the transcription of specific intestinal genes can be 
defmed. 
1.2 Transcriptional regulation and RNA processing: 
Transcriptional control in the context of cellular differentiation involves a network of 
interactions between cis-acting regulatory elements in the DNA of a particular gene and trans-
acting factors (transcription factors) that bind to cis-acting elements. Most of the transcriptional 
regulatory DNA sequences are in the 5' -flanking region of genes, although intronic (14) and 3' 
control (87) also occur. The rate of transcription of target genes is mainly regulated by the rate of 
the formation of the transcription initiation complex (45), which binds to TAT A-box and start 
site of target genes (Fig. 1). Promoters can include a TAT A-box, a start site or both of these 
control elements. The formation of the transcriptional initiation complex starts with the initial 
binding ofTATA-box binding protein (TBP) to the TAT A-box. Hereafter, the transcription 
factors that bind to their cis-acting elements upstream form the T A TA -box facilitate the forming 
of the transcriptional initiation complex. Specific transcription factors manipulate the formation 
of transcriptional initiation complex by their presence, abundance, affinities for their cis-acting 
elements, and physical interactions with other proteins. Transcription factors are cell-type and 
tissues specific and have expression patterns that are divers during the life of the cell. Presence 
of a certain transcriptional repressor in tissue specific cells will repress the transcriptional 
activation in this cell type, but not in other cell type that do not produce this repressor. 
Abundance of transcription factors can favor the transcriptional activation in a certain direction. 
When, a transcriptional activator is in higher abundance than a transcriptional repressor, the 
transcription will be overall directed towards the activation state, depending on affinity 
differences as well. The affinity of specific transcription factors for their cognate binding sites 
are defined by the specific sequences contained within the binding site and the configuration of 
the DNA-binding domains in transcription factors. The physical protein-protein interactions 
among transcription factors and other transcriptional modulators such as co-activators or co-
repressors (72) provide an additional mechanism for control of transcription. The cis/trans-acting 
elements regulate the formation rate of the transcription initiation complex, which is required for 
the transcriptional activity of specific genes. These data show that transcriptional activation 
occurs through complex mechanisms whereby a large number of proteins each play a role in the 
transcription process. The transcriptional process is the rate limiting step in the presence and 
abundance of proteins. 
The binding of transcription factors at cis-acting elements of the 5'-flanking regions of 
target genes, modulate the assembly rate of the transcriptional initiation complex (45). The effect 
of these transcription factors result in either higher assembly rate of transcriptional initiation 
complex, which results in higher transcriptional activity (activated transcription) or lower 
assembly rate of the transcriptional initiation complex, which results in a lower transcriptional 
activity (repressed transcription) (158). 
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Figure 1: Schematic representation of the process of gene transcription and processing of RNA. 
Transcriptional initiation complex (TIC) is necessary for the basal transcription of genes. The circles represent 
transcription factors and co-factors that form protein complexes that regulate transcription. The interaction of 
proteins found in nucleus with each other and the DNA and their function in the transcription process is the main 
scoop ofthis thesis work. Courtesy of S.D. Krasinski. 
The transcriptional activators once bound to their cis-elements facilitate assembly of the 
transcriptional initiation complex, either by direct contact with proteins that are part of the 
transcription machinery, or indirectly through the recruitment of coactivators that may facilitates 
strand separation and open complex formation ( 45). Transcriptional repressors once bound to 
their cis-elements can repress formation of the transcriptional initiation complex by several 
mechanisms, including direct interference with binding of transcriptional activators, or by direct 
interaction with the transcriptional initiation complex, analogous to how activators activate gene 
transcription. Also, transcriptional repressors cause repression by indirect mechanisms, like 
recruitment of corepressors that may cause strand tightening complex formation ( 45). In contrast 
to transcription factors that bind directly to their consensus binding sites at the DNA (cis-
element), co-factors do not bind directly to the DNA, but generally form protein-protein 
complexes with cis-acting transcription factors. Cooperative regulation by multiple transcription 
factors that results in a transcription rate that is greater than the sum of the activation of each 
transcription factor individually is referred to as synergy. Cooperative regulation by multiple 
transcription factors that results in a transcription rate that is lower than the sum of the activation 
of each transcription factor individually is referred to as antagonism. Interactions between 
transcription factors and co-factors in their role in the regulation of gene transcription for specific 
intestinal genes will be the main focus of this thesis. 
Although the abundance of proteins available in the cell is regulated mainly by the 
transcription process, other processes subsequent to transcription play a role in establishing the 
biologically active protein products. Newly transcribed RNA, named pre-mRNA, is processed 
and spliced into mature rnRNA, which is released into the cytoplasm and is sorted to specific 
regions within the cell (Fig. 1). These processes include capping of the 5' end of the pre-mRNA 
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with 7methylGTP (3) and addition of a poly A tail (24) to the 3' end, both of which protect the 
mRNA in the cytoplasm. Splicing processes involve cutting the intronic regions and precisely 
fusing the exons in-frame (Fig. 1). The mature mRNA consists of three specific regions. The 5'-
untranslated region (5' -UTR) has been suggested to play a role in the regulation of the rate of 
translation (78), The open reading frame is the translated portion of the mRNA. The 3'-UTR has 
been suggested to contain localizing (60,61) and stabilizing signals (78), The mRNA in the 
cytoplasm is than translated into precursor polypeptides by the ribosomes. Post-translational 
processing allow the cell to react to a large variety of extracellular stimuli and manipulate its 
gene expression repertoire accordingly (13). These post-translational processes include 
phosphorylation and glycosylation. Protein phosphorylation is the mechanism of choice for 
situations where rapid changes in transcriptional activity is required (18). Glycosylation is 
important in sorting and transport as well as peptide folding. 
The final biologically active proteins and their role in the cell are determined by the 
abundance of their rnRNAs and post-transcriptional processes. The pathway from transcription 
of target genes to the final processes that establish the biologically active proteins is shown in 
Fig. 1. The transcriptional process is the rate limiting step that regulates the abundance of 
proteins in the cell. It is this process that is the main focus of this thesis and is discussed below 
for intestine-specific genes. 
1.3.1 Lactase-phlorizin hydrolase and sucrase-isomaltese. 
Lactase-phlorizin hydrolase (LPH) and sucrase-isomaltese (SI) are both trans-membrane 
glycoproteins that protrude from the apical membrane of the absorptive enterocyte into the 
intestinal lumen. LPH is a beta-galactosidase responsible for the cleavage of the disaccharide 
lactose, which is the principle carbohydrate of mammalian milk, into its absorbable 
monosaccharides, glucose and galactose. LPH also shows specificity for phlorizin, a naturally 
occurring glucoside found in some mushrooms, bark and apple tree leaves (15). SI contains 
isornaltase and sucrase activities, and plays a key role in the final degradation of glycogen and 
starch (51). 
LPH and SI are both expressed in absorptive enterocytes on villi demonstrating tissue-, 
cell-type, and differentiation-specific expression (64,142,157), The cells in the proliferative crypt 
compartment do not express either LPH (121) or SI (140). However, as the cells emerge from the 
crypts, and differentiate, the cells start to express LPH and SI. In adult mice, high levels ofLPH 
and SI mRNA are expressed in the lower half of the villus with decreasing levels towards the tip 
of villi, in contrast to the respective proteins which are expressed throughout the entire villi 
(63,121,131), The hypothesis is that the cell since LPH and Sl are stable and anchored at the cell 
membrane, it can "turn off' the transcription ofLPH and SI genes. Although the expression 
patterns of LPH and SI show similarities along the crypt-villus axis, these proteins demonstrate 
differences along the horizontal and developmental gradients. This is exemplified in all 
mammals by the lactase specific activity which is high at birth and declines during weaning, 
whereas the sucrase specific activity is low at birth and increases rapidly to adult levels during 
weaning (63). These enzymatic changes coincide with the transition from a milk-based diet, in 
which the primary carbohydrate is lactose, to a diet of solid foods that contain a-
dissaccharidases. The mechanism underlying this differential pattern of regulation is unkno\Vll. 
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1.3.2 Intestine-specific gene expression for lactase-phlorizin hydrolase (LPH) and sucrase-
isomaltose (Sf) coincides with critical transitions in intestinal differentiation and development. 
LPH is expressed at the time of villus formation in fetal mice whereas SI expression is 
detectable but low at this time. At El8, the proximal intestine is characterized by the presence of 
primitive villi lined by an epithelial monolayer of colunmar cells, whereas the distal intestine 
continues to exhibit a stratified multi-layered epithelium. LPH mRNA is first detected, at this age 
and is found in all of the epithelial cells lining the primitive villi (96, 120) but cannot be detected 
at this age in the stratified multi-layered epithelium of the distal intestine. In contrast to the 
increasing expression ofLPH, SI expression remains detectable but low at this age (96,120). 
Since LPH is first expressed at the time of villus formation in the developing gut, it is a good 
marker for this event during the intestinal development. 
In contrast to the uniform expression of LPH mRNA in fetal intestine, expression in 
postnatal intestine undergoes a topographic redistribution. At E22 (day of birth) and immediately 
after birth, LPH mRNA becomes restricted to the lower half of the villi, whereas LPH proteins 
remain detectable along the length of the villi (Fig. 2) (120). 
ISH IHC 
Fig. 2. LPH mRNA and 
immunoreactive protein expression in 
the jejunum of7~day-old rats. H&E 
staining (left panel) shows the structure 
of the crypts and villi. In situ 
hybridization assays (ISH) demonstrate 
that LPH mRNA is expressed at the 
lower half of villi (middle panel). LPH 
protein, revealed by 
immunohistochemistry (ICH) is present, 
along the length of the villi (right panel). 
Courtesy of Edmond Rings. 
This pattern does not appear to be a result of suckling, since prevention of suckling does 
not influence the distribution ofLPH mRNA (120). The restriction to the lower half of the villi 
remains essentially unchanged at all subsequent ages, including adult animals. Neither LPH 
mRNA nor protein is detectable in crypts (120). Therefore, LPH is an excellent marker for 
intestinal development around birth and during suckling. 
During the suckling/weaning transition, LPH and SI expression undergo redistribution 
that parallels changes in the dietary nutrients. 
L ~p~~~M~~~~D 16days S[ Fig. 3. Distribution ofLPH(L) and SI (S) protein along the horizontal axis of small intestine in 16~, and 28-days-
old rats (121). P, M, and D indicate proximal, middle, and 
28 days ._ Ill .: . J length and growth. White segments represent no 
s immunodetection. Light shaded segment represents low 
L ~~i;·;ij'"-ij::;i,]ii'ii·:·.i!=~M~~~~;·.,ii .... i:i,!:·i}·'·i::·.;li~q distal small intestine. Bars represent intestines at relative 
expression. Middle dark shaded segments represent patchy 
expression (approximately half of the cells express proteins) and dark shaded areas represent expression in all 
enterocytes. 
The pre-weaning (16 days) expression ofLPH is high throughout the small intestine, in contrast 
to the low expression of SL As is shown in Fig. 3, during weaning and after weaning (28 old 
days), LPH expression per enterocyte is reduced and is also restricted to the jejunum and 
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proximal ileum (M) (63) but during weaning SI expression rapidly reaches adult levels 
throughout the entire small intestine (77,121). Also, SI mRNA is mainly found from crypt/villus 
junction to the mid of villus and lower expression from mid villus to tip of the villus in adult rat 
jejunum (140). These data demonstrate that the changes ofLPH and SI expression to adult levels 
coincide with the final transition of intestine development during weaning. Therefore LPH and 
SI are excellent markers for final intestinal developmental differentiation process. 
1.3.3. Intestine-specific gene expression for lactase-phlorizin hydrolase (LPH) and sucrase-
isomaltase (Sf) along the horizontal and developmental gradient coincides with the abundance 
of its respective mRNA and pre-RNA. 
Lactase and sucrase specific enzyme activities correlate with their protein expression 
patterns and abundance of their mRNAs along the horizontal and developmental gradients 
suggesting fundamental control at the level of gene transcription. This lab was the first to show 
that the developmental pattern oflactase and sucrase activity in rats (16) and the genetic lactase 
pattern in humans (30) is coordinated with the abundance of its mRNAs (Fig.4), findings 
subsequently confirmed by this laboratory (31,63) and others (32,47,58,68,80). As shown in Fig. 
4, the specific activity oflactase is high in the pre-weaning period (7 to 14 days) and restricted to 
the middle segment of small intestine after weaning (21 and 28 days), whereas sucrase activity is 
low before weaning (7 to 14 days), and increases just prior to weaning. In the adult, sucrase 
activity is isolated to the proximal and middle segments of the mouse small intestine. 
~:,oo,---~'£'1_ ___ ~----'"---c--cc-e< Fig.4. Quantitative determination ofLPH and 
SI specific activity, protein, and mRi'l"A in 
o 7 different intestinal segments during postnatal 
II 14 development (63). Proximal intestinal segments 
D 21 were taken from the proximal 1- to 2-cm of small 
I:J 28 intestine adjacent to the pylorus; middle segments 
were taken from the geometric center of the small 
oflJWl"'-LI"'-"L:.LJ...J"'=-j--"ili:i-JllLL_~'-1 intestine; and distal segments were taken from the 
distal 1- to 2-cm of small intestine adjacent to the 
ileocecal junction. Fragments were taken from 7, 
14, 21, and 28 days old mice, respectively. 
Specific activity, protein and mRNA ofLPH and 
SI detenninations were carried out using activity 
tests, rocket immunoelectrophoresis, and RNase 
protection assays, respectively. Courtesy of S.D. 
Krasinski 
These patterns of lactase and sucrase specific activity closely parallel the levels ofLPH 
and SI and mRNA. In addition, Krasinski et. al. (63) demonstrated that the mRNA levels ofLPH 
and SI are also closely correlated with the abundance of the pre-mRNAs. Pre-mRNA is the direct 
product of transcription of the LPH gene (Fig.l) and can be used as an indicator of transcription 
rate. These data demonstrate that the levels of protein correlate well with the abundance of their 
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respective mRNAs and pre-mRNAs demonstrating that the abundance of LPH and SI is 
regulated in gene transcription. 
Developmental pattern of LPH during weaning in human demonstrates differential 
patterns in geographical different populations. Additionally in Fig. 4 is confirmed the horizontal 
and developmental expression of LPH and SI as previously described. The developmental 
decline ofLPH at weaning in all mammals and the majority of humans is not regulated by the 
presence oflactose substrate, but rather is genetically "hard-wired" (94). The LPH decline occurs 
in humans at around age 5, although a minority of humans, mainly those from or related to 
societies of northern and western Europe (a traditional milk drinking population), continue to 
express LPH throughout adulthood. Since LPH and SI are expressed in tissue-, cell type-, and 
differentiation-specific manner and their expression along the horizontal and developmental 
gradient coincide with specific transitions in the intestinal development, LPH and SI genes are 
well established markers for these cell differentiation and intestine developmental processes. 
1.3.4. The 5 '-flanking regions contain important information for tissue-, cell type-, and 
differentiation-specific as well as the horizontal and developmental expression patterns. 
The 5 '-flanking region of the LPH gene regulates tissue-, cell type-, and differentiation-
specific expression patterns as well as the horizontal and developmental expression patterns of 
LPH. Transgenic studies show that 2038 base pairs (bp) of 5' -flanking region of the rat LPH 
promoter directs reporter (human growth hormone) expression to absorptive enterocytes on small 
intestinal villi (64). Transgene expression was not detected in crypts, enteroendocriene (Fig 5), 
and goblet cells. These data demonstrate that information for enterocyte- and tissue-specific LPH 
gene expression is contained in the 2038 bp 5 '-flanking region. Other transgenic studies using 
the pig and rat LPH 5 '-flanking sequence (76,145) are consistent with these findings. 
Fig 5. Cellular distribution of human growth 
hormone (hGH) in proximal segment of 
transgenic mouse small intestine. Dark-field 
exposure immunofluorescence microscopy 
revealing that hGH (A), visualized with FITC, is 
not present in (B) enteroendocrine cells (detected 
with Texas red). Arrows show serotonin-
containing enteroendocrine cells. These data 
demonstrate that the transgene is not expressed in 
endocrine cells. 
The trans gene expression pattern along the horizontal axis was shifted proximal than that 
of the endogenous LPH expression. The developmental expression of the transgene was also 
ectopic. However, a report by Lee et. al. demonstrated in transgenic mice, that a 2.0 kb of the rat 
5 '-flanking sequence directed appropriate horizontal and developmental expression of the 
transgenic (76).ln addition, a report by Troelsen eta!. (145) described that a 1038 bp region of 
the pig LPH 5 '-flanking region directed correct horizontal and developmental LPH expression. 
Trans gene expression pattern along the horizontal and developmental gradient is also 
regulated by the SI 5 '-flanking sequence. A construct containing bases -3424 to +54 of the 
human SI gene directed the appropriate intestine-specific transcription and differential 
expression along the crypt-villus axis (82). The horizontal expression pattern is regulated by 
additional DNA regulatory regions in the human SI gene. In addition, an evolutionarily 
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conserved region between human and mouse (nucleotides -210 to +54 of the mouse SI gene) 
directed the appropriate transcription to enterocytes in developmental and differentiation-
dependent patterns that was parallel to that of the endogenous gene (152). 
Together these data demonstrate that the LPH and SI (63,76,82,131, 145) tissue-, cell 
type-, and differentiation-specific expression patterns as well as the horizontal and 
developmental expression patterns ofLPH are regulated by their 5 '-flanking region. 
1.3.5. The proximal LPH and Sf promoters both contain binding sites for intestinal transcription 
factors. 
The effects of intestinal transcription factors on the regulation ofLPH and SI gene 
expression will provide insights in differentiation process of intestinal enterocytes. Homology 
comparisons of the 5' -flanking sequence among the human, pig, mouse and rat LPH genes and 
the 5' -flanking sequence of human and mouse SI genes reveal conserved regions at putative 
binding sites for a number of intestinal transcription factors, including Cdx-2, GAIA, and 
hepatocyte nuclear factor-! (HNF-1) transcription factor families (Fig. 6). 
-
1?0 GATA HNF-1 GATA Cdx-2 -4.0 Cdx-2 hLPH 
5' -A TCA T AGA T AACCCAGTT AAA T A TT AAGTCTT AA TT A TCACTT AGT A TTTT ACAACCTCAGTTGCAGTT AT AAAGT AAG-3' 
GATA HNF-1 GATA Cdx-2 Cdx-2 rLPH 
5' • T A TCT A TCCT AGA T AACCCAGTT AAA T A TTGTGTGGA T AA TCACT A TGTTTT ACAGCCTTGG CTGTGCTCA T AAAGTT A-3' 
GATA HNF-1 GATA Cdx-2 Cdx-2 mLPH 
5' • T A TCTGTCCT AGA T AACCCAGTT AAA T A TT GT A TGGA T AA TCACTGT A TTTT ACAGCCTT GG CTGTGCTCA T AAAGTCA-3' 
GATA HNF-1 Cdx-2 Cdx-2 pLPH 
5'-A TCACAGA T AACCCAGTT ACA T A TT AAGTGTT AAAAA TCACCT AGT A TTTT ACAACCTCAGTTGT AGT AT AAAGT AAGT -3' 
HNF-1 GATA Cdx-2 Cdx-2 hSI 
S' • TGT A TGTT GAGCAGAAGA TT A TT AAACACTGA T AGG CTG GTGAGGGTGCAA T AAAACTTT A TGAGT AGGTCAA TAT AT -3' 
GATA Cdx-2 Cdx-2 mSI 
5'-TTGAA TGTTGAACAGAAGAA T A TT AAACA TTGA T AGG CTTGTGAAAGTGCAA T AAAACTTT A TGAGT AGTCAA TAT AT -3. 
Fig. 6. The -100 to -20 bp region of the human (h), rat (r), mouse (m), pig (p) LPH and mouse and human SI 
5'-flanking region sequences. These promoters contain conserved binding sites for GATA (A/TGATAA/G), HNF-
1 (GTTAATNATTAAC), and Cdx-2 (TTTAT/C) (underlined). TATA-boxes are in boldface type. The mouse 
sequences were obtained from the genetic data base of the Celera Discovery system (Rockville. MD) (courtesy Dr. 
M. Fleming). 
Since the cognate binding sites of these transcription factors are in close proximity to 
each other and to the TAT A-box in the LPH and SI promoters, we hypothesize that these factors 
together might interact and play an important role in the regulation ofLPH and SI gene 
expression. In addition, since the number and arrangement of these binding sites is specific to 
each gene (e.g. one of each Cdx-2 and HNF-1 binding sites in LPH, and two of each in the SI), it 
is further hypothesized that each of these factors individually as well as in cooperativity will 
demonstrate differential effects on each of the promoters. 
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1.4lntestinal-specific transcription factors 
1.4.1 Transcription factors Cdx-2, GATA-4, -5, and -6 and HNF-1 a are only expressed together 
in the small intestinal epithelium. 
Expression of numerous transcription factors identified in other tissue has been shown in 
the gastrointestinal tract. Binding sites for Cdx-2, HNF-1, and GATA factors were identified in 
the 5' -flanking region of rat and human LPH and human SI genes. Cdx-2, HNF-1 and GATA 
factors (Fig. 7) are expressed contiguously together only in intestinal epithelium. The intestinal 
expression of Friend ofGATA (FOG) cofactors in unclear. These transcription factor families 
have all been shown to influence the regulation of cellular differentiation in intestinal as well as 
non-intestinal systems. These factors and co factors have been separated in two groups, including 
members ofhomeodomain containing transcription factor family and members of transcription 
factor family containing zinc fingers. The role these factors play in the intestine-specific cellular 
development and gene expression is only beginning to be revealed. 
Homeodomain proteins 
AD I AD II AD III HD 
Cdx-2 
DD POU HD AD II AD I 
HNF-1 
21 AA loop 
Zinc finger proteins 
~A~D~lo=~AD~~ll:C:jZ~n~liiZ~njii~B>c:=:=:=:=:=:=:=:=~ GATA-4,-5,-6 c 
FOG-1 1 2 3 t?J??????J????d ... ... .... 
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6 
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8 
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Figure 7. Schematic representation of the three major transcription factors and FOG-land FOG-2 co-factor 
family used in this thesis report. Cdx-2 contains three N-terminal activation domains (AD) of which the third one 
at amino acid serine position 60 is a phosphorylation site, and a homeodomain (HD). HNF-la contains a 
dimerazation domain (DD), POD-domain POU, homeodomain (HD) with an extra 21-AA loop, and two C-terrninal 
activation domains, and the GATA-4, -5, and -6 subfamily of zinc finger proteins contain two N-terminal activation 
domains (AD) and two zinc fingers (Zn) and a basic region (B) near the C-tenninus. FOG-I contains anN-terminal 
active site, 9 zinc fingers, and a PDIFLS where FOG-2 only contains 8 zinc fingers. 
1.4.2 Hom eo box protein families. 
The homeobox gene family is important for developmental pattern formation and 
organogenesis in multiple species (28). These proteins were also shown to bind to specific DNA-
binding sequences within the regulatory regions of specific target genes and regulate their rate of 
transcription. The homeodomain contains three well-defined a-helices of which helices two and 
three form a helix-turn-helix motif that binds to the DNA of specific target genes. Walters et al. 
(153) showed that many homeobox genes are expressed in the adult human small intestinal 
mucosa. These data suggest that homeobox transcription factors may play a role in the regulation 
of intestinal development and transcription of specific genes. Two examples ofhomeodomain 
proteins are Cdx-2 and HNF-la and are described further. 
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1.4.2.1 Cdx-2 transcription factor 
Cdx-2 (Fig. 7), a member of the homeobox gene family related to Drosophila caudal, is 
necessary for embryonic development, and may play an important role in intestinal 
differentiation. Mice homozygous for the Cdx-2 null mutation fail to implant, and die between E 
3.5 and E 5.5, whereas heterozygous knockout mice develop adenocarcinoma of the small 
intestine and colon (20). Cdx-2 is first detected atE 3.5 in extra-embryonic tissue (20). Within 
the embryo, Cdx-2 expression first occurs atE 8.5 in the posterior gut, tailbud, posterior region 
of the neural tube, and unsegmented paraxial mesoderm before the development of somites (20). 
In adult mammals, Cdx-2 is highly expressed in small intestine and colon (39,54,55,132) and is 
also detected in pancreas (127). In adult mouse small intestine, Cdx-2 is expressed in all 
epithelial cells in crypts and on villi, but only at low levels in Paneth cells at the bases of crypts 
(53,127). Stable transfection ofCdx-2 into IEC-6 cells, which are undifferentiated crypt-like 
cells that do not express Cdx-2, result in inhibition of cell growth, induction of marked 
morphological differentiation, and activation of intestine-specific gene expression (132). 
Together, these data suggest that Cdx-2 is important for implantation during early embryogenesis 
as well as development and maintenance of a differentiated intestinal epithelium. 
As described above, Cdx-2 can modulate epithelial cell phenotype, the regulation of 
cellular growth as well as transcription of multiple genes expressed in the intestinal epithelium. 
The gene expression repertoire of cells is constantly modulated by a variety of extra-cellular 
stimuli. Protein phosphorylation is one of the posttranslational modifications of choice for 
situations where rapid change of transcriptional activity is required (119). Rings et aL (119) 
shown that the Cdx-2 activation domain is phosphorylated at position serine 60 (S60) via a 
mitogen-activated protein kinase (MAPK) pathway. S60-phophorylated and S60-non-
phosphorylated Cdx-2 have different transactivating capacities and show different spatial 
expression patterns along the crypt-villus axis, suggesting distinct functions for these t\.vo forms 
as they relate to intestinal differentiation. 
Originally shown to bind a conserved region in the sucrase-isomaltase (SI) gene called SI 
footprint I (SIFI) (131,157), Cdx-2 has now been demonstrated to bind and regulate the activity 
of the promoters of several intestinal genes, including SI (131 ,138), lactase-phlorizin hydrolase 
(LPH) (34,48,107,145,146), clusterin (133), calbindin-D9K (CaBP9K) (5,69), carbonic 
anhydrase I (CAl) (26,27), HOX CS (138), the vitamin D receptor (160), guanylyl cyclase C 
(GC-C) (Ill), and human apolipoprotein B (73). Cdx-2 has also been shown to activate the 
glucagon promoter in a pancreatic islet cell line (70). Most of these genes contain the Cdx-2 
binding consensus, TTTA Y (Y is C or T), in a conserved position within the first 100 bp of the 
transcriptional initiation site in the 5'-flanking sequence. Localization to a position adjacent to 
the core promoter (i.e., TAT A-box and transcriptional start site) suggests a critical role for Cdx-2 
in the transcriptional regulation of gastrointestinal genes. 
Recently, it has been suggested that Cdx-2 may modulate the activity of the promoters of 
certain intestinal genes through interactions at their TAT A-boxes. Rat clusterin, a glycoprotein 
that has been associated with apoptosis, and rat and human CaBP9K, a mammalian intestinal 
vitamin-D-dependent Ca2+-binding protein, both have been shovm to bind Cdx-2 at their TATA-
boxes using supershift and competition EMSAs (5,69,133). The rat clusterin and the rat and 
human CaBP9K promoters contain a Cdx-2 binding consensus sequence at their TAT A-boxes. 
Cdx-2 may modulate transcription through this site as observed in transient co-transfection 
assays using intestinal and non-intestinal cell lines (5,69,133). Xu et al. (159) have demonstrated 
that Cdx-2 is capable ofbinding to its ovm TAT A-box and repressing Cdx-2 expression. Thus, 
these studies suggest an alternative mechanism for Cdx-2 regulation of intestinal gene expression 
by interaction at the core promoter. Since mutations that disrupt Cdx-2 binding were not 
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introduced into this site, mechanism by which Cdx-2 regulates gene transcription through this 
site remains unclear. 
The genes for rat and human LPH contain a well characterized Cdx-2 binding site located 
within a region called cis-element (CE)-LPH-la (-54 to -40 bp) (12,34,146,147). Sequence 
analysis (Fig. 5) of the rat and human LPH genes also reveal Cdx-2 binding sites overlying the 
rat and human LPH TAT A-boxes. Whether this binding site actually binds Cdx-2 or plays a role 
in the transcription of the LPH gene has yet not been determined but will be discussed in thesis. 
Although it is widely knowu that Cdx-2 binds to CE-LPHla (34,65,146, 148), several 
reports have suggested that non-Cdx-2-proteins also bind to CE-LPHla (12,48,88,108,146,147). 
Using EMSAs, several studies revealed the presence ofnon-Cdx-2 complexes interacting at CE-
LPHla, but did not report a function associated with this binding activity (12,34,48,108). 
Mitchelmore et. al. (88) suggested that a homeodomain protein, HOXCll, interacts at CE-
LPHl a and potentiates HNF-1a-dependent transcription of the LPH promoter, but did not report 
direct protein binding to this site. Troelsen et al. (146) have shown that a specific mutation 
outside of the Cdx-2 consensus but within CE-LPH1a demonstrated a higher transcriptional 
activity than that of the wild type promoter suggesting the presence of a silencing element within 
CE-LPHla. However, an alternative complex forming at CE-LPHla by EMSAs was not 
reported. A focus of this thesis is linking binding of a non-Cdx-2-complex to CE-LPHla with a 
function in the regulation of the human LPH promoter. 
1.4.2.2 HNF-1 homeodomain transcription factor family 
HNF-1 transcription factors (Fig. 7) contain a novel DNA-binding homeodomain 
distantly related to the POU domain and bind as dimers to the consensus sequence 
GTTAATNATTAAC (85,149). The homeodomain ofHNF-1 is novel since it contains an 
insertion of21 amino acids bet\.veen t\.vo of the homeobox helices (28). Dimerization is stabilized 
by a cofactor ofHNF-1 (DCoH) (46,86). Two members of the HNF-1 family, HNF-la and HNF-
1 p, share highly homologous DNA binding domains but have divergent activation domains at the 
C-terminus (28) suggesting diverse regulation of target genes. 
Two reports of mice lacking HNF-la gave variable results (75,114), including decreased 
growth rate, sterility, liver enlargement, renal dysfunction, and non-insulin-dependent diabetes 
mellitus. These mice also exhibit a reduction in the expression of certain liver genes, such as 
albumin, o.l-antitrypsin, phenylalanine hydroxylase, and liver fatty acid binding protein (L-
FABP) (1,75,114). Indeed, oligonucleotide microchip expression analysis revealed alterations in 
the expression over 800 liver genes in HNF-lo. knockout mice (126). The enlarged liver in these 
animals has been attributed to an accumulation oflipid due to decreased expression of the 1-fabp 
gene (1). Despite alterations in other tissue, gastrointestinal structure was nonnal in these 
animals, although expression of the ileal sodium-dependent bile transporter was reduced (126). 
HNF-1~ knockout mice have a disorganized visceral endoderm and die at E7.5 (4,21) and 
therefore do not provide any information about their role in intestinal differentiation. 
Originally thought to be liver-specific, HNF-1o. and HNF-1 ~ are both expressed also in 
kidney, stomach, and small and large intestine (6,66,85). HNF-1~ is also expressed in ovary and 
lung (141). In mice, HNF-la mRNA is uniformly distributed in the stratified epithelium at El0.5 
and in the epithelium of primitive gut tube at El5.5 suggesting a role in early intestinal 
morphogenesis (10). In mouse small intestine, HNF-1o.: and HNF-1~ 1nRNAs are expressed at 
high levels in crypt cells, and expression is gradually reduced until there are low levels at the 
villus tips (125). Expression ofHNF-la mRNA in the crypt and lower villus is consistent with a 
role in the induction of cellular differentiation and intestinal gene expression along the vertical 
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axis. Although the pattern ofHNF-1a mRNA has been well characterized, little is known 
regarding the pattern of expression of the HNF-la protein and is discussed in this thesis. 
Originally thought to be specific for the activation of liver genes (85), HNF-lo: has now 
been shown to activate the promoter of several genes expressed in the intestine, including 
guanylin ( 49), aminopeptidase N (1 06), phosphoenolpyruvate carboxykinase (7), aldolase B ( 42), 
the ileal sodium-dependent bile acid transporter (126) the sodium-glucose cotransporter (SGL T1) 
(126), LPH (130), and Sl (156). The pig LPH promoter is activated by HNF-lo: through binding 
to an HNF-1 site (called CE-LPH2c) (130), which is conserved in position in the human (-90 to-
70 bp) and rat (-86 to- 66 bp) LPH genes (Fig. 5). The human SI promoter has two HNF-1 
binding sites, sucrase-isomaltase footprint 2 (SIF2) (-90 to -70) and SIF3 (-176 to -159 bp ), that 
interact with both HNF-lo: and HNF-1~ (157). These two family members, which can form 
homodimers as well as heterodimers with each other, differentially activate both LPH and SI 
promoters (11,130,157). In addition, Mitchelmore et al. (89) demonstrated that HNF-lo: 
physically associates with Cdx-2 to cooperatively activate the pig LPH promoter. HNF-la also 
cooperates with SPl to activate the SGLTl promoter (84). Two recent reports have indicated that 
the homeobox transcription factor, HNF-la, activates certain liver-specific genes by recruitment 
of coactivator proteins with intrinsic histone acetylase activity (112,129). Soutoglou et al (129) 
found that HNF-la physically associates with the histone acetyltransferases (HATs) CREB-
binding protein and p300/CBP-associated factor, and that the HNF-la-recruited HAT activity 
was important for the transcriptional activation of a genome-integrated promoter containing 
HNF-1 binding sites. Using hn.flo. null mice, Parrizas et al (112) demonstrated that recruitment 
of HAT activity by HNF-la is necessary for the activation of certain genes in vivo. They 
showed that although HNF-la may occupy HNF-1 binding sites on promoters, recruitment of 
HAT activity is necessary for transcription. The results of these studies indicate that HNF-1a 
occupies target gene promoters in diverse tissues but plays an obligate role in transcriptional 
activation only in cellular- and promoter-specific contexts in which it is required to recruit HAT 
activity. The effect ofHNF-la on the human and rat LPH and human SI promoters in 
combination with other intestine-specific transcription factors has not been described thus far and 
is a focus of this thesis. 
1.4.3. Zinc finger transcription factor and cofactorfamilies 
The zinc finger gene family is divers and have been described to be important for 
developmental of multiple organs in different species, including heart, muscle, gonads, and lung. 
Zinc finger regions are evolutionarily highly conserved domains and form a loop structure that 
can mediate binding to specific cis-acting elements and/or physical interaction with other 
proteins. Two zinc finger families are described below that are found to be expressed in the 
intestine and suggested to play a role in the intestinal development. Two groups are described 
further, GATA zinc finger family are transcription factors bind directly to DNA, whereas Friend 
of GATA (FOG) is a multiple zinc finger family of co factors that mediate through protein-
protein interaction. 
1.4.3.1. GATAfactors 
The GAIA family of transcription factors has been implicated in cell lineage 
differentiation, organ development, and cell-specific gene expression during vertebrate 
development (67,90,93,103,110,113,128,154). Six GATA transcription factors have been 
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described in vertebrates, each of which is defined by two evolutionarily conserved zinc fingers of 
the motifCys-X,-Cys-Xn-Cys-X,-Cys (90)(Fig. 7) that mediate binding to the nucleotide 
sequence element (A/T)GATA(AIG). The GATA family is generally categorized into two 
subfamilies, GATA-1, -2,-3 and GATA-4, -5,-6 based on expression patterns and amino acid 
homologies. GATA-1, -2, -3 are expressed in developing blood cells and are critical for 
hematopoiesis (109), whereas GATA -4, -5, -6 have a more diverse pattern of expression and are 
found in small intestine, heart, liver, lung, and gonad where they play critical roles in regulating 
tissue-specific gene expression (2,59,71,101,102,134). Comparison of the deduced amino acid 
sequence ofGATA-4, -5, -6 reveals a low level of identity with that of the GATA-1, -2, -3 
subfamily (90). However, within the GATA-4, -5, -6 subfamily, a high level of sequence 
homology is present across the two zinc fingers and the adjacent C-terminal basic region (85-
95%) (90). 
Mice homozygous for the GATA-4 null allele die by E9.5 and lack both a primitive heart 
tube and foregut (67,91). GATA-5 knockout mice survive and reproduce despite pronounced 
genitourinary abnormalities in females (93), but show no gross abnormalities in intestinal 
structure or histology (intestinal gene expression was not reported). Interestingly, a GA TA-5 null 
mutation in zebrafish resulted in embryonic lethality with an identical phenotype to that observed 
in GATA-4 null mice, suggesting a similar role for GATA-5 in zebrafish to that ofGATA-4 in 
mice (117). GATA-6 null mice die before gastrulation (62,103) and therefore provide little 
information regarding intestinal development. Interestingly, in GA TA-4 null mice, GATA-6 was 
up-regulated whereas in GATA-6 null mice, GATA-4 was down regulated, suggesting that 
expression ofGATA-4 and -6 is dependent on each other (67,91,103). In Drosophila and C. 
elegans, GATA homologs have been implicated in gut development (37,118,128). These studies, 
however, demonstrate independent functions for individual GAT As, although functional 
redundancy among GATA subfamily members has been reported (105,143). 
GATA-4, -5, -6 are expressed together only in cardiac tissue and small intestine, but 
individually, or in overlapping patterns in stomach, liver, lungs, spleen, ovary, testis, and bladder 
(2,59,71,101,102,134). Expression of all three intestinal GATA mRNAs is detected as early as 
E9.5 in the primitive gut and continues to be expressed in intestinal epithelium throughout 
embryogenesis (2,38,71,101,102).1n both mouse (2) and chicken (38) intestine, GATA-4 
transcripts are distributed in epithelial cells all along the villus, with increasing levels 
accumulating toward the villus tips. In chicken intestine (38), GATA-5 mRNA is localized to 
differentiated cells of the villi, whereas GATA-6 transcripts are localized to cells of the upper 
crypt and lower villus. The similarities and differences in the pattern ofGATA-4, -5, -6 
expression patterns suggest common and independent regulatory pathways for the control of 
intestine and cardiac gene expression. 
GATA-4 regulates, independently and in cooperation with other proteins, multiple 
cardiac-restricted promoters including those from the cardiac troponin C (cTnC) (52), atrial 
natriuretic factor (ANF) (29,74,124), brain natriuretic peptide (BNP) (43), myosin heavy chain 
(MHC) (100), the rat troponin I promoter (Tni) (104), and camitine palmitoyltransferase I~ 
(CPT -I~) (98) genes as well as genes from nervous system AI adenosine receptors (A lARs) 
(122). Characterization of the cTnC promoter revealed that the C-terminal zinc finger and 
adjacent basic region ofGATA-4 are necessary for DNA binding, and that theN-terminus 
contains two independent activation domains (92). Several transcription factors including 
Krtippel-like factor, SPl, Nkx2.5(29,74,124), nuclear factor of activated T cells 3 (NAFT3)(92), 
serum response element (SRE) (8) and a multifunctional zinc finger transcription factor (YYl) 
(9) can associate specifically with the C-terminal zinc fingers of GA;: A proteins resulting in 
modulation of transcriptional activation. GATA-4 and GATA-6 also are capable of physically 
interacting with each other in cardiac myocytes (19). GATA-4 is also involved in the regulation 
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of the Mullerian-inhibiting substance (MIS) gene (144). GATA-4 physically associates with 
nuclear receptor SFw 1 which results in the synergistic activation of MIS promoter. GATA-5 has 
been suggested to be a potential transcriptional activator of the ~-myosin heavy chain promoter 
(99) and to regulate the expression ofNkx2.5 which is expressed early in cardiac tissue. GATA-
6 has been shovm to play a specific role in gene expression in lung tissue (90). Interestingly, 
GATA-5, but not GATA-6 also physically associates with Nkx2.5 and together cooperatively 
activates the ANF promoter (29). These data demonstrate that GAIA transcription factors 
physically interact with a number of other transcription factors, which result in modulation of the 
transcriptional activity of tissue-specific target genes. 
Although the function ofGATA-4, -5,-6 in cardiogenesis has been under intense 
investigation, only recently has the role of these factors in the control of intestinal gene 
expression been studied. Gao. et al. (38) showed that GATA-4, -5, and -6 can each activate the 
promoter for the Xenopus i-fabp gene. Fitzgerald et. al. (35) demonstrated a 15-fo1d induction of 
the human LPH promoter using a chicken GATA-6 expression vector. A report by Fang et al. 
(33) showed that all three GATA subfamily members are capable of activating the rat LPH 
promoter. The SI promoter has not been reported to be regulated by GAT A factors, nor has 
interaction between GAIA factors and other transcriptional regulators been defined. 
1.4.3.2. Friend ofGATA-1, and -2 (FOG-l,and -2) cofactors 
Friend of GAIA (FOG) is a recently described family of evolutionarily conserved multi-
zinc finger transcriptional co-factors that bind to GATA factors and modulate GAT A-specific 
activation of target genes during cellular differentiation. Two FOG cofactors have been 
described FOG-I and FOG-2, based on their protein structure and expression patterns (137, 139). 
FOG-2 contains eight zinc fingers (Fig. 7), of which four are of the C2H2 type and four of the 
C2HC type. By comparison, FOG-1 contains nine zinc fingers, with finger eight missing in 
FOG-2. This additional zinc finger is largely responsible for the difference in size between FOG-
I and FOG-2. The zinc fingers are the most conserved domains ofFOG-1 and FOG-2. Like 
FOG-I, FOG-2 shares homology with the Drosophila zinc finger protein, U-shaped, which 
serves as a co-factor for the GATA factor, Pannier, (81) suggesting evolutionar conservation of a 
critical structure/function relationship. 
FOG-1 is highly expressed in parallel with GATA-1 in erythroid and megakaryocytic cell 
lines and in spleen, liver and intestine (151 ). As with GA TA-l, FOG-1 plays a critical roll in 
hematopoiesis. The targeted disruption ofFOG-1 in mice leads to embryonic lethality, with mice 
dying of severe anemia between Ell and E12 (113,150). FOG-1 can either further activate 
(synergy) or repress the GAT A-activation of target genes. FOG-1 also interacts with the 
transcriptional co-repressor C-terminal binding protein-2 (CtBP2), which may be recruited by 
FOG-I to repress gene expression (50). However, FOG-1 can also have an effect on GAT A-I 
activation without CtBP2 (57). FOG-1 co factors are mainly expressed and interact with GA TA-l 
transcription factors. 
FOG-2 is more widely expressed then FOG-1, generally paralleling that ofGATA-4. In 
mice, FOG-2 mRNA is first detected in developing heart and septum transversum at E8.5 
followed by expression in neural epithelium and the urogenital ridge at Ell.5 (81,137,139). At 
El5.5, expression is detected in the developing lung, kidney, and gut (139). In adult mice, FOG-
2 is expressed highly in heart, brain, and testis, and at lower levels in lung, liver, and kidney 
(139). FOG-2 expression in adult small intestine has not been reported. 
As with GATA-4, FOG-2 plays a critical role in cardiogenesis. Mice harboring a targeted 
mutation ofFOG-2 die of congestive heart failure at EI3 with a syndrome of tricuspid atresia. 
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These mice also demonstrate an absent tricuspid valve, a large atrial septum defect (ASD), a 
vertical septum defect (VSD), an elongated left ventricular outflow tract, rightward displacement 
of the aortic valve, and pulmonic stenosis. The molecular mechanism by which FOG-2 
deficiency leads to endocardial defects is unclear (136). 
FOG-2 can cooperate with GATA-4 to activate the MHC promoter in Cos-7 cells, 
whereas FOG-2 inhibits the GATA-4 activation of this promoter using other cell lines. The 
repressor mechanism is also sho\VTI in primary rat cardiomyocytes for the promoters of the ANF, 
BNP and cTnC genes (81,137,139). Interestingly, expression ofFOG-2 repressed the synergistic 
activation of the ANF promoter by GATA-4 and Nkx2.5, reducing the level of activation to that 
ofNkx2.5 alone. These data demonstrate that FOG-2 represses the GATA-4-specific as well as 
cooperative activation of cardiac gene promoters. 
FOG-2 function requires, in part, physical association with GATA-4 as well as specific 
structures that are independent of the protein-protein interaction domains. As with GATA-
1/FOG-1 interactions (151), the N-terrninal zinc-finger ofGATA-4 is required for physical 
association with FOG-2 (137). Indeed, disruption ofGATA-4/FOG-2 interactions through a 
targeted mutation in the N-terrninal zinc finger ofGATA-4 not only interferes with physical 
association and FOG-2-mediated repression in vitro, but also results in tricuspid atresia in vivo 
(22), demonstrating the importance of this physical interaction for cardiogenesis. Indeed, the n-
terrninal zinc finger of mammalian GAIA factors is highly related to the N-terrninal zinc finger 
of Drosophila GAIA factor, Pannier, which has been shown to interact physically with a FOG-
like protein, U-shaped (23,44), suggesting that GAIA-FOG interactions have been conserved 
throughout evolution. Although FOG-2 consists of eight zinc-fingers, zinc fingers 1 and 6 are 
independently capable of physically associating with GATA-4 (135). As with FOG-1, FOG-2 
also contains the conserved CtBP2 terminal domain, and is both necessary and sufficient to 
repress GATA-4-dependent transcription by FOG-2 (135). Although studies on the critical 
importance of FOG-2 for cardiogenesis are beginning to emerge, there are as yet no reports on 
the role ofFOG-2 in intestine. The mechanisms by which FOG co-factors regulate the LPH gene 
expression will be revealed in this thesis. 
1.5 Protein-protein association for the regulation of gene expression. 
Protein-protein association mediated through homeodomain and zinc finger regions 
might be a mechanism to regulate the tissue and cell specific level of abundant gene expression. 
Synergy of a specific gene promoter is defined by a higher transcriptional activation by a 
combination of two or more transcription factors than the additive transcriptional activation of 
these transcription factors individually. A~ [Fl + F2]/([Fl] + [F2]) where A~ total activation, 
[Fl] =activation from transcription factor 1, [F2] =activation from transcription factor 2, and 
[F1 + F2] =activation from transcription factor 1 & 2 together. The ratio of the effects of both 
factors together over the additive effect of individual factors will predict interactions. If A= 1, 
then there is an additive effect; A> 1, synergistic; A< 1, antagonistic. The families of 
transcription factors are members ofhomeodomain and zinc finger families. Members of 
homeodomain and zinc finger families have both been evolutionarily conserved. Moreover, in 
Drosophila, interactions between the zinc finger of Ftz-F 1 a member of the nuclear receptor 
super family and the homeodomain of thefushi tarazu (FTz) protein result in the cooperative 
activation of the engrailed gene (36, 162). Therefore these data suggest that protein-protein 
interaction between zinc-fingers and homeodomains is an evolutionary conserved mechanism of 
gene regulation. 
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The physical interaction betvveen HNF-1 a and other proteins enables these proteins to 
form stable DNA/protein complexes which can facilitate gene transcription. HNF-1a has been 
reported to be necessary for claudin-2 expression in mice and was able to enhance claudin-2 
promoter activity only in the presence ofCdx-2 (123). In addition as mentioned above, Cdx-2 
and HNF-la physically associate and cooperatively activate the pig LPH promoter (89). The 
cooperative activity betvveen Cdx-2 and HNF-1a requires an HNF-1 binding site, but not Cdx-2 
binding sites (89). Also, HNF-la is capable of physically interacting with histone 
acetyltransferases (HATs), CREB-binding protein (CBP), p300/CBP-associated factor (P/CAF), 
Src-1, and RAC3 (129). HNF-la may recruit multiple co-activators which activate transcription 
by coupling nucleosome modification and recruitment of the general transcription machinery. 
HNF-la may therefore be capable mediating chromatin destabilization, which opens the DNA 
strang of target genes in order to enable the transcription machinery to transcribe the codons in 
this open-reading frame. Together, these data suggest that HNF-la has the ability to physically 
associate with diverse proteins, which support nucleosome modification, necessary for gene 
transcription. 
The GATA-4!Nkx2.5 interaction can cause cooperative activation at promoters of 
specific genes, whereas other promoters might be down-regulated by that complex. GATA-4 and 
Nkx2.5 physically associate through the C-terminal zinc finger and basic region ofGATA-4 and 
homeodomain ofNkx2.5 causing a cooperative activation of atrium natriuretic factor (ANF) 
(29,74,124) and cardiac a-actin (aCA) promoters (124). Their models for cooperative activation 
of these promoters suggest that the physical interaction betvveen GATA-4 and Nkx2.5 causes a 
conformational change in Nkx2.5 which opens its activation domains and DNA binding domain. 
These data show a functional co-localization of protein-protein and DNA-binding domains in the 
GATA-4 and Nkx2.5 transcription factors, suggesting a relative equal importance. Although, 
both transcription factors must bind to the DNA for cooperative activation of ANF promoter, the 
cooperative activation of o.:CA promoter requires only Nkx2.5 binding. However, in contrast to 
the cooperative activation of the ANF and aCA promoters, the combination of GA TA-4 and 
Nkx2.5 causes a down regulation of the camitine palmitoyltransferase-I~ (CPT -I~) cardiac 
promoter (98). These data demonstrate that the same GATA-4 and Nkx2.5 complexes 
synergistically activate the ANF promoter but down regulate the CPT -I~ activation, suggesting 
that the cooperative regulation of protein-protein complexes is regulated by promoter specific 
elements. 
The Cdx-2, HNF-1 and GATA-4, -5, and -6 transcription factor families are only 
expressed together in the intestine and have individually demonstrated roles in the regulation of 
intestinal genes, including LPH and SI, transcription. These transcription factors might 
cooperatively regulate these intestinal genes. One report (89) describes the synergy between 
Cdx-2 and HNF-la at the pig LPH promoter. Whether these three transcription factors act in 
concert to regulate the human LPH and SI genes, and the role ofFOG-2 cofactor is unknown, 
and is a focus of this thesis. 
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1.6. SPECIFIC AIMS OF THE STUDY 
As might be concluded from the general introduction about gene regulation, our 
understanding of how transcription factors regulate transcription ofLPH and SI is extensive. 
Both LPH and SI are enterocyte specific membrane anchored enzymes that are necessary for the 
digestion of nutrients present in the specific diets of mammals according to their age before and 
after weaning. Previous work by Grand et. al. has demonstrated that LPH and SI are expressed in 
complex patterns along the vertical, horizontal, and developmental gradient of the small 
intestine. LPH and SI expression patterns coincide with important transitions during small 
intestine development. Furthermore, Krasinski et. al. demonstrated that specific regions in the 
LPH promoter contain the information necessary for the specific patterns of expression. 
Krasinski et. al also demonstrated that the vertical, horizontal, and developmental LPH and SI 
expression patterns are regulated at the level of transcription. Therefore, LPH and SI genes are 
perfect markers for cell differentiation of small intestine. 
Seqeunce analysis of the 5 '-flanking regions ofLPH and SI genes revealed consensus 
binding sites for Cdx-2, HNF-1, and GATA transcription factors. The families of these 
transcription factors have all been indicated to play a role in cell differentiation and 
morphogenesis. These transcription factors are turned on in early stages of intestinal 
development, are only expressed together in the small intestine, and their binding sites are in 
close proximity to each other and the TAT A-box regions suggesting that they play an important 
role in cell differentiation and intestine specific gene regulation. The close proximity of these 
binding sites to each other and the fact that these transcription factors have been shown 
individually to cooperate with comparable proteins for the regulation of gene expression, it is 
hypothesized that these factors act in concert to regulate LPH and SI transcription. 
Therefore, the aims of this study were: 
-To define the independent and cooperate function among Cdx-2, HNF-1, and GAIA 
transcription factors in the regulation of LPH and SI gene expression. 
-To define the importance ofCdx-2 and its binding sites in the LPH 5' -flanking region. 
A. Effect of a Cdx-2 consensus binding site overlapping the TAT A-box ofLPH gene. 
B. Effect ofnon-Cdx-2 protein binding at CE-LPHla on the LPH gene expression. 
-To define the mechanism of GATA-5 and HNF-la functional synergy at the LPH 
promoter in vivo. 
-To detennine the mechanism of differential control ofLPH transcription by individual 
members of the GATA transcription factor family 
-To define the function ofFOG-1 and 2 in regulating the GAT A-mediated expression of the 
LPH gene in the absence and presence ofHNF-la. 
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ABSTRACT 
The effects ofGATA-4, -5, and -6, HNF-la and~, and Cdx-2 on the rat and human 
lactase-phlorizin hydrolase (LPH) and human sucrase-isomaltase (SI) promoters were studied 
using transient transfection assays in Caco-2 cells. GATA factors and HNF-la were strong 
activators of the LPH promoters, whereas HNF-la and Cdx-2 were strong activators of the SI 
promoter, although GATA factors were also necessary for maximal activation of the SI gene. 
Co-transfection of GATA-5 and HNF-1 a together resulted in a higher activation of all three 
promoters than the sum of the activation by either factor alone, demonstrating functional co-
operativity. In the human LPH promoter, an intact HNF-1 binding site was required for 
functional synergy. This report is the first to (a) demonstrate differential activations of the LPH 
and SI promoters by multiple transcription factors co-transfected singly and in combination, and 
(b) show that GATA and HNF-1 transcription factors co-operatively activate intestinal gene 
promoters. Synergistic activation is a mechanism by which higher levels of tissue-specific 
expression might be attained by overlapping expression of specific transcription factors. 
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INTRODUCTION 
Absorptive enterocytes originate from undifferentiated, multipotent stern cells located 
near the base of small intestinal crypts (20). Through a continuous process of cell division, 
migration, differentiation, apoptosis, and exfoliation, these cells are renewed every 3-5 days. 
Absorptive enterocytes comprise over 95% of mucosal cells on small intestinal villi and are 
responsible for the terminal digestion and absorption of nutrients. To carry out these specialized 
functions, absorptive enterocytes acquire a differentiated phenotype characterized by the 
expression of functionally relevant proteins such as digestive enzymes, receptors, transporters, 
and cytoplasmic carriers. Differences in the panel of genes expressed along the proximal-to-
distal (horizontal) axis result in regional differences in intestinal function. The mechanisms that 
underlie the process of intestinal differentiation are poorly understood. 
Analysis of the effects of specific transcription factors in the regulation of absorptive 
enterocyte-specific differentiation can be studied by the use of marker genes whose expression 
parallels that of key events in the differentiation process. Lactase-phlorizin hydrolase (LPH) and 
sucrase-isomaltase (SI) are intestinal disaccharidases that are expressed in villus enterocytes and 
display a differentiation-specific pattern of expression. The LPH and SI genes are similarly 
expressed in jejunum and proximal ileum, but demonstrate different patterns during 
development. LPH gene expression is highest in newborn mammals and declines during 
weaning, whereas SI gene expression is low or undetectable at birth and increases to adult levels 
during weaning. In most humans, LPH expression declines, similar to that in other mammals, but 
in a subpopulation of humans, LPH expression remains high throughout adult life. Previous work 
in our laboratory have shuwn that the developmental pattern of lactase activity in rats (8) and the 
genetic pattern in humans (14) is correlated with the abundance of its mRNA, and also that the 
horizontal and developmental patterns ofLPH expression in rats are transcriptionally regulated 
(32). It is now widely accepted that LPH expression is controlled mainly by the rate of gene 
transcription. 
Studies in transgenic mice indicate that the 5'-flanking regions of both the LPH and SI 
genes direct transgene expression to villus epithelium (33, 40, 41, 64, 68). Analysis of published 
sequence reveals that the LPH (6, 71) and SI (9, 63, 73) genes contain GATA, HNF-1, and Cdx-
2 consensus binding sites in their 5'-flanking regions (Fig. 1). These transcription factor families 
have all been shown to influence the regulation of cellular differentiation. Since GA TA, HNF-1, 
and Cdx-2 factors are expressed contiguously only in intestinal epithelium, and since their 
cognate binding sites in the LPH and SI genes are adjacent to the TAT A-box and to each other, 
we hypothesized that these transcription factors together are important regulators of LPH and SI 
gene expressiOn. 
The GAIA family of zinc finger proteins, defined by a highly conserved DNA-binding 
domain that interacts specifically with DNA elements containing a consensus WGATAR 
sequence (W =A or T; R =A or G), has been implicated in cell lineage differentiation during 
vertebrate development. GATA-1, -2, and -3 are expressed in developing blood cells during 
hematopoiesis, whereas GATA-4, -5, and -6 are expressed together only in cardiac tissue and 
small intestine, but individually, or in overlapping patterns in stomach, liver, lungs, spleen, 
ovary, testis, and bladder (3, 29, 36, 50, 51). In both mouse (3) and chicken (18) intestine, 
GATA-4 transcripts are distributed all along the villus, with increasing levels accumulating 
toward the villus tips. 
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GATA HNF-1 GATA Cdx-2 
" ,--, ,--, 
rLPH 5'-TATCTATCCTAGATAACCCAGTTAAATATTGTGTGGATAATCACTATGTTTTACAGCCTTGGCTGTGCTCATAAAGTTAGG-3' 
hG1 hH hG2 
GATA HNF-1 GATA Cdx-2 
" " ;--; hLPH 5'-ATCATAGATAACCCAGTTAAATATTAAGTCTTAATTATCACTTAGTATTTTACAACCTCAGTTGCAGTTATAAAGTAAGGG-3' 
3'-AATAGT-5' --
hSIF2 hSI/G hSIF1 
HNF-1 GATA Cdx-2 Cdx-2 
" ;--; ;--; hSI 5'-TGTATGTTGAGCAGAAGATTATTAAACACTGATAGGCTGGTGAGGGTGCAATAAAACTTTATGAGTAGGTCAATATATAC-3' 
3'-TATTT-5' 
-100 -90 -80 -70 -60 -50 -40 -30 -20 
Fig. 1. The -100 to -20 bp regions of the rat LPH (rLPH), human LPH (hLPH), and human SI (hSI) 5'-
flanking sequence contain binding sites for GATA (WGATAR; W =A or T, R =A or G), HNF-1 
(GTTAATNATTAAC; N =A, C, G, or T), and Cdx-2 (TTTAY; Y =A or T) transcription factors (indicated 
in italics above the DNA sequence). In the human and rat LPH genes, rG1 and hG 1 are the 5' GAT A sites whereas 
rG2 and hG2 are the 3' GATA sites. The 3' GATA site in rLPH is indicated with a question mark(?) because it is not 
a true 6-base consensus. The hG1 site is the lactase upstream element (LUE) characterized previously using GATA-
6 (17). hSVG refers to the GATA site in the human SI gene. rH and hH are the HNF-1 consensus sites that 
correspond to CE-LPH2c in the pig LPH gene (59). rC and hC are the CE-LPHla sites that bind Cdx-2 (7, 16, 22, 
53, 65, 66). The HNF-1 (hSIF2 & hSIF3) and Cdx-2 (hSIFl) binding sites in the human SI gene have been 
previously characterized (60, 72). The TAT A-boxes are underlined. 
In chicken intestine (18), GATA-5 mRNA is localized to differentiated cells of the villi, whereas 
GATA-6 transcripts are localized to cells ofthe upper crypt and lower villus. Mice homozygous 
for the GATA-4 (35, 48) or GATA-6 (31, 52) null allele die in utero and therefore provide little 
information regarding maintenance of intestinal differentiation in adults. GATA-5 knockout 
mice survive and reproduce despite pronounced genitourinary abnormalities in females (49), but 
show no gross abnormalities in intestinal structure or histology (intestinal gene expression was 
not reported). Recent studies have suggested that GATA-4, -5, and -6 may modulate the 
expression of intestinal genes (15, 17, 18). Gao et al. (18) showed that GATA-4, -5, and -6 can 
stimulate directly the activity of the promoter for the Xenopus intestinal fatty acid binding 
protein (1-FABP) gene. Fitzgerald et al. (17) demonstrated a 15-fold induction of a human LPH 
promoter-reporter construct using a chicken GATA-6 expression vector. Fang et. al. (15) showed 
that all three members of this subfamily are capable of activating the rat LPH promoter. Two 
potential GAT A-binding sites are present in the rat and human LPH genes (Fig. 1), although the 
31 site in the rat LPH gene contains only 5 ofthe 6-bp consensus. The human SI gene contains a 
single putative GATA motif within 100 bp 5' to the transcriptional start site, the characterization 
of which has not yet been reported. 
HNF-1 transcription factors contain a novel DNA-binding homeodomain distantly related 
to the POU domain and bind as dimers to the consensus sequence, GTTAATNATTAAC (42, 
67). Two members of this family, HNF-la and HNF-1~, have been described and share highly 
homologous DNA binding domains, but divergent activation domains (43, 55). Originally 
thought to be liver-specific, these tvvo proteins are also expressed in kidney, stomach, and small 
and large intestine (5, 34, 43). HNF-1~ is also expressed in lung and ovary (43). In mouse small 
intestine, HNF-la and HNF-1~ mRNAs are expressed at high levels in crypt cells and 
expression is gradually reduced until there are low levels at the villus tips (58). Reports of mice 
lacking HNF-la gave variable results (1, 38, 54) including sterility, liver enlargement, renal 
dysfunction, non-insulin-dependent diabetes mellitus, and reduction in the expression of certain 
liver genes such as albumin, a:l-antitrypsin, phenylalanine hydroxylase, and liver fatty acid 
binding protein (L-FABP). The effect ofHNF-la gene disruption on gastrointestinal function 
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has not been described. HNF -1 B knockout mice have a disorganized visceral endoderm and die 
at embryonic day 7.5 (4, 11). In addition to regulating the expression of liver genes, HNF-1 
factors also modulate genes that are expressed only in small and/or large intestine, including 
LPH (59), SI (72), and guanylin (23). In the pig LPH gene, mutational analysis in cotransfection 
experiments localized an HNF-la-mediated response to an HNF-1 binding site within 227 bp of 
the transcriptional start site (called CE-LPH2c) (59), which is conserved in position in the human 
(-90 to -70 bp) and rat (-86 to -66 bp) LPH genes (Fig. 1). The human SI promoter has two 
HNF-1 binding sites, SIF2 ( -90 to -70 bp) and SIF3 (-176 to -159 bp ), that interact with both 
HNF-lo: and HNF-1~ (72). These two family members, which can form homodimers as well as 
heterodimers, differentially activate both the LPH and SI promoters (59, 72) suggesting that the 
relative abundance ofHNF-1 isoforms may be important for the regulation of genes with HNF-1 
binding sites. 
Cdx-2, a homeodomain-containing transcription factor that binds to the consensus, 
TTTAY (Y =A or C), is highly expressed in adult mammalian small intestine and colon, and is 
also detectable in pancreas (19, 25, 26, 60). In mouse small intestine, Cdx-2 is expressed in all 
epithelial cells in both crypts and on villi, with the exception ofPaneth cells at the base of crypts 
(24). Mice heterozygous for a Cdx-2 null mutation develop adenocarcinoma of the small 
intestine and colon, whereas homozygote null mutant embryos die between 3.5 and 5.5 days post 
coitum (10). Cdx-2 has been shown to induce differentiation in IEC-6 cells, suggesting a role in 
cellular differentiation (61). Cdx-2 has also been showu to bind and activate the LPH (7, 16, 22, 
53, 65, 66) and SI (60) genes via conserved cis-elements called CE-LPH!a and S!Fl, 
respectively, both of which are adjacent to their TATA boxes (Fig. 1). CE-LPH1a contains a 
single binding site whereas SIFl contains two adjacent sites on opposite strands. Additional 
Cdx-2 binding sites, CE-LPH!b (59) and CE-LPH-lc (47), have been identified in the pig LPH 
gene. 
At present, the relative importance ofGATA-4, -5, and -6, HNF-lo: and~, and Cdx-2 on 
LPH and SI gene expression, and possible species differences between rat and human LPH gene 
expression have not been characterized together under the same experimental conditions. 
Further, possible interactions among these transcription factors have only recently been 
examined. Michelmore et al. (47) have demonstrated that HNF-la and Cdx-2 physically interact 
and co-operatively activate the pig LPH promoter. In the present study, we demonstrate for the 
first time that GAIA, HNF-1, and Cdx-2 transcription factors regulate the LPH and SI promoters 
differently, and that GATA-5 and HNF-lo.: synergistically activate these promoters. 
MATERIAL AND METHODS 
Chemicals and reagents. All chemicals were purchased from Sigma Chemical Company 
(StLouis, MO), Gibco-BRL (Gaithersburg, MD) or Fischer Scientific (Fair Lawu, NJ) unless 
indicated othenvise. Enzymes were purchased from Gibco-BRL, Promega Biotec (Madison, WI) 
or Pharmacia Biotech (Piscataway, NJ) unless indicated otherwise. Radioactive nucleotides and 
14C chloramphenicol were purchased from DuPont-New England Nuclear (Boston, MA). 35S 
methionine (Redivue™) was purchased from Amersham Life Science {Arlington Heights, IL). 
Plasmids. The human growth hormone gene was used as a reporter in transfection assays. 
As described previously (33), the human growth hormone gene was subcloned into pBluescript 
II KS+ (Stratagene, La Jolla, CA). This construct, referred to as bluescript growth hormone 
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(BSGH), served as a promoterless control for background and the basic construct into which all 
promoter sequences were subcloned. Sequence from the rat LPH (rLPH) gene (-2038 to +15 bp) 
was isolated (71) and subcloned into BSGH 5' to the human growth hormone reporter as 
previously described (33). A segment of the human LPH (hLPH) gene (-1025 to +II bp) was 
amplified by PCR from human DNA isolated from discarded jejunum of patients undergoing 
elective gastric bypass surgery. The 5' (5'-
ATGGGTACCAAGATACTTATTATAGGAAGAGGA-3') and 3' (5'-
ATCTAAGCTTTTTCTAGGAACTGTTAGGAGG-3') primers, designed from published 
sequence (6), contain Kpn I and Hind III sites, respectively (underlined), to facilitate subcloning 
into BSGH. A segment of the human SI (hSI) gene (-183 to +54 bp, gift of Dr. P. Traber, U. 
Penn.) (73) was also amplified (5'-ATGGGTACCTGACAGTACAATTACTAATTAAC-3 and 
5'-ACGTAAGCTTAGCCTGTTCTCTTTGCTATG-3) and subcloned into BSGH. Deletions and 
mutations of all other rat LPH, human LPH, and human SI promoter-reporter plasmids were 
constructed by PCR using the same Kpn I-Hind III strategy. Mutations were introduced into 
primer and template oligonucleotides. All constructs were confirmed by sequencing. 
The Reus sarcoma virus (RSV) promoter and the enhancer sequence within its long 
terminal repeat were fused to the chloramphenicol acetyltransferase (CAT) gene (called 
RSVCAT) and used to control for transfection efficiency (21 ). The RSV promoter without the 
enhancer sequence (21) was fused to the human grovvth hormone gene (called RSVdE) and used 
as a control promoter-reporter construct in co-transfection experiments. This promoter does not 
contain GATA, HNF-1, or Cdx-2 binding sites. 
Previously characterized expression vectors for mouse GATA-4 (35), GATA-5 (51), and 
GATA-6 (50) (gifts ofM. Parmacek, U. Penn.), mouse HNF-Io: (34) and HNF-1~ (43) (gifts of 
G. Crabtree, Stanford), and mouse Cdx-2 (60) (gift ofr. Traber, U. Penn.) were employed in the 
present study. The GATA and Cdx-2 expression vectors were constructed from pcDNA3 
(Invitrogen, Carlsbad, CA) and pRC-CMV (Invitrogen), respectively, both of which contain 
cytomegalovirus (CMV) promoters. The HNF-1 expression vectors were constructed from pBJ5, 
which contains the SRo: (human T celllymphotropic virus type 1) promoter. pRC-CMV 
(Invitrogen) served as a negative control expression vector for all co-transfection experiments. 
All expression vectors were authenticated by supershift EMSAs using extracts from transfected 
cells, as described below. 
Cell culture and transfections. The Caco-2 cell line was the principal cell line used in the 
present study. Originally derived from a human colon adenocarcinoma, Caco-2 cells differentiate 
upon confluence exhibiting characteristics of small intestinal absorptive enterocytes, including a 
microvillus membrane and expression of small intestinal genes. The Caco-2 cells used in the 
present study have been previously characterized with respect to LPH and SI expression (69). 
All cells were grown in Dulbecco's modified Eagle's medium (Bio Whittaker, 
Walkersville, MD) supplemented with 5 !J.g of penicillin-streptomycin per ml and containing 
I 0% fetal calf serum. Cells at 80-95% confluence were collected by trypsinization, and aliquots 
were transfected using 10 ).lg of the promoter-reporter constructs, and, when indicated, 8.0 !lg of 
expression vector and 1.0 ).lg of RSVCAT as a control for transfection efficiency. pBluescript II 
KS+ (Stratagene) was added as a carrier (total DNA/transfection=35 !J.g). Transfections were 
carried out by electroporation (Pulse Controller II, Bio-Rad, Hercules, CA) at 300 volts and 950 
f!F in cytomix buffer (240 mM KCl, 0.3 mM CaClz, 20 mM HPO.IKH2P04 pH 7.6, 50 mM 
HEPES pH 7.6, 4 mM EGTA pH 7.6, 10 mM MgCJ,) supplemented with fresh glutathione (3.08 
mg/ml). After transfection, cells were plated at 75-90% confluence in 6-well plates. Media were 
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replaced after 24 h, and cells were harvested after 48 h (i.e., 24 h after the last media change). 
All plates were confluent at the time of harvest. 
The amount of human growth hormone secreted into the media over a 24 h period was 
used as an indicator of transcriptional activity. The concentration of human growth hormone was 
measured using an 1251 immunoassay kit (Allegro hGH, Nichols Institute, San Juan Capistrano, 
CA). To analyze CAT activity, celllysates were prepared by freeze-thaw cycling, and the protein 
concentration of the supernatant was determined by a Coomassie protein assay (Pierce, 
Rockford, IL). CAT activity was measured in celllysates as described (56). Transcriptional 
activity was expressed as total human growth hormone secreted into the media over 24 h relative 
to total CAT activity in celllysates (expressed as mg hGH!Unit CAT activity). The 
transcriptional activity ofBSGH was subtracted from all other constructs to correct for 
background. 
Nuclear extracts. Nuclear extracts were isolated from confluent cells grown on 1 0-cm 
plates directly (untransfected), or after transfection of specific expression vectors. For 
transfected cells, 8 ~g of expression vector were transfected as described above, and two 
transfection reactions were combined on 1 0-cm dishes. Nuclear extracts were prepared by a 
modification of published methods (2). Cells were harvested by scraping, and resuspended in 
ice-cold buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM 
DTT, 0.5 m1Y1 PMSF), incubated on ice for 10 min, and lysed by vortexing for 10 s. Nuclei were 
pelleted in a microcentrifuge for 10 s at full speed and extracted in 100 ~1 of buffer C (20 m1Y1 
HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.5 mM PMSF) for 20 
min on ice. The resulting lysate was cleared of cellular debris by centrifugation for 15 min, and 
stored as a nuclear extract at -80°C. The protein concentration was determined as described by 
Kalb and Bemlohr (28) 
In vitro transcription-translation. Labeled ess methionine) and unlabeled proteins were 
synthesized using a reticulocyte lysate transcription-translation system (TNT, Promega) 
according to the manufacturers instructions. Since all expression vectors contain a T7 DNA-
dependent, RNA polymerase site bet\veen the viral promoter and the eDNA insert, a T7-based 
TNT system was employed. However, since in vitro transcription of the GATA-5 expression 
vector using a T7 polymerase transcription-translation system was inefficient, and since the 
GATA-5 coding region could not be amplified by PCR, a 1.5 kb Sma 1-Eco RV fragment 
containing the GATA-5 coding region was subcloned into the Sma I site ofpGEM-7Zf(-), and 
plasmids whose orientation enabled correct transcription from the SP6 polymerase site were 
isolated (screened by restriction digests, confirmed by sequencing). GATA-5 was efficiently 
synthesized from this plasmid using an SP6 TNT system. 
EMSAs. Oligonucleotides used as probes and competitors in EMSAs are shown in Fig. 2. 
Probes were made by annealing a 1 0-fold molar excess of 10 or 11 base reverse strand 
oligonucleotide to the forward strand by boiling for 2 min in annealing buffer (100 m1Y1 NaCl, 10 
mM Tris, pH 8.0, 1 mM EDTA), then slow cooling for 2 h (< 32'C). The annealed 
oligonucleotides were extended with the large fragment of DNA polymerase I (Klenow) in the 
presence of 32P dATP in extension buffer (50 mM Tris, pH 8.0, 10 mM MgC!,, l mM DTT) for 
1 hat37'C. 
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Name Sequence 
Oligonucleotides containing GATA binding sites: 
xiFABP/G 5' -GGAGATCCCTGTACAGATATGGGGAGAC-3' 
rG1 5 1 -TCTATCCTAGATAACCCAGTTAAA-3' 
rG2 5'-TATTGTGTGGATAATCACTATGTT-3' 
hGl 5 I -GTGATCATAGATAACCCAGTTAAA-3 I 
hG 1m 5'-GTGATCAgctcgAACCCAGTTAAA-3' 
hG2 5 I -ATACTAAGTGATAATTAAGACTTA-3' 
hG2m 5'-ATACTAAGTGAgAATTAAGACTTA-3' 
hSI/G 5 I -TTAAACACTGATAGGCTGGTGAGG- 3 I 
Oligonucleotides containing HNF-1 binding sites: 
r~-Fib/H 5' -CAAACTGTCAAATATTAACTAAAGGGAG-3' 
rH s, -AACCCAGTTAAATATTGTGTG-3' 
hH 5'-AACCCAGTTAAATATTAAGTC-3' 
hHm 5' -AACCCAGgTAAATAgTAAGTC-3' 
hSIF2 5 I -GCAGAAGATTATTAAACACTG- 3 I 
hSIF3 5 I -AGTACAATTACTAATTAACTT-3 1 
Oligonucleotides containing Cdx-2 binding sites: 
rC 5' -ATGTTTTACAGCCTTGGCTGT-3' 
hC 5' -TATTTTACAACCTCAGTTGC-3' 
hSIFl 5' -GGGTGCAATAAAACTTTATGAGTA-3' 
Oligonucleotide containing multiple binding sites: 
hG1H 5' -GTGATCATAGATAACCCAGTTAAATATTAAGTC-3' 
Localization (bp) 
x!FABP, -57 to -30 (18) 
rLPH, -98 to -75 
rLPH, -74 to -51 
hLPH, -103 to -80 
hLPH, -53 to -76 
hSI, -79 to -56 
r~-Fib, -102 to -75 (12) 
rLPH, -86 to -66 
hLPH, -90 to -70 
hSI, -90 to -70 
hSI, -179 to -159 
rLPH. -55 to -35 
hLPH, -55 to -36 
hSI, -57 to -34 
hLPH, -103 to -70 
Fig. 2. Oligonucleotides used as probes and competitors in EMSAs. The names used in the present study, 
specific sequences, and localization in their respective genes are indicated. Binding sites are in bold. An "m" 
indicates a mutation introduced into the binding site and the mutation itself is shown in lower case letters. 
xiF ABP/G and r~-Fib/H are previously characterized probes for binding of GATA (18) and HNF-1 (12) factors, 
respectively. 
After removing an aliquot for specific activity determinations by TCA precipitation, the labeled 
probe was separated from the short antisense oligonucleotides using a spin column with a 12 
bose cutoff(STE Select-D G-25, 5 Prime-3 Prime, Inc, Boulder CO). Purified probes were stored 
at ~20°C The specific activity of all probes exceeded 107 cpm/pmol. Competitors were 
synthesized by annealing equimolar amounts of full-length sense and antisense oligonucleotides 
as described above. 
EMSAs were carried out using 10,000 cpm of probe, 5 )lg of protein from nuclear 
extracts, 1.0 11g poly di:dC-poly di:dC, and 2 )lg bovine serum albumin in EMSA reaction buffer 
(25 rnM Tris, pH 8.0, 50 rnM KCl, 5 mM MgC!,, 0.5 rnM EDTA, 8% glycerol) unless indicated 
otherwise. These conditions resulted in maximal specific binding and minimal non-specific 
binding as determined by competition EMSAs and supershifts. After a 20 min incubation at 
room temperature, the reaction was run on a 5% non-denaturing polyacrylamide gel at constant 
voltage for 1-2 h. The gel was dried and exposed to film. Competitors and antibodies were 
preincubated with the nuclear extract for 10 min prior to the addition of the probe. The Cdx-2 
antibody was a gift from Dr. D. Silberg (University of Pennsylvania) and was previously 
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characterized (60). All other antibodies were purchased from Santa Cruz Biochemicals (Santa 
Cruz, CA) as the concentrated gel shift stock. 
RT-PCR. RNA was isolated from Caco-2 cells grown on 6-well plates using TRizol 
Reagent (Gibco-BRL) according to the manufacturers instructions. To synthesize first strand 
eDNA, purified RNA was annealed to oligo dT and extended with Superscript II (Gibco-BRL) 
according to the manufacturers instructions. PCR was carried out on the first strand eDNA using 
the following oligonucleotides: human LPH (5'-GTCCCACTACCGTTTTTCCA-3', 5'-
CGTCTGTGGTAGGTCCCAGT-3'), human SI (5'-CTCTCCATCGGTCTTTCCAA-3', 5'-
AGAAGGCTCTGGGAGGTGTT-3'), human glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH; 5'-GGGTCATCATCTCTGCCCCCTCTG-3', 5'-
CCATCCACAGTCTTCTGGTGGCA-3'), and mouse GATA-5 (5'-
GCCTCTTCTCCCACTCTCCT-3', 5'-GTAGGACCCCACTGAGACCA-3'). After an initial 
melting step at 95°C for 2 min, the oligonucleotides were annealed to the eDNA template at 55°C 
for 40 s, extended at 72°C for 60 s, and melted at 95°C for 20 s. After 30 cycles, the reaction was 
extended for 10 min at 72°C, then cooled to 4°C. The amplification products were analyzed on 
1.8% agarose gels stained with ethidium bromide. 
Statistics. The t test or the one-way analysis of variance (ANOVA) was employed in all 
statistical analyses using InStat software (Graphpad Software, Inc., San Diego, CA). The 
Dunnett's or Tukey multiple comparison test was employed for all statistically significant 
AN OVA analyses. 
RESULTS 
Characterization of individual effects of transcription factors on the LPH and Sf 
promoters. The individual effects of multiple transcription factors on the LPH and SI promoters 
have not been compared under the same experimental conditions. Thus, transient co-transfection 
assays in Caco-2 cells were carried out using individual expression vectors for each of the 
transcription factors under study. As sho\VTl in Fig. 3A, GAIA factors are capable of activating 
the LPH and SI promoters. Transcriptional activities of promoter-reporter constructs were 
increased when co-transfected with expression vectors for GATA-4, GATA-5, or GATA-6 as 
compared to that with pRC-CMV, a plasmid containing only the CMV promoter. GAT A-
stimulated transcriptional activities were higher for constructs that contain consensus GAIA 
binding motifs in their promoters (i.e., rLPH108, rLPH2038, hLPH118, hLPHl025, and hSII83). 
Activation was generally strongest with the GATA-5 expression vector demonstrating 
statistically significant increases from pRC-CMV controls for rLPH108, rLPH2038, hLPHll8, 
and hSI183 (see Fig. 3A for P-values). Transcriptional activities of the basal promoter 
constructs, rLPH37 and hLPH37, and the negative control promoter-reporter construct, RSVdE, 
co-transfected with the GATA expression vectors revealed minimal responses, although all were 
significantly increased over the pRC-C:M:V controls with GATA-5 co-transfection (P < 0.01 for 
each). These data demonstrate that GATA-family transcription factors activate the LPH and SI 
promoters, consistent with previous reports for LPH (15, 17). Activation of the SI promoter by 
GATA-5 has not been previously reported. 
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Fig. 3. GATA, HNF~l, and Cdx-2 transcription factors 
individually activate the LPH and Sl promoters in 
transient co-transfection assays in Caco-2 cells. Regions 
of the rat LPH (rLPH), human LPH (hLP H), and human SI 
(hSI) Y-flanking sequences (indicated by the number of 
bases 5' to the transcriptional start site) fused to the human 
growth hormone reporter were co-transfected with 
individual expression vectors into Caco-2 cells as 
described in MATERJALS AND METHODS. Expression 
vectors are indicated in the boxes. A: co-transfection with 
GATA-4, -5, and -6 expression vectors. B: co-transfection 
with HNF-1 a and j3 expression vectors. C: co-transfection 
o+---r""'-r~~"""'-,-""''!.J::J~,J-"'-~~ with the Cdx-2 expression vector. pRC-C:MV was used as 
i' a negative control expression vector, and RSVdE, which 
«<f?' does not contain GATA, HNF-l, or Cdx-2 binding sites, 
was used as a negative control promoter-reporter 
construct. 
Transcriptional activity (mean± SEM, n = 4) is expressed as total human grovvth hormone secreted into the media 
over 24 h relative to total CAT activity in celllysates per well (mg hGH/Unit CAT activity). Significant differences 
from the pRC-CMV controls are indicated: *P < 0.05, **P < 0.01. 
HNF-la was also capable of activating the LPH and SI promoters (Fig. 3B). For all constructs 
that contain HNF-1 binding motifs in their promoters (i.e., hLPH108, rLPH2038, hLPH118, 
hLPH1025 and hSI183), mean transcriptional activities with HNF-la co-transfection were 
significantly greater than that with pRC-CMV (P < O.Dl for each). The hLPH37 and rLPH37 
constructs were also significantly increased with HNF-la co-transfection (P < 0.05). The 
transcriptional activities after HNF-1~ co-transfection were not significantly greater than the 
unstimulated controls, although mean values were always higher. These findings are consistent 
with previous reports that demonstrate activation of both the LPH and SI promoters by HNF-la 
(46, 59, 72) 
Cdx-2 was also capable of activating the LPH and SI promoters (Fig. 3C). The 
transcriptional activities of the rLPH108 (P < 0.001), hLPH118 (P < 0.001), and hSI183 (P < 
0.01) constructs, all of which contain Cdx.-2 binding sites, were significantly increased from the 
pRC-CMV controls when the Cdx-2 expression vector was co-transfected. Activation of the LPH 
and SI promoters by Cdx-2 has been well characterized (16, 60, 65). 
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Differences among the rat and human LPH and human SI promoters were determined by 
comparing the transcriptional responses (fold change over baseline) for rLPH108, hLPH118, and 
hSI!83 (Table 1). 
:;:=====:==:=::;===;:::;;:;::=~==;::~::;:=;:;:====;:;:::=::;== Table 1. Transcriptional responses of LPH 
and SI promoter-reporter constructs co-
transfected with expression vectors in Caco-2 
cells. Values are mean (± SEM) transcriptional 
response (n = 4), expressed as fold change over 
baseline (transcriptional activity expression 
vecto/transcriptional activity pRC-CJIAV ). 
Transcriptional responses ofrLPH108, 
Expression vector rLPH108 hLPH118 hSI183 
GATA-4 18.6±3.1* 28 ±4.4! 2±0.3*:): 
GATA-5 36.5±7.1* 53.7 ± 10.2t 5.3±0.7*t 
GATA-6 22.4 ±4.2*") 10 ±2* 1.6±0.51 
HNF-1a 16 ± L3* 31.4±2.6't 13.5±21 
HNF-1B 3.2±0.8 2.4 ±0.6 2.4±0.1 
--"'='------'-'----'-'-----'"'----''---==-- hLPH118, and hSI183 to each of the expression Cdx-2 5.3±0.5 10.9 ± 1.4 9±1.7 
vectors were compared. 
Values with the same symbol in each row are significantly different; *P<0.05, tP<O.Ol, tP<O.OOl. 
These constructs were chosen because they contain all of the GATA, HNF-1, and Cdx-2 binding 
sites under study, but little additional sequence. With GATA-4 and GATA-5 co-transfection, the 
transcriptional responses of the rLPHl 08 and hLPH118 were each significantly greater than that 
ofhSI!83 (see Table I for P values). With GATA-6 co-transfection, the transcriptional response 
forrLPHI 08 was significantly greater than either hLPH118 (P < 0.05) or hS1!83 (P < 0.01 ). 
With HNF-la co-transfection, the transcriptional response for hLPH118 was significantly 
greater than either rLPHI 08 (P < 0.05) or hSI183 (P < 0.0 I). Data from this table demonstrate 
that the three promoters respond differently to individual transcription factors. 
To characterize binding site affinities, competition EMSAs were carried out using test 
probes for GATA (x!FABP/G), HNF-1 (r~-Fib/H), and Cdx-2 (hS!Fl), and titrations of specific 
competitors for each of the binding sites under study (Fig. 4). Competition for GATA-5 (Fig. 
4A) was apparent and similar for the 5' GATA sites in the rat and human LPH gene (rG1 and 
hG,, respectively), the 3' GATA site in the human LPH gene (hG,), and the GATA site in the 
human SI promoter (hSI/G). The 3' GATA site in the rat LPH gene (rG,), which contains only 5 
of the 6-base consensus, demonstrated minimal competition (lanes 7-9) similar to that of the non-
specific control (lanes 22-24). The specific competitor (lanes 19-21), x!FABP/G, showed the 
most efficient competition, even though this sequence also contains only 5 of the 6-base 
consensus (although different from that ofrG2). 
Competition for HNF-la (Fig. 4B) and Cdx-2 (Fig. 4C) transcription factors were 
highest using binding sites from the human SI promoter (hSIF3 and hSIFI, respectively) as 
compared to the HNF-1 (rH and hH) and Cdx-2 (rC and hC) binding sites in the LPH promoters. 
Comparison of the two HNF-1 binding sites in the SI promoter (hSIF2 and hSIF3) demonstrated 
that HNF-1 has a higher affinity for hSIF3 than hSIF2, as previously reported (72). 
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Fig. 4. GATA, HNFwl, and Cdx-2 
A GATA binding sites in the rat LPH, human 
Competitor 
" Antibody ;-:.:-=--"'-"'~'-=~"'-'c=""-""'='--"''='-=="'-===' 
LPH, and human SI genes demonstrate 
different affinities in protein-DNA 
interactions. A: using xiFABP/G as a test 
probe for GAT A binding (lane 1) and 
reticulocyte lysates (5 ).1!) enriched in 
mouse GATA-5 (TNT, Promega) (lanes 2-
24), competition EMSAs were carried out 
using 20-, 50-, and 200-fold molar excess 
of double-stranded oligonucleotides 
containing the putative GATA sites under 
study (lanes 4-18). Specific (S) and non-
specific (NS) titrations were carried out 
C Cdx-2 rc hC hStFJ., withxiFABP/G(lanes 19-2l)andhSIF2 
competitor-- ..2:::::] ~ ~Ns (lanes 22-24), respectively. for 
comparison. A supershiftcomplex (SC) 
with a GATA-5 antibody (lane 3) 
td demonstrated that the main complex 
" (arrowhead) is authentic GATA-5. Other 
complexes, which also specifically 
competed and supershifted, are indicated 
with an asterisk(*). B: using the r~-Fib/H 
oligonucleotide as a test probe for HNF-1 
binding and nuclear extracts (5 !lg) from 
12 3 4 s e 7 s 91o1112 Hep-G2cells.whichareenrichedinHNF-
l. competition of the HNF-1 
complex (arrowhead, lane l) was carried out using 10-, 50-, and 200-fold molar excess of oligonucleotides 
containing the HNF -1 binding sites under study (lanes 4-15). The specific (S) and non-specific (NS) competitors 
(r~-Fib/H and hSIFl, respectively) were added at 200-fold molar excess. C: using the hSIFl site as a test probe 
(lane 1) and nuclear extracts from Colo-DM cells (lanes 2-12), which are enriched in Cdx-2, competition of the 
Cdx-2 complexes A and B (lane 2) were carried out using 20-, 100-, and 500-fold molar excess of competitors 
(lanes 3-11). The non-specific competitor (NS) was hSIF3 and was added at a 500-fold molar excess (lane 12). 
Combined effects of transcription factors on LPH and Sf expression. To characterize the 
combined effects of multiple transcription factors, and to identify possible functional interactions 
among transcription factor families, co-transfection experiments were carried out using all 
possible combinations ofGATA-5, HNF-la:, and Cdx-2. These transcription factors were chosen 
because they were either strong activators (GATA-5 and HNF-la:) or the only member (Cdx-2) 
of the transcription factor families under study. Further, all are expressed on villi coincident with 
LPH and SI expression. As shown in Fig. SA, the individual effects ofHNF-la and Cdx-2 
produced significantly greater transcriptional activities for hSI183 than for rLPHl 08 and 
hLPH118. The combination ofGATA-5 plus HNF-la: resulted in mean transcriptional activities 
that were similar for all three promoter constructs. The combinations ofGATA-5 plus Cdx-2, 
HNF-1 a plus Cdx-2, and all three transcription factors together resulted in mean transcriptional 
activities that were significantly greater for hSI183 than for either of the LPH promoter-reporter 
constructs (P < 0.05 for each). GATA-5 plus HNF-la produced the highest activation of all 
combinations for rLPH108 and hLPH118, whereas all three expression vectors together 
produced the greatest response for hSI183. 
Additive, synergistic, or antagonistic interactions among transcription factors were 
identified by comparing the effect of multiple expression vectors co-transfected together to the 
additive effect of each of the expression vectors co-transfected singly. This relationship, termed 
interaction response, is depicted as the logarithm of the ratio of the combined over the added 
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individual effects. Values of -0.1 to 0.1 were defined as additive effects, greater than 0.1, 
synergistic effects, and less than -0.1, antagonistic effects. As shown in Fig. 5B, the combination 
ofGATA-5 plus HNF-la demonstrated synergistic responses for all three promoters with 
hLPH118 having the highest mean interaction response (interaction response of0.67, which 
corresponds to a 5-fold increase of combination over added individual activities). 
0.8 
06 
~ OA, 
~ 
i 
" 
-0.6-
DrLPHI08 
~hLPHII8 
II hSII83 
0rLPH108 
~hLPH118 
llhSI183 
Expression vector 
G•H G+C H+C 
Expression vector 
combinations 
G+H+C 
Fig. 5. Combinations of expression vectors 
reveal differential activation of promoters and 
functional interactions among transcription 
factors. A: transcriptional activities (mean± 
SEM, n"" 5) after co-transfection of all possible 
combinations ofGATA-5 (G), HNF-la (H). and 
Cdx-2 (C) expression vectors were compared 
among rLPH108, hLPHII8, and hSI183. 
Unstimulated expression (pRC-CMV) is indicated 
as a control. Significant differences from 
rLPH108 and hLPH118 are indicated: *P < 0.05, 
**P < 0.01. B: interactions among transcription 
factors were characterized by comparing the 
activity of multiple expression vectors co-
transfected together to that of individual 
expression vectors co-transfected singly and 
added together. This relationship, termed 
interaction response, is depicted as the mean(± 
SEM, n = 5) logarithm of the ratio of the 
combined over the added individual effects (e. g., 
log [(GATA-5 + HNF-Ia)/((GATA-5) + (HNF-
la))]). Values of -0.1 to 0.1 were defined as 
additive effects, greater than 0.1 synergistic 
effects, and less than -0.1 antagonistic effects. 
Interaction responses for each combination of 
expression vectors were compared among 
rLPH108, hLPH118, and hSI183. Bars with the 
same letter within each expression vector 
treatment group were significantly different: "P < 
0.05, bp < 0.001. 
The combination ofGATA-5 plus Cdx-2 was antagonistic for the LPH promoters and additive 
for the hSI183 construct, the difference between rLPH108 and hSI183 being statistically 
significant (P < 0.05). The rat and human LPH promoters responded differently to the 
combination ofHNF-la plus Cdx-2 as well as the combination of all three expression vectors 
together. The rLPH108 construct demonstrated additive or antagonistic responses, whereas the 
hLPH118 construct demonstrated synergistic responses (see Fig. 5B for P values). The 
combination ofHNF-la plus Cdx-2 was additive for hSI183 whereas the combination of all 
three transcription factors together demonstrated synergistic interactions on this promoter. These 
data demonstrate that interactions among transcription factors are determined, in part, by the 
configuration of the binding sites in the promoters under study. 
The effect of combinations of transcription factors on endogenous expression of the LPH 
and SI genes were characterized in Caco-2 cells using RT-PCR (Fig. 6). 
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Fig. 6. GATA~S, HNF-la., and Cdx-2 activate 
endogenous LPH and SI gene expression in Caco-2 
cells. RT-PCR was carried out on RNA isolated from 
Caco-2 cells transfected with all combinations of the 
GATA-5 (G), HNF-la: (H), and Cdx-2 (C) expression 
vectors as described in MA TERJALS AND METHODS. 
Amplification of endogenous human LPH and SI 
mRNAs are indicated by 166 and 201 bp fragments, 
respectively. Amplification ofGAPDH mRNA (208 bp 
fragment) was used as a positive control for all RNAs 
and that of mouse GATA-5 mRNA (G5, 226 bp 
fragment) was used as positive control for transcription 
of the GATA-5 expression vector. A size marker 
(lanel) was included. pRC-CMV was used as the 
negative control expression vector (lane 2). 
An amplified product corresponding to LPH rnRNA was identified in all lanes. The intensity of 
this product on agarose gels was similar between baseline (pRC-CMV -transfected, lane 2) and 
the Cdx-2-transfected cells (lane 5), and increased when either GATA-5 or HNF-la expression 
vectors were transfected (lanes 3, 4, 6-9). However, there was no evidence for synergistic 
enhancement of LPH rnRNA abundance by any combination of transcription factors. An 
amplified product reflecting SI rnRNA abundance was identified only in the lane corresponding 
to expression of all three transcription factors (lane 9). These data demonstrate that GATA, 
HNF-1, and Cdx-2 transcription factors differentially modulate the endogenous expression of the 
LPH and SI genes. 
Cell-specific activation of the human LPH promoter by GATA-5. To determine if the GATA-5 
response is cell-specific, co-transfection experiments with 
Cell line Transcriptional response the GATA-5 expression vector and the hLPH118 
Intestinal cells construct were carried out in different cell lines. Table 2 
T84 
Caco-2 
HT-29 
COLO-OM 
109 ±7 
84±20 
19 ±6 
5±2 
Non-intestinal cells 
HepG2 
MOCK 
Hela 
NIH/3T3 
95 ± 26 
62 ± 13 
9±6 
0 
Table 2. Transcriptional responses of 
hLPHllS to GATA-5 co-transfection in 
different cell lines. Values are mean(± SEM, n 
""3) transcriptional responses (fold increase over 
baseline) with co-transfection of the GATA-5 
expression vector. 
shows a wide range of transcriptional responses (fold 
change over baseline) in both intestinal (T-84, Caco-2, 
HT-29, Colo-DM) and non-intestinal (Hep-G2, MDCK, 
HeLa, 3T3) cell lines. The highest responses were found 
in T-84, Caco-2, (both colonic adenocarcinoma), Hep-G2 
(hepatocellular carcinoma), and MDCK (kidney 
epithelial) cells, whereas the lowest responses were 
observed in HeLa (cervical carcinoma), Colo-DM 
(adenocarcinoma of the colon), and 3T3 (fibroblast) cells. 
Parallel results were found for rLPHl 08 and hSI183 (not 
sho\VTI.). EMSAs using a probe specific for HNF-1 or 
Cdx-2 binding (Fig. 7) revealed a close correlation 
between the presence ofHNF-1 binding activity and 
GATA-5 
activation ofhLPH!!S (Table 2). Those cell lines that had abundant HNF-1 binding activity 
(Fig. 7A) also displayed high levels ofGATA-5 activation responses (Table 2), whereas those 
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cell lines with no evidence ofHNF-1 binding activity demonstrated limited GATA-5 responses. 
There was no correlation bet\veen the presence ofCdx-2 binding activity (Fig. 7B) and GATA-5 
activation. 
Fig. 7. HNF-1 and Cdx-2 binding activity is different in 
different cell lines as determined by EMSAs. A: using the 
hH (human HNF-1 binding site) probe, EMSAs were canied 
out using 10 f!g of nuclear extract from different cell lines. 
The main complex (arrowhead) and secondary complex(*) 
competed specifically and supershifted with HNF-1a and/or 
HNF-1~ antibodies (not shown). B: using the hC (human 
Cdx-2 binding site) probe, EMSAs were carried out using 10 
!J.g of nuclear extract from different cell lines. The main 
complex (arrowhead) and secondary complexes(*) competed 
specifically and supershifted with the Cdx-2 antibody (not 
shown). The secondary complexes become more intense with 
repeated thawing and refreezing of nuclear extracts (not 
shown), suggesting that these complexes represent 
degradation products ofCdx-2. 
To detennine if the introduction ofHNF-1 into HeLa cells, which do not synthesize 
endogenous HNF-1 (Fig. 7A), results in GATA-5 activation, GATA-5 and HNF-la expression 
vectors were co-transfected (individually and in combination) with hLPH118, and the 
transcriptional activity was determined. Parallel experiments were carried out in Caco-2 cells as 
a control. As shown in Fig. 8, GATA-5 demonstrated minimal activation ofhLPH118 in HeLa 
cells as compared to that in Caco-2 cells (P < 0.001). 
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Fig. 8. GATA-5 activates hLPH118 in HeLa cells when 
HNF-la is co-transfected. Transient co-transfection assays 
(mean± SEM. n = 6) were carried out in HeLa and Caco-2 
cells using hLPH118 and expression vectors for GAT A-5 
and HNF-la, singly, and in combination. Significant 
differences from HeLa cells within each expression vector 
treatment group are indicated: **P < 0.01. 
0 +---:-=:c-L pRC-CMV GATA-5 HNF-1a GATA-5 + 
HNF-1u 
Expression vector 
In contrast, significant differences by cell line could not be found for co-transfection with HNF-
la alone or with HNF-la plus GATA-5. Co-transfection of both GATA-5 and HNF-la resulted 
in a synergistic activation ofhLPH118 in both cell lines. Transfection ofGATA-5 or HNF-1a 
into HeLa cells resulted in specific protein levels similar to that in transfected Caco-2 cells, as 
determined by supershift EMS As (not shown), demonstrating that HeLa cells are synthesizing 
the transcription factors from the transfected expression vectors. These data suggest that GATA-
5 activation of the human LPH promoter is dependent on the presence ofHNF-1 transcription 
factors. 
Mutational analysis of the GATA and HNF-1 binding sites in the human LPH promoter. 
To characterize the effects of disruptions in protein-DNA interactions during individual and 
combined GATA-5 and HNF-la co-transfections, mutations were introduced into the GATA 
and HNF -1 binding sites of the human LPH promoter. To first demonstrate that the introduced 
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mutations disrupt specific protein-DNA interactions, EMSAs were carried out using nuclear 
extracts from Caco-2 cells transfected with the GATA-5 expression vector and a probe that spans 
the 5' GATA and the HNF-1 site of the human LPH gene (called hG1H). As shown in Fig. 9, two 
main complexes were identified (arrowheads). The faster mobility complex was competed with 
Antibodies 
Competitors 
Fig. 9. Specific mutations disrupt specific protein-DNA 
interactions. EMSAs were carried out using a probe that spans the 5' 
GATA and the HNF-1 sites of the human LPH gene (hG1H, lanes 1-9) 
and nuclear extracts from Caco-2 cells transfected with the GATA-5 
expression vector (lanes 2-9). Competitions (200-fold molar excess) 
were carried out using oligonucleotides spanning only the GATA (hG 1) 
or HNF¥ 1 (hH) sites as well as oligonucleotides spanning both of these 
sites, but with specific mutations introduced into the GAT A or HNF -I 
binding motifs (hG 1m and hHm, respectively). Supershifts were carried 
out using antibodies specific for GATA-5 (G5) or HNF-1cx (Hlo:). 
Nonirnmune (NI) serum was used as a negative control. GATA-5-
specific complex (G5C), HNF-1-specific complex (HIC), and 
supershift complexes (SC) are indicated. The asterisk (*) indicates a 
non-specific complex that neither competes nor supershifts. 
an oligonucleotide containing the wild-type GATA site (hG1, lane 3), but not with an 
oligonucleotide containing the specific mutation in the GATA motif(hG1m, lane 4). This 
complex also supershifted with a GATA-5 antibody (lane 5) and was therefore indicated as 
GATA-5 complex (G5C). The slower mobility complex competed specifically with an 
oligonucleotide containing an intact human HNF-1 site (hH, lane 6), but not with an 
oligonucleotide containing a mutated site (hHm, lane 7), and supershifted specifically with an 
HNF-lo: antibody (lane 8). This complex was indicated as HNF-1 complex (HlC). Noteworthy 
is that specific competition with hH revealed partial competition of the GATA-5 complex. An 
oligonucleotide probe containing the 3' GATA site (hG2) also binds GATA factors, but a 
mutation introduced into this site (hG2m) does not compete (not shown). These data demonstrate 
that mutations introduced into the GATA and HNF-1 sites of the human LPH promoter disrupt 
specific protein-DNA interactions at these sites. 
To test the importance of the GATA and the HNF-1 binding sites in the human LPH 
promoter, transient co-transfections using all combinations of wild-type and mutated sites in the 
hLPH118 construct and the GATA-5 and HNF-la: expression vectors were carried out in Caco-2 
cells. As shown for GATA-5 activation (Fig. 10, top panel), a promoter-reporter construct 
containing 55 bp of 5'-flanking sequence of the human LPH gene (h55v.1:), which includes the 
Cdx-2 binding site, but not the GATA or HNF-1 sites, demonstrated a significantly lower 
transcriptional activity than that of the wild-type hLPH118 (wt) construct (P < 0.01). Mutations 
introduced into either GATA site alone (G1m or G2m) had no effect on GATA-5-stimulated 
activity, but mutations introduced into both GATA sites (G1mG2m) resulted in a significantly 
reduced GATA-5 response (P < 0.01). Interestingly, all constructs containing mutations in the 
HNF-1 site had mean GATA-5-stimulated activities that were less than 70% of that ofh118v,rt; 
significantly lower activities were found for G2rnHm and G1rnHmG2m (P < 0.01 for each). 
These data demonstrate that GATA-5 is capable of activating the human LPH promoter through 
either of the tvvo GATA motifs, and that full GATA activation is dependent on an intact HNF-1 
binding site. In HNF-la: co-transfection experiments (Fig. 10, middle panel), all constructs 
containing a mutation in the HNF-1 binding site (Hm) had transcriptional activities that were less 
than 40% of that of h118v.1:, although none were statistically significant. 
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Fig. 10. Functional co-operativity between GAT A-5 and 
HNF-la is dependent on an intact HNF-1 binding site. 
Transient co-transfections using all combinations of wild-
type and mutated sites in the hLPH118 (hilS) construct and 
the GATA-5 and HNF-la expression vectors were carried 
out in Caco-2 cells. h55vvt is a promoter-reporter construct 
containing 55 bp of 5'-flanking sequence of the human LPH 
gene. Specific mutations were introduced according to the 
gel shift probes depicted in Fig. 2 (e. g., the hll8G1m 
promoter-reporter construct contains the hG 1m mutation). 
Transcriptional activities (mean± SEM, n = 4) were 
determined as described in l\t1A TERlALS AND METHODS. The 
co-transfected expression vectors are indicated in the upper 
center of each paneL Those means that were significantly ~~-"'LJIIL_.-IIIW""-.-111'-,._R~~JIIL, different from hll8vvt (Dunnett's test) are indicated: *P < 
GATA-5 + 
HNF-1o: 
0.05. **P < 0.01. 
I HNF-la-stimulated activities were not affected by ii I ii I .. constructs that contain only GATA mutations. 
-1--:-• .,..JI~IL.-JOEL.-•Eo_,._"EW'"EWIIEWE~-'E"" These data suggest that the HNF-1 binding site is 
~- $ ~x x ef',cf'ci'r.f ~ C9 E E '-' E E critical for HNF-la-stimulated activation. 
0 
x cl ~ Co-transfection of both the GATA-5 and 
h 118 ell HNF-la expression vectors demonstrated 
Construct 
significantly lower transcriptional activities from 
hll8vvt for all constructs containing HNF-1 mutations (Fig. 10, lower panel). Individual GAIA 
mutations alone had no effect on transcriptional activity, although mutations in both GAIA sites 
resulted in a mean transcriptional activity that was 72% of that ofh118wt (P > 0.05, not 
significant). These data suggest that the HNF-1 binding site is critical for combined activation by 
GATA-5 and HNF-lo:. 
DISCUSSION 
This is the first report to extensively compare under the same experimental conditions the 
effect of specific transcription factors on multiple intestinal gene promoters and to identify 
functional co-operativity bet\veen t\vo major classes of transcription factors, the zinc-finger 
GAIA proteins and the homeobox HNF-1 family. Studies to date have generally examined 
regulation of individual intestinal gene promoters, and only recently have the effect of multiple 
transcription factors been examined (46, 47, 72), but only on single promoters. In the present 
report, we found that GAIA, 1:-INF-1, and Cdx-2 transcription factors regulate the rat LPH, 
human LPH, and human SI promoters differently, and that GATA-5 and HNF-lcx co-operatively 
activate these promoters. Together, these data suggest that the specific expression of intestinal 
genes is modulated by complex interactions involving multiple transcription factors. 
Our data are in agreement with previous reports demonstrating individually that members 
of the GATA-4, -5, and -6 subfamily are capable of activating the human (17) and rat (15) LPH 
promoters, that HNF-lo: is capable of activating the pig LPH (59) and human SI (72) promoters, 
and that Cdx-2 is capable of activating the pig (65) and rat (16) LPH and human SI (60) 
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promoters. Our data also parallel a recent report by Mitchelmore et. al. (47), who showed that 
HNF-la and Cdx-2 co-operatively activate the pig LPH promoter, a finding we have also 
demonstrated for the human LPH promoter. Thus, our data are in general agreement with 
previous reports. 
GATA and HNF-1 transcription factors together are key activators ofLPH gene 
expression, whereas Cdx-2 has a comparatively weak effect on the LPH promoters. Although 
GATA-4, -5, and -6, HNF-la, and Cdx-2 are all capable of activating the LPH promoters 
individually in co-transfection assays, comparative analyses reveal that the rat and human LPH 
promoters generally demonstrate greater transcriptional responses to the GATA factors and 
HNF-1 a than to Cdx-2 (Fig. 3). Similarly, activation of endogenous LPH transcription in Caco-2 
cells occurred with over-expression ofGATA-5 or HNF-la, but not with that ofCdx-2 (Fig. 6). 
In contrast to our data, in which Cdx-2 showed no effect on LPH mRNA abundance, Fang et. al. 
(16) reported a modest 2-fold increase in LPH mRNA abrmdance in Cdx-2-transfected Caco-2 
cells, which could be due to a more sensitive quantification technique (densitometry ofthe 
negative image of ethidium bromide-stained bands in agarose gels) employed in their study. Our 
results depict the comparative effects of single and multiple transcription factors, and thus, 
relative to GATA-5 or HNF-la co-transfection, Cdx-2 appears to be a comparatively weak 
activator of endogenous LPH gene transcription in Caco-2 cells. Finally, the combination of 
GATA-5 and HNF-la produces the strongest activation of the LPH promoters demonstrating 
functional co-operativity between these t\.vo transcription factor families (discussed below). 
Together, these data suggest that members of the GATA and HNF-1 transcription factor families 
are significant activators ofLPH gene expression, whereas Cdx-2, although perhaps necessary 
for LPH expression in vivo, has a comparatively lesser role in modulating LPH gene expression. 
Although some experiments argue that HNF-1 and Cdx-2 have a greater role than GATA 
factors in the modulation of the SI promoter, other experiments suggest that all three 
transcription factor families are important in the activation of SI gene expression. As shown in 
Table 1, transcriptional responses for the human SI promoter were strongest for HNF-1a and 
Cdx-2 as compared to that for the GATA factors. Further, greater basal expression of the human 
SI promoter as compared to the LPH promoters could be due to the relative abundance of 
endogenous transcription factors synthesized in Caco-2 cells. Based on amount of extract used, 
intensity of complexes on autoradiographic film, and length of exposure time, data from EMSAs 
suggest that Caco-2 cells synthesize abundant amounts of HNF-1 and Cdx-2 proteins, but limited 
amounts ofGATA proteins (not shown). Thus, it could be argned that HNF-1 and Cdx-2 have a 
greater role than GATA factors in the activation of the SI promoter (in contrast to the LPH 
promoters) resulting in a greater basal (unstimulated) expression. HNF-1 and Cdx-2 have greater 
affinities for SIF3 and SIFl, respectively, as compared to their cis-element counterparts in the 
LPH genes (Fig. 4), which could explain the greater basal transcriptional activities of the SI vs. 
the LPH promoters. Noteworthy is that hSIF1 contains two Cdx-2 motifs whereas rC and hC 
(i.e., CE-LPHla) has a single binding motif which likely accounts for the differences in affinity 
between the two elements. 
Co-transfection experiments using combinations of expression vectors, however, suggest 
that all three transcription factor families co-operatively activate the human SI promoter. For 
hSI183, co-transfection of the combination of GATA-5, HNF-1a, and Cdx-2 expression vectors 
produced the highest transcriptional activity of any combination of transcription factors (Fig. 
SA), and demonstrated a strong synergistic interaction response (Fig. 5B). Further, all three 
transcription factors were also important for endogenous SI gene expression, since an amplified 
product corresponding to human SI mRNA was detected only in the RNA isolated from Caco-2 
cells transfected with the GATA-5, HNF-la, and Cdx-2 expression vectors (Fig. 6). Activation 
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ofSI individually by HNF-1 and Cdx-2 transcription factors has previously been demonstrated 
(60, 72), but the present study is the first to show activation of the SJ promoter by the GAIA 
family, and co-operative activation of the SI promoter by members of the three different 
transcription factor families. 
The rat and human LPH promoters, with some exceptions, demonstrated similar 
responses to the transcription factors under study. Both promoters were significantly activated by 
GAIA, HNF-1, and Cdx-2 transcription factors (Fig, 3), and their patterns with co-transfection 
of multiple expression vectors were similar to each other (Fig. SA). A significant difference 
between the two promoters, however, was revealed by co-transfection of the GATA-6 expression 
vector, in which the rat LPH promoter demonstrated a greater transcriptional response than the 
human LPH promoter (Table 1). This suggests a preferential activation ofthe rat promoter by 
GA TA-6, and may indicate differential affinities of the GATA factors for specific sequence in 
the binding sites, although this has not been specifically tested. A second difference was found 
with HNF-la co-transfection, in which the human LPH promoter demonstrated a significantly 
greater activation response than the rat LPH promoter (Table 1 ), suggesting a preferential 
activation of the human LPH promoter by HNF-la (although no difference in HNF-1 binding 
affinity was noted between the rat and human HNF-1 sites; Fig. 4B). Finally, the combination of 
HNF-1 a plus Cdx-2 as well as the combination of all three expression vectors demonstrated 
antagonistic or additive responses for rLPHl 08, but a strong synergistic response for hLPH118 
(Fig. 5B, discussed further below). Together, these data suggest that the position, configuration, 
and/or specific sequence within binding motifs of the LPH promoter may influence the 
magnitude and direction (activation vs. repression) of responses to specific combinations of 
transcription factors. Implications for the differential regulation ofLPH gene expression between 
humans and other mammals are unknown at this time. 
The basal promoter constructs (i.e., rLPI-!37 and hLPI-!37), with varying degrees of 
statistical significance, were activated by many of the transcription factors tested (Fig. 3). It is 
possible that sequence in the human growth hormone reporter gene may activate reporter 
expression in response to specific expression vectors. However, the activity ofBSGH after 
specific transcription factor stimulation was subtracted from that of all other constructs 
stimulated with the same transcription factor thus eliminating activity due to the reporter itself. 
In a preliminary report (70), we showed that Cdx-2 is capable of binding and activating the LPH 
and SI promoters at their TAT A-box regions. Thus, Cdx-2 may directly activate these promoters 
at their TAT A-boxes, whereas GAIA and HNF-1 factors, which do not bind to the -37 to -1 bp 
region (not shown), may activate transcription of a basal promoter indirectly (in contrast to direct 
protein-DNA interactions), or by direct interactions with the transcriptional initiation complex. 
In the human LPH gene, we confirm that the two GAIA motifs bind GATA-5 with 
similar affinities (Fig. 4A), and demonstrate that both sites play a role in the activation of the 
human LPH promoter (Fig. 10). Mutations introduced into either one of the sites had little effect 
on GAT A-stimulated activity, but mutations introduced into both sites resulted in a significant 
reduction in GAT A-S-stimulated transcriptional activity (Fig. 10). In a previous report, 
Fitzgerald et. al. (17) demonstrated that a mutation in the 5' GATA site of the human LPH 
promoter resulted in a decrease in GATA-6 activation from the wild-type control. The reason for 
the apparent difference between our study and that of Fitzgerald et. al. is uncertain, but could be 
due to differences in the ability of chicken GATA-6 as compared to mouse GATA-5 to activate 
the human LPH promoter. In the human LPH gene, the 5' GATA site (hG1) is on the forward 
strand whereas the 3' GATA site (hG2) is on the reverse strand, which could result in possible 
differences in the ability of different GAIA proteins to activate the LPH gene through the hG, 
site. We conclude from our data that GATA-5 is capable of activating the human LPH promoter 
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through either GATA motif, and that the two sites together do not activate the LPH gene any 
more than either of the sites individually. 
Binding site affinity experiments suggest that GATA-5 prefers to bind WGATAT. 
Unbiased analysis of random GATA motifs revealed the consensus for the GATA-1, -2, and -3 
subfamily is WGATAR, where W is A or T and R is A or G, but clear preferences in core and 
adjacent sequences were noted (30, 45). A similar characterization of the GATA-4, -5, and -6 
subfamily has not been reported. Comparison of the relative affinity ofGATA-5 for each of the 
GATA motifs (Fig. 4A), as summarized in Fig. 11, reveals that GATA-5 binds equivalently if an 
"A" or "T" (but not a "G") is in the 5' position, and prefers a 'T" in the 3' position, although it 
continues to bind with less affinity if an "A" or "G" are present in this position. We therefore 
propose that the GATA-5 consensus is WGATD, where Dis A, G, or T. 
Consensus 
xiFABP/G 
cG1 
cG2 
hG1 
hG2 
hSI/G 
AJTGATAAIG 
5'-T ACAGAT ATGGG-3' 
CCTAGATAACCC 
TGTGGATAATCA 
CATAGATAACCC 
AAGTGAT AA TT A 
CACTGATAGGCT 
Affinity for 
GATA-5 
++ 
+ 
+/-
+ 
+ 
+ 
Fig. 11. Sequence analysis demonstrates that 
GAT A-5 preferentially binds a AGAT AT 
motif. Based on affinity experiments shown in 
Fig. 4A, the relative affinities of GAT A-5 for 
each of the GAT A motifs were assigned either 
"++"for strong competition,"+" for intermediate 
competition, or"+/-" for weak or lack of 
competition. The core motif (bold) and adjacent 
sequence are shown. 
In co-transfection experiments, the combination ofHNF-la and Cdx-2 demonstrated 
synergistic activation of the human LPH promoter (hLPH118), but antagonistic interactions on 
the rat LPH promoter (Fig. 5B). Our data on the human LPH promoter are in agreement with a 
previous report by Mitchelmore et. al. (47), who demonstrated that HNF-la and Cdx-2 
functionally interact resulting in a synergistic activation of the pig LPH promoter. Although the 
reason for the apparent species difference in response to HNF-la and Cdx-2 is not readily 
known, structural similarities and differences among the rat, human, and pig LPH promoters 
were noted. There is greater conservation of sequence identity in the first 100 bp of 5'-flanking 
region between the human and pig LPH (93 %) genes than between the human and rat LPH (78 
%) genes. This includes the HNF-1 binding motif, in which the 3' half is completely conserved 
between the human and pig sequence and more closely correlates with the HNF-1 consensus 
than that of the rat LPH HNF-1 (rH) site. Noteworthy, however, is that rH and hH demonstrate 
similar affinities for HNF-1 binding in competition EMSAs (Fig. 4). Sequence differences also 
include the TATA boxes, in which the human and pig LPH genes contain a true "TATA" motif, 
whereas the rat LPH gene contains a "CATA" motif, although the effect of such a difference on 
transcriptional regulation is unknovm. The recent demonstration of a second Cdx-2 binding site 
(called CE-LPHlc) 5' to the HNF-1 site in the pig LPH gene (47) is unlikely to explain the 
species differences in response to these transcription factors because CE-LPH1c is not present in 
the human LPH gene, but is present in the rat LPH gene (-102 to -97 bp). Since rLPH108 does 
not demonstrate synergistic activation by HNF-la and Cdx-2, it is likely that the presence or 
absence of this site does not play a direct role in the co-operative activation by these two 
transcription factors. Finally, with regard to binding site position, the distance between the 5' 
base of the HNF-1 motif and that ofthe Cdx-2 binding site at CE-LPHla is 33 bp for the human 
and pig promoters and 28 bp for the rat LPH promoter, which represents a difference of 
approximately one-half tum of the helix which could affect the ability ofHNF-la and Cdx-2 to 
interact. At present, the process underlying the co-operative interactions between HNF-la and 
Cdx-2 is unknovm, but the findings in the present study imply that the mechanism is more 
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complex than simple protein-protein interactions and the presence ofHNF-1 and Cdx-2 binding 
sites. 
In the present report, we demonstrate for the first time functional co-operativity between 
GATA-5 and HNF-la. This co-operativity was strongest for the human LPH promoter, but was 
present for the rat LPH and human SI promoters (Fig. 5B) as well. Functional co-operativity 
between zinc-finger GATA proteins and homeobox transcription factors has been previously 
demonstrated for GATA-4 and Nkx-2.5, a cardiac-restricted homeobox protein (13, 37, 57). 
GATA-4 was shown to physically associate with Nkx-2.5 and co-operatively activate cardiac-
specific promoters. Further, mutational analysis of each transcription factor indicated that 
physical interaction was required for functional synergy. Deletional analysis in GST pull-down 
assays revealed that the carboxy-terminal zinc finger of GA TA-4 was required to interact with 
Nkx-2.5, and helix III of the homeodomain ofNkx-2.5 was necessary to associate with GATA-4. 
Both regions are known to bind their cognate DNA binding sites, demonstrating a close 
association between protein-protein and protein-DNA interactions. Indeed, the homeodomain of 
HNF-la was shown to be necessary for interactions with Cdx-2 (47). Based on these models, we 
hypothesize that the C-terminal zinc finger of GATA-5 and the homeodomain ofHNF-1 a 
physically interact, and that this interaction is necessary for synergistic activation of the human 
LPH promoter. 
Based on the findings in the present study, we hypothesize that the patterns of expression 
of certain intestinal genes are due, at least in part, to the simultaneous presence of GATA, HNF-
1, and Cdx-2 transcription factors. Members of all three transcription factor families are present 
in the upper crypt and lower villus, which corresponds to the region that LPH and SI 
transcription is activated during intestinal differentiation. However, the net effect on intestinal 
gene expression during differentiation is far more complex than the simple presence of these 
transcription factors and their cognate binding sites. Data in the present study suggest that the 
number of binding sites and their relative positions on the promoter is important. Further, as 
shown by transcription from longer promoter constructs (Fig. 3) or from the endogenous genes 
(Fig. 6), which do not always parallel expression of shorter promoter constructs, other 
interactions involving sequence further upstream may also influence transcriptional activation. 
Finally, interaction with other transcription factors, such as HOXCll (46), as well as with 
specific cofactors, including friend ofGATA-2 (FOG-2) (39, 62), dimerization co-factor for 
HNF-1 (DCoH) (44), and p300 (27) must be considered. 
We conclude that the complex hierarchies of control that govern gene expression during 
intestinal differentiation and development are detennined by the stoichiometry of transcription 
factors and cofactors within intestinal cells at any given time, and the type, number, and 
arrangement of cis-acting elements in the regulatory regions of intestinal genes. LPH and SI, 
markers of intestine-specific gene expression and intestinal differentiation, are regulated by 
complex interactions involving multiple transcription factors. Synergistic activation by 
combinations oftranscriptions factors is likely a mechanism by which specific patterns of tissue-
specific expression might be attained by the overlapping expression of specific transcription 
factors. Characterizing specific interactions will provide insight into the regulatory mechanisms 
that control the pathways of intestinal differentiation, and is presently under study in our 
laboratory. 
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ABSTRACT 
Sucrase-isomaltase, an intestinal specific gene, is strongly induced in the differentiated 
small intestinal villous epithelium during the suckling-weaning transition in mice. We have 
previously identified cis-acting elements within a short evolutionarily conserved SI promoter. 
However, the nature and profile of expression of the interacting proteins have not been fully 
characterized during this developmental transition. Herein, we show that HNF-la, GATA-4, 
Cdx2 and Cdxl are the primary transcription factors from the adult mouse intestinal epithelium 
to interact with the SIF3, GATA and S!Fl elements of the SI promoter. We then aimed to study 
whether HNF-la, GATA-4 and Cdx2 can cooperate in the regulation ofSI gene expression. 
Immunolocalization experiments revealed that HNF-la is detected in rare epithelial cells of 
suckling mice and become progressively expressed in the villous epithelial cells during the 
suckling-weaning transition. GATA-4 protein is exclusively expressed in villous differentiated 
epithelial cells of the proximal small intestine, decrease in expression in the ileum and become 
undetectable in the colon. HNF-la, GATA-4 and Cdx2 can interact in vitro and in vivo. In 
addition, these factors activate SI promoter activity in co-transfection experiments where GATA-
4 requires the presence of both HNF-la and Cdx2 to influence this activity. These findings 
imply a combinatory role of HNF-1 a, Cdx2 and GATA-4 for the temporal and positional-
dependent regulation of SI transcription during intestinal development. 
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INTRODUCTION 
The maturation of the intestinal epithelium involves several steps that are initiated early 
during embryogenesis and completed at the reach of adulthood (1,2). In mice, important changes 
in the acquisition of mature enterocyte functions are observed during the third postnatal week 
that corresponds to the suckling-weaning transition. Among these changes are the activation of 
transcription of distinct genes related to specific functions of the intestinal epithelium (3). 
Sucrase-isomaltase (SI) 1, an enzyme expressed in the brush border of mature enterocytes, 
represents one of the most extensively studied genes activated during this developmental 
transition (4). SI is first detectable in mouse embryonic intestine and remains stable through the 
first two weeks of life after birth. At the time of the suckling-weaning transition, a dramatic 
induction of SI mRNA and protein is observed. A proximal to distal gradient of SI expression 
and activity is then established with highest level in the jejunum and no detectable level in the 
colon (3,5,6). A vertical gradient of expression is also observed along the crypt-villus axis with a 
maximal level in the lower two-third part of the villi and no expression in the crypts (3,7,8). 
Although the distribution of SI expression is well documented during intestinal development, the 
exact developmental mechanisms that govern SI and intestinal gene expression are still poorly 
defined. 
In the past, we have identified a number ofSI promoter elements important to support 
expression in intestinal epithelial cells (9). Furthermore, a short evolutionarily conserved SI gene 
promoter was shown to recapitulate the developmental expression of SI in transgenic mice (6). 
This indicated that all the elements required for the developmental regulation of the SI gene are 
comprised within this short region. This short promoter contains three identified regulatory sites, 
SIFI (Sucrase lsomaltase Footprint 1), SIF3 and GAT A. 
The SIFl element interacts with Cdx transcription factors (10,11) that belong to 
mammalian homeobox gene family related to the Drosophila melanogaster gene caudal (12). 
The expression ofCdx1 and Cdx2 is restricted to the intestinal epithelium (13). Cdxl protein is 
mainly found in the crypt compartment whereas the Cdx2 protein is detected in both the crypt 
and the villus compartments (13-15). Cdx2 stimulates differentiation and expression ofSI in 
intestinal epithelial cells (16). However, the specific role of the SIF1 element in the regulation of 
SI promoter activity in vivo is unclear. 
The SIF3 element interacts with the transcription factors HNF-la and HNF-1~ that bind to 
DNA as either homodimers or heterodimers. They are expressed in a variety of tissues, including 
liver, kidney and intestine and have been implicated in the regulation of multiple genes (17). 
HNF-1a stimulates SI promoter activity via the SIF3 element whereas HNF-lP down-regulates 
this effect (18). Although HNF-la mRNA has been localized in the crypts and bottom of the villi 
in the small intestine (19), the exact pattern ofHNF-1a protein distribution during intestinal 
development is unknown. 
More recently, we have identified a GAIA element localized in the proximal region of the 
SI promoter (20,21). GATA-4, 5, and 6 are expressed in the intestine as well as various 
mesoderm- and endoderm-derived tissues such as heart, liver, lung and gonad where they play 
critical roles in regulating tissue-specific gene expression (22). GATA-4 transcripts are detected 
in villi ofthe small intestine both in mice (23) and chicken (24) whereas the GATA-6 mRNA is 
predominantly localized at the crypt-villus junction (24). However, the exact distribution of 
GATA proteins in the intestine has not been addressed. GATA-4 and GATA-6 play critical roles 
in the definitive formation of the endoderm early during embryonic life (25-28). Their 
involvement in the maintenance of the intestinal epithelium remains speculative. 
In this study, we investigated whether HNF-la, GATA-4 and Cdx2 could activate the 
developmental regulated SI gene through combinatorial interactions. We report that HNF-1a and 
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GATA-4 protein expression is temporally and regionally modulated in a way that correlates well 
with the activation ofSI expression during the suckling-weaning transition in the intestine. We 
show that these proteins physically interact with each others and functionally cooperate in the 
activation of the SI gene promoter. These findings imply a combinatory role ofHNF-la, Cdx2 
and GATA-4 for the maturation of the small intestinal mucosa. 
EXPERIMENTAL PROCEDURES 
Plasmid construction, mutagenesis and transgenic mice--The -201 to +54mSI-luciferase 
and~ 134 to+ 40 IPAL-luciferase constructs were described elsewhere (18,29). Point 
mutagenesis of the SI promoter was performed using a PCR-based mutagenesis approach (30). 
The following oligonucleotides were designed to create point mutations (underlined) of the 
specific elements: S!Flm (sense) 5'GTGAAAGTGCAAGGCAAC GGGATGAGTAGTCAA-3' 
and S!Flm (antisense) 5'-TTGACTACTCATCCCGTT GCCTTGCACTTTCAC-3'; GAT Am 
(sense) 5'-TAAACATTGAT1:GGCTTGTG AAAG -3' and GAT Am (antisense) 5'-
CTTTCACAAGCCQATCAATGTTTA-3'. Integrity of the mutant constructs was confirmed by 
sequence analysis. The -8.5 to +54 S!FlmutantSI-hGH plasmid was constructed and injected to 
produce transgenic mice as described previously (18). The presence of the transgene in mouse 
genomic DNA was determined as described previously (18,31,32). Trans gene founders of the 
BGSJL/Fl strain (Jackson Laboratory, Bar Harbor, ME) were bred with normal CD! mice 
(Charles River) and offspring were analysed for the trans gene by PCR. 
Cell culture and transfections---HEK293T, COS-7 and Caco-2 cells were maintained in 
DMEM supplemented with 4.5 g/liter D-glucose, 25 mM HEPES, 10 % fetal bovine serum, 50 
units/ml penicillin, and 50 ~g/ml of streptomycin in 5% C02• For luciferase assays, transfections 
were performed using Lipofectamine (Life Technologies Inc., CA) according to manufacturer's 
recommendations. Cells at 30-40% confluence were incubated with 1.2 ~g of total DNA and 2.5 
~1 oflipofectamine /ml ofOPTI-MEM for 18 h. The media was then changed to DMEM 
complete medium containing 10% FBS. The luciferase and renilla activities were determined 48 
h after the transfection using the dualluciferase assay kit (Promega Biotech, Madison, WI). Each 
experiment was repeated at least three times in triplicate. For stable transfections, Caco-2/15 
cells were trypsinized 48 h following transfection and maintained in selection medium 
containing 1 mg per ml of 0418. 
RNA ana6'sis---RNA was extracted from multiple tissues or from cultured cells and 
Ribonuclease (RNase) protection assays were performed as previously described (18). 
Riboprobes for the detection ofmSI, hSI, hGH, h36B4 and m36B4 mRNA were prepared as 
previously described (18). 
Immunohistochemistry--Immunohistochemistry was performed exactly as described 
previously (13,15). After blocking with protein-blocking agent (Coulter-Irmnunotech, Miami, 
FL), the slides were incubated overnight at 4·c with affinity-purified antibodies. The following 
antibodies from Santa Cruz Biotechnology (Santa Cruz, CA) were used: anti-goat GATA-4 (SC-
1237) at a concentration of0.2 ~g/ml; anti-rabbit GATA-4 (H-112) at a concentration of0.2 
~g/ml; anti-goat HNF-la (SC-6547) at a concentration of0.067 ~g/ml. Cdx2 protein was 
detected with the affinity purified CNL antibody(! :1000) (15). All primary antibodies were 
visualized with a biotinylated secondary antibody and alkaline phosphatase detection system. 
The slides were developed with nitroblue tetrazolium chloride (NBT) and 5-Bromo-4-chloro-3-
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indolyl-phosphate (BCIP; Roche Molecular Biochemicals, Indianapolis, IN). The tissue was 
lightly counterstained with 2% neutral red and mounted with Permount (Fisher Scientific). 
Immunohistochemistry was repeated at least 3 times for each antibody with sections obtained 
each time from different mice. Each animal was routinely sacrificed between 10-12 AM to 
prevent any modification of expression related to the circadian rhythm as it has been reported for 
HNF-lproteins (33). Specificity of the signal for each antibody was confirmed by blocking 
experiments as previously described (13). 
Isolation of nuclear proteins from adult intestinal epithelium--Nuclear protein was 
isolated from the intestinal epithelium of adult mice by an adaptation of a previously described 
method that used human intestine (34). Briefly, mice were sacrificed and the intestine was 
separated in sections of jejunum, ileum and proximal colon. Each section was open 
longitudinally and rinsed with cold PBS. The sections were further cut in 5mm pieces and 
incubated in 5 ml of cold MatriSperse (Becton Dickinson, Franklin Lakes, NJ) in 15ml tubes at 
4 OC for 18 to 24 hr. The epithelial layer was dissociated by gentle manual shaking. The epithelial 
suspension was collected, centrifuged and washed with cold PBS. Nuclear proteins were then 
isolated from the epithelial cell pellet as described previously (9). 
Western Blot analysis-20 ).Lg of nuclear protein extracts was analyzed by a 4-12% Bis-
Tris NuPAGE (Invitrogen, Carlsbad, CA) electrophoresis and transferred to an Immobilon-P 
membrane. Western blot was then performed exactly as described previously (18). The following 
antibodies from Santa Cruz Biotechnology (Santa Cruz, CA) were used: HNF-la affinity-
purified goat polyclonal antibody raised against a peptide mapping to the carboxy terminus of 
human HNF-la. (SC-6545); GATA-4 affinity-purified goat polyclonal antibody raised against a 
peptide mapping to the carboxy terminus of mouse GATA-4 (SC-1237); HDAC-2 affinity-
purified rabbit polyclonal antibody raised against a peptide mapping to amino acids 435-488 of 
human HDAC-2 (SC-7899). A Cdx2 affinity-purified rabbit poly clonal antibody raised against a 
peptide mapping to theN-terminus of murine Cdx2 (CNL) was used for Cdx2 detection (15). 
Electrophoretic Mobility Shift Assays (EMSA)--EMSA was perfonned essentially as 
described previously (10). The reactions were performed in 20 )ll of binding buffer (10) 
containing 5 )lg of nuclear extracts, 1 )lg of poly dldC and 20,000 cpm of 32P-labeled DNA 
probe during 30 min. Complexes were then separated on a 4% polyacrylamide gel at room 
temperature (S!Fl and SIF3) or 4'C (GATA), dried and exposed on a phosphoimager screen. 
The following double stranded oligonucleotides were used as DNA probes: GATA: 5'-
AAACATTGATAGGCTTGTGA-3'; MUT-GATA: 5'-AAACATTGATQGGCTTGTG A-3'; 
a.l-globin GATA: 5'-GATCTCCGGCAAC TGATAAGGATTCCCTG-3'. The S!Fl and SIF3 
DNA probes have been described previously (9). \Vhen indicated, antibodies were included in 
the binding reaction for supershift analysis. 
GST-pulldown--GST -protein interaction assays were performed essentially as described 
elsewhere (35). Briefly, bacterial expression ofGST fusion proteins was induced in medium 
containing 0.1 ).1M isopropyl-1-thio-D-galactopyranoside for 3 h. The bacterial pellet was 
resuspended in PBS containing proteinase inhibitors and sonicated to disrupt the bacteria. The 
bacterial residues were removed by centrifugation, and the supernatant was incubated with GST 
beads (Arnersharn Phannacia Biotech) on a rotating wheel for 30 min. The beads were washed 
6 times with PBS and the GST fusion proteins eluted with 10 mM reduced glutathione according 
to the manufacturer's instructions. Reduced glutathione was removed by dialysis in dialysis 
buffer (0.1 M NaCl, 1 mM EDTA, 20 mM Tris pH 8, 0.5% NP-40 and 5% glycerol). HNF-la., 
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GATA-4 and Cdx2 proteins were labeled with C5SJ methionine by coupled in vitro transcription 
and translation using the TNT reticulocyte lysate system (Promega) according to the 
manufacturer's instructions. GST fusion proteins (20).Lg) were incubated with labeled proteins 
and pre-washed GST beads (10~1) in 200 ~1 ofHND buffer (10 mg/ml bovine serum albumin, 
20 mM Hepes, 50 mM NaCl, 0.1% Nonidet P-40, 5 mM dithiothreitol) at 4 'C for 1 hr. The 
beads were then washed 4 times with MTPBS (PBS, 0.1% Nonidet P-40) buffer and proteins 
eluted from the beads in SDS sample buffer. The eluted proteins were separated on a 4-12% 
NuPAGE electrophoresis gel. 
Immunoprecipitation (IP)-EMSA analysis--IP-EMSA was performed essentially as 
described elsewhere (36). Transiently transfected HEK293T cells were washed three times in 
PBS and lysed with lysis buffer A (150 mM NaCl, 40 mM Tris-HCl at pH 7.6, 10% glycerol, 
0.3% NP-40) containing protease and phosphatase inhibitors (15) for 20 min and pelleted. 
Supernatants containing 150 ~g of total protein were allowed to bind anti-FLAG (Sigma, 
St.Louis, MO) agarose beads 5 hrs at 4°C. Pellets were washed three times in lysis buffer A and 
three times in EMSA binding buffer. Immunoprecipitated proteins were dissociated with 
deoxycholate for 10 min on ice, neutralized with 1% ofNP-40 and analyzed by EMSA. 
RESULTS 
HNF-la, GATA-4, Cdx2 and Cdxl interact with the SI promoter in adult mouse 
enterocytes--The SI gene promoter contains several cis-acting elements important for 
transcriptional regulation (9) (Fig. 1A). The identity of proteins able to interact with these 
elements has been previously investigated with the use of intestinal cell lines. We wanted to 
confirm the nature of proteins of the mouse intestinal epithelium susceptible to interact with the 
SIF3, GATA and SIF1 elements. Since the SI gene is highly transcriptionally active in the adult 
small intestinal epithelium, nuclear extracts were prepared from adult mouse isolated 
enterocytes, incubated with a SIF3, GATA or SIFl 32P-labeled probe and migrated on a 
polyacrylamide geL As previously reported, the SIF3 probe produced a single complex that was 
supershifted when an HNF-1o.: polyclonal antibody was included in the binding reaction (Fig. 
1B)(l8). 
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Fig. 1. Interaction of nuclear extracts of mouse 
adult intestinal epithelial cells with the mouse SI 
promoter. (A), Diagram of the short evolutionarily 
conserved SI promoter with previously characterized 
SIF3, GATA and SIFl elements. 32P-labeled SJF3 
(B), SI-GATA (C), a:l-globin-GATA (C), and SIFI 
(D) oligonucleotides were used for EMSA as 
previously described (9). 5 )lg of nuclear extract of 
intestinal epithelial cells isolated from adult mice was 
used for each binding reaction. When indicated, 
specific antibodies (Ab) were included in the binding 
reaction for supershift (S) analysis. The following 
antibodies were used: a (HNFla:); pre- (pre-immune 
serum); G4 (GATA-4), G5 (GATA-5); G6 (GATA-
6); Cdxl; Cdx2. Ctl: control. 
c 
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The GATA probe produced an intense complex that was mostly supershifted with the addition of 
a GATA-4 polyclonal antibody (Fig. lC, upper panel). The addition ofGATA-5 or GATA-6 
polyclonal antibodies did not supershift this complex (Fig. I C, upper panel). Control 
experiments performed with nuclear extracts prepared from GAT A -5 and GAT A -6 transfected 
COS-7 cells confirmed the ability of both antibodies to supershift a GATA specific complex 
(Fig. 1 C, lower panel). This suggested that GATA-4 was the main protein in adult intestinal 
epithelium to interact with the SI-GATA site. Incubation of intestinal nuclear extracts with the 
SIF I probe produced two very close migrating complexes (Fig. lD). Supershift analysis showed 
that both Cdxl and Cdx2 complexes were present and separable by size (Fig. !D). 
Mutagenesis of the SIFJ element abolishes Sf promoter activity in vivo-The role of SIF3 
and GATA elements in the regulation of SI promoter activity in vivo has been previously 
characterized (18,20). The SIFl element is crucial for high level of SI promoter activity in vitro 
(9, 1 0). To evaluate the importance of the SIFl element in the regulation of SI gene in the intact 
mouse intestinal epithelium, we designed a transgenic construct harboring point mutations within 
this element and linked nucleotides -8.5kb to +54 of the mSI gene to the hGH reporter gene (Fig 
2A). The wild-type construct supports hGH expression in enterocytes of transgenic mice (18,32) 
and the SIFl mutation abolishes in vitro interaction ofCdx proteins (10). 
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Fig. 2. Effect of the SIFl mutation 
on Sl promoter activity in transgenic 
mice and Caco-2/15 cells. A, Diagram 
of the SI reporter constructs used to 
generate transgenic mice and stable 
Caco-2115 cell lines. Mutations within 
the SIFl element are indicated in italic 
and underlined. B, Total RNA was 
isolated from intestinal tissues of2 
different adult founder lines obtained 
with the -8.5 to +54 SIFlmSI-hGH 
construct and analyzed by an RNase 
protection assay for the simultaneous 
detection ofhGH and 36B4 mRNA. 
Total RNA isolated from founder 17 
with the genomic integrated -8.5 to 
+54 WTSI-hGH construct was used as 
a reference control. Du, duodenum; 
PJ, proximal jejunum; DJ, distal 
jejunum; IL, ileum; Ce, cecum; PC, 
proximal colon; DC, distal colon. C, 
Caco-2/15 cells were stably transfected 
with the neomycin resistance 
h36H4 
pRC/CMV vector in combination with 
either the empty hGH reporter vector 
(p0hGH), the WTSI-hGH construct 
(\VT) or the SIFl mSI-hGH construct 
(SIFlm). Total RNA was extracted 
from G418 resistant cell populations at 
different days of cell confluency (PC, 
pre¥confluent; C, confluent; +7, 7 days 
after confluence;+ 14, 14 days after 
confluence). RNase protection assay 
was performed using hSI, hGH and 
h36B4 riboprobes. D, Intensity of the signals was measured from 3 to 4 independent experiments by densitometric 
analysis using a phosphoimager (Molecular Dynamics). Expression level ofhGH mRNA was reported to the h3684 
signal and represented graphically (mean± SD). 
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The effect of the SIF1 mutation on hGH expression in two transgenic lines was compared 
to the previously characterized WT Fo(l7)FI(32) transgenic line (32). Total RNA isolated from 
different portions of the intestine was analyzed by an RNase protection assay. Each RNA sample 
was incubated with probes for hGH and an internal control (36B4) in the same hybridization 
solution in order to correlate hGH mRNA levels among these different lines. The WT transgenic 
line showed high level expression ofhGH in the small intestine (Fig. 2B), as previously reported 
(32). In contrast, no detectable level for hGH mRNA was found in the intestine ofthe SIFl 
mutant transgenic lines (Fig. 2B). To further analyze the importance of the SIFl element to 
regulate SI promoter activity in vivo, we utilized the Caco-2/15 cell line that spontaneously 
differentiates in post-confluence with concomitant high induction of SI expression. The WT and 
the SIF1 mutant constructs were co-transfected with a neomycin resistance expression vector 
(pRC/CMV) to stably transfect Caco-2/15 cells. As a control, Caco-2115 cells were co-
transfected with the empty hGH reporter and pRC/CMV. Expression ofhSI, hGH and h36B4 
was detenninerl in RNA samnles isolaterl from neomycin resistant population of clones at 
(; 
da,· 15 different times of cell confluence. Expression 
B c D E ~- F of the WT construct increased in a similar 
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Fig. 3. Distribution ofHNF-la., GATA-4 and 
Cdx2 proteins in the mouse intestine during the 
suckling-weaning transition. 
Immunohistochemistry was performed to detect 
HNF-la (A, D, G and J), GATA-4 (B, E, Hand K) 
and Cdx2 ( C, F, I and L) in the jejunum (upper 
panels) and the colon (lower panels) at post-natal 
day 12 (A,BandC), 15 (D,EandF), 17 (G,Hand 
I) and 21 (J, K and L). The antibodies were 
developed with NBT/BCIP (purple nuclei) and the 
tissue sections were lightly stained with neutral red. 
The arrows indicate positive HNF-la labeled cells. 
Original magnification: 200 X. 
manner to endogenous human SI mRNA during 
cellular differentiation (Fig. 2C and D). In 
contrast, the SIFl mutant construct showed 
stable level of hGH expression during 
differentiation (Fig. 2C and D) and was 
comparable to the level detected in Caco-2/15 
stably co-transfected with the empty vector 
(Fig. 2C and D). These results indicate that the 
SIF1 element is essential to activate the SI 
promoter in vivo. 
The combined temporal and spatial distribution 
ofHNF-1 a; GATA-4 and Cdx2 correlates well 
with the induction of SI expression during the 
suckling-weaning transition--Although our 
results demonstrate that the SIF1 element is 
essential for SI gene transcription in 
enterocytes, it is unlikely that Cdx proteins 
alone are responsible for the strong induction of 
SI expression during the suckling-weaning 
transition. Indeed, the pattern of Cdx2 protein 
expression remains primary unchanged 
throughout post-natal development and the 
Cdx 1 protein is mainly found in the crypt 
compartment where SI is not expressed (13). 
Since HNF-lo: and GATA-4 interact with the 
SI promoter (Fig. 1 ), we investigated the 
expression profile of these proteins by 
immunohistochemistry from post-natal day 12 
to post-natal day 21. This transition period 
reflects the major changes observed for SI gene 
expression (6). The Cdx2 protein distribution 
was monitored as a reference control. 
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At post-natal day 12, a period of time when SI is undetectable in the small intestine, the HNF-lo: 
protein was detected in the nucleus of very rare enterocytes of the jejunum (Fig. 3A, upper 
panel). This pattern was observed throughout the entire small intestinal tract (data not shown). 
In contrast, HNF-lo: was detected in the nucleus of mostly all epithelial cells of the proximal 
colon (Fig. 3A, lower panel). The GATA-4 protein was mainly detected in the nucleus of 
enterocytes localized in villi of the jejunum (Fig. 3B, upper panel) whereas it was undetectable in 
the ileum (data not shown) as well as the colon (Fig. 3B, lower panel). Cdx2 protein was mainly 
detected in villus-enterocytes of the small intestine as well as in the surface colonocytes of the 
proximal colon with the use of the CNL antibody that recognizes the unphosphorylated form of 
the serine 60 residue ofCdx2 (15)(Fig. 3C). At post-natal day 15, HNF-la became detected in 
the nucleus of enterocytes localized mainly at the crypt-villus junction in the jejunum while the 
pattern in the proximal colon remained the same as compared to post-natal day 12 (Fig. 3D). 
GATA-4 was restricted to the nucleus of villus enterocytes in the jejunum (Fig. 3E, upper panel) 
and remained undetectable in the colon (Fig. 3E, lower panel). Cdx2 remained unchanged 
compared to day 12 (Fig. 3F). At post-natal day 17, HNF-la and GATA-4 were primarily 
detected in all enterocytes of the villus compartment in the jejunum (Fig. 3G and H) and the 
ileum (not shown) while the Cdx2 pattern remained unchanged as compared to previous time 
points (Fig. 31). GATA-4 remained undetectable in the colon (Fig. 3H, lower panel). From post-
natal day 21 to adulthood, HNFlo: was detected along the entire axis of the small intestine in 
abundance in the nucleus of villous enterocytes with only rare positively stained nuclei in crypt 
epithelial cells (Fig. 31). GATA-4 protein was detected in the nucleus of villous epithelial cells 
of the entire small intestine (Fig. 3K, upper panel) with no detectable signal in the colon (Fig. 
3K, lower panel). Cdx2 localization was comparable to the earlier time points during 
development (Fig. 3L). 
To confirm the changes observed in HNF-lo: and GATA-4 expression, western blots 
were performed with nuclear extracts obtained from isolated enterocytes at different time during 
post-natal development. A profound increase in HNFI o: protein level was observed during the 
suckling-weaning transition, while the level ofHDAC-2, a protein used as a control, remained 
relatively unchanged (Fig. 4A). GATA-4 protein level was decreased toward the distal part of the 
intestine at both days 17 and 22 with no detectable level in the colon (Fig. 4B). While the level 
of Cdx2 protein increased toward the distal part of the intestine, both HNF-lcx. and HDAC-2 
proteins remained relatively unchanged (Fig. 4B). Thus, HNF-lo: and GATA-4 are subjected to a 
complex regulation during post-natal development that parallels the restricted induction of SI 
gene transcription in the differentiated epithelium of the small intestine (5,6,31 ,32). 
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Fig. 4. Western analysis of HNF-lcx, GATA-4 and Cdx2 in 
the mouse intestinal epithelium during the suckling-
weaning transition. A, Nuclear extracts were prepared from 
isolated epithelial cells of the jejunum from post-natal (p.n.) 
day 13 to day 24 and analyzed by western with the use of an 
HNF~la polyclonal antibody. The blot was striped and 
incubated with an HDAC-2 polyclonal antibody to monitor 
protein integrity. B, Nuclear extracts were prepared from 
isolated epithelial cells of the jejunum (Je), ileum (II) and 
proximal colon (PC) at post-natal day 17 and 22 and analyzed 
by western with the use ofHNF-la, GATA-4, Cdx2 and 
HDAC-2 polyclonal antibodies. 
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HNF-1 a:, GATA-4 and Cdx2 interact in vitro and in vivo--We next explored whether 
HNF-la, GATA-4 and Cdx2 could physically interact. An in vitro GST pull-down assay was 
performed with the use of recombinant GST-GATA-4 and GST-HNF-la proteins and in vitro-
translated [35S] methionine-labeled HNF-la, GATA-4 and Cdx2 proteins (Fig. 5A). The GST-
GATA-4 recombinant protein was able to pull-down Cdx2 protein as opposed to the GST protein 
or beads alone (Fig. 5A, left panel). Furthermore, GST -HNF-1 a was able to interact with 
GATA-4 and Cdx2 proteins (Fig. 5A, right panel). The interaction still occurred when both 
GATA-4 and Cdx2labeled proteins were simultaneously included with GST-HNF-la (Fig. 5A). 
To test whether HNF-la, GATA-4 and Cdx2 could interact natively, we conducted an IP-EMSA 
experiment with the use of protein extracts from HEK293T cells co-transfected with FLAG-
Cdx2 or empty FLAG (control), both in the presence ofHNF-la and GATA-4 expression 
vectors. Irnmunoprecipitated FLAG-Cdx2 (F-Cdx2) extract interacted with the SIFl element 
whereas the immunoprecipitated FLAG (F) did not produce any specific band (Fig. 5B, lanes 1 
and 2). The IP-F-Cdx2 produced specific complexes when incubated with the SIF3 or GATA 
labeled oligonucleotides in contrast to the IP-F control extract (Fig. 5B, compare lanes 4 and 7 to 
lanes 3 and 6). The addition ofHNF-la or GATA-4 polyclonal antibodies resulted in the 
supershift ofSIF3 and GATA upper complexes respectively, confirming the presence of these 
proteins in the IP-F-Cdx2 complex (Fig. 5B, lane 5 and 8). These results suggest that native 
HNF-la, GATA-4 and Cdx2 proteins co-exist in a same complex. 
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Fig. 5. HNF-la., GATA-4 and Cdx2 physically interact. 
A, A GST pull-down assay was performed with GST-
GAT A-4 (gst-04 left panel), GST-1-lliF-la (right panel) or 
GST (as a control of specificity) attached to Sepharose beads 
and incubated with in vitro translated e5s] methionine-
labeled HNF-la (H-la, lane 5), GATA-4 (04, lanes 6, 8, 9 
and 11) and Cdx2 (lanes 2, 3, 4, 7, 8, 10, 11) proteins. After 
repeated washing procedures, the labeled proteins were 
subjected to a SDS-PAGE and detected by autoradiography. 
B, beads; I, 20% input. B, An IP-EMSA was performed with 
the use of total extracts from HEK293T co-transfected with 
empty-FLAG, HNF-la and GATA-4 expression vectors (IP-
F) or with FLAG-Cdx2, 1-lliF-la and GATA-4 (IP-F-Cdx2). 
Following the IP, proteins attached to the beads were 
dissociated by deoxycholate treatment and subjected to an 
EMSA with the use of SIFI-labeled oligonucleotides (lanes 
1 and 2), SIF3-labeled oligonucleotides (lanes 3 to 5) or 
GATA-al-globin-labeled oligonucleotides (lanes 6 to 8). 
When indicated, specific antibodies (ab) for HNF-la (a) 
and GATA-4 (G4) were included in the binding reaction for 
supershift analysis (arrows). Uncharacterized complexes are 
indicated by asterisks. 
HNF-1 a; GATA-4 and Cdx2 cooperate to activate intestinal promoter activity-To 
further characterize the functional significance of the protein-protein interaction among HNF-la, 
GATA-4 and Cdx2 on SI gene transcription, we performed co-transfection experiments in Caco-
2 cells with the use of the SI promoter linked to a luciferase gene reporter. Similar constructs 
harboring mutations within HNF-1, GATA and Cdx interacting sites were also used to monitor 
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the specificity of these interactions (Fig. 6A). These mutations have been previously 
characterized by EMSA (10,37). Co-transfection of either Cdx2 or HNF-la. expression vector 
with the SI promoter construct increased the transcriptional activity whereas co-transfection of 
the GATA-4 expression vector alone did not significantly influence SI activity in Caco-2 cells 
(Fig. 6B). 
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Fig. 6. HNF-1, GATA-4 and Cdx2 synergistically activate the intestinal SI promoter in Caco-2 cells. A, 
Diagram of the SI and IPAL constructs used in co-transfections. The different mutations within the SIF3, GATA and 
SIFl elements are underlined. B, Caco-2 cells were co-transfected using LipofectAMINE with 300 ng of SJ-
luciferase or IP AL-luciferase reporter vectors, 2 ng of CMV -renilla, and different combinations of Cdx2 (50 ng), 
HNF-la (150 ng) and GATA-4 (200 ng) expression vectors. The pRC/CMV plasmid was used as an empty vector 
to calibrate the various amounts of expression vectors used in each condition. Results obtained in triplicate were 
reported as fold difference (mean± SD) from transfections with the reporter construct alone and are representative 
of three independent experiments. C, Western blot analysis was performed with the use of HNF-1 a, GAT A-4, Cdx2 
and actin antibodies on protein extracts from Caco-2 cells co-transfected as described in B.D, Caco-2 cells were co-
transfected with Cdx2, HNF-la and GATA-4 expression vectors in combination with wild-type or mutant SI-
luciferase constructs. E, Western blot analysis was performed on protein extracts from Caco-2 cells co-transfected as 
described in D. 
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Although some minor synergy in the transcriptional activation of SI was observed when both 
Cdx2 and HNF-la were combined, the addition ofGATA-4 with both Cdx2 and HNF-la 
enhanced the synergistic activation of the SI promoter (Fig. 6B). This effect was observed only 
when Cdx2 and HNF-la were simultaneously co-transfected with GATA-4 (Fig. 6B). Similar 
results were obtained when an IPAL (intestinal phospholipase A/lysophospholipase) promoter-
luciferase construct was used in the co-transfection assay (Fig. 6B), suggesting that the 
interaction among HNF-la, GATA-4 and Cdx2 could be important for the regulation of other 
intestinal genes. A Western blot was performed in parallel to confirm the production ofHNF-la, 
GATA-4 and Cdx2 proteins in these co-transfection experiments (Fig. 6C). Individual mutations 
within the HNF-1 and Cdx sites of the SI promoter resulted in a reduction of the synergistic 
effect ofHNF-la.:, GATA-4 and Cdx2 on SI gene promoter activity, while a mutation in the 
GATA site did not affect the combined effect of these factors on SI transcriptional activity (Fig. 
6D). A western blot confirmed that similar levels ofHNF-la.:, GATA-4 and Cdx2 proteins were 
produced in these co-transfection experiments (Fig. 6£). These results confirmed that GA TA-4 
synergies with HNF-la and Cdx2 in the transcriptional activation of the SI promoter and that a 
functional GAT A-interacting site is not required for this effect. 
DISCUSSION 
The understanding of molecular mechanisms that govern tissue-specific gene expression 
often lead to the identification of transcription factors responsible for tissue specialization and 
maturation. In the past and herein, we used the SI gene as a model to study the molecular basis -of 
the establishment and maintenance of the intestinal phenotype. A short evolutionarily conserved 
SI promoter contains cis-acting elements that interact with HNF-la, GATA-4 and Cdx proteins. 
Interestingly, similar elements are present in a number of intestinal specific gene promoters such 
as !PAL (29), lactase-phlorizin hydrolase (21,38,39), and iFABP (24,40). We have recently 
described the importance of the HNF-1 and GATA elements in the regulation ofSI promoter 
activity in vivo (18,20). In the current study, we showed that the Cdx element is essential for SI 
gene transcription. Our findings also indicated that HNF-la.: protein expression was induced in 
the villous epithelium during the suckling-weaning transition. In addition, GATA-4 protein was 
restricted to the villous epithelium with a decreasing gradient of expression along the horizontal 
axis of the intestine. We demonstrate that HNF-la, GATA-4 and Cdx2 interact and cooperate 
for the transcriptional activation of intestinal specific genes. Our results imply that the Cdx 
element is required for SI gene transcription but that combinatorial interactions ofHNF-la.:, 
GATA-4 and Cdx2 are important for the temporal and spatial regulation of SI gene expression 
during post-natal development. 
The HNF-la protein is detected in only few epithelial cells in suckling animals to 
become progressively expressed in differentiated enterocytes during the suckling-weaning 
transition. In adult mice, HNF-la.: mRNA has been found to be highest in crypts of the small and 
large intestine with a decreasing gradient along the vertical axis (19). Our analysis shows that 
HNF-la protein is abundantly detected in the villous enterocytes with only minor expression in 
the crypt compartment. The molecular network involved in the regulation ofHNF-la has been 
partly characterized in embryoid bodies (41) but remains largely unkno\Vtl in the intestinal 
epithelium context. GATA-4 protein expression is also restricted to villous epithelial cells but is 
not expressed in the most distal part of the intestine. GATA-4 transcripts were originally 
reported to be present in the mouse small intestinal villus region and undetectable in the colon 
(23). Other studies have reported that the GATA-4 rnRNA was localized in the entire tract of the 
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intestinal epithelium late in mouse embryonic development ( 42) and up-regulated along the 
crypt-villus axis in chicken (24). Our findings demonstrate that the GATA-4 protein is restricted 
to the small intestinal villus region and absent in the colon, a pattern that is established early 
during embryonic development2• The molecular mechanisms that control GATA-4 expression 
are still to be determined. Our findings coupled to others suggest that regulation ofHNF-la and 
GA TA-4 rely on transcriptional and post-transcriptional mechanisms that promote the 
regionalization of gene expression along both the horizontal and vertical axis during intestinal 
development. 
The overall distribution ofHNF-la, GATA-4 and Cdx2 proteins during the suckling-
weaning transition corresponds well with the induction of SI (6) and !PAL (43) mRNA 
expression. Nevertheless, it is likely that post-translational modifications may play a role in the 
functional interaction of these factors to regulate intestinal gene transcription. We have 
previously reported that phosphorylation of the serine-60 residue within the Cdx2 protein that 
occurs in the crypt compartment reduces its transactivation capacity (15). The phosphorylation of 
GATA-4 by certain activated-kinase pathways influences both binding and transactivation 
potency (44,45). Two different GATA family members (GATA-1 and GATA-3) are direct 
targets ofCREB-binding protein (CBP) histone acetyltransferase activity (HAT) and the 
acetylation of family-conserved GAT A-specific domains results in the modification of their 
activation capacity (46-48). In addition, other transcription factors and co-factors are likely to be 
involved in the modulation ofSI gene expression. For example, Cux/CDP interacts with and 
represses SI promoter activity via an element that encloses the GA TA site (20). Furthermore, 
Cdx2 and GATA-4 interact with the cofactor p300 (49,50) while HNF-la interacts with both 
CBP and CBP-associated factor (PCAF) (51). Whether these post-translational and physical 
interactions occur along the vertical and horizontal axis of the intestine during development 
remains to be determined. 
The Cdx2 and HNF-la proteins can interact via their respective homeodomain region in 
vitro (52). Our results suggest that Cdx2, HNF-la and GATA-4 all interact with each other and 
are part of a same complex. However, detailed mechanisms and nature of the domains involved 
for the formation of a stable complex with transcriptionally active intestinal genes in vivo will 
need further studies. It has been suggested that GAIA proteins can influence the activity of 
certain gene promoters without physically interacting with DNA but through physical 
interactions between other proteins binding to regulatory elements of the promoter (53). GATA-
5 and HNF-la cooperatively activate the lactase gene promoter, an effect that is independent of 
intact GATA interacting site (21). Our results suggest that the transcriptional activation of the SI 
promoter by GATA-4 does not require an intact GATA site but depends on Cdx2 and HNF-1 a. 
Therefore, it is possible that other family members such as GATA-5 and GATA-6 could 
influence SI promoter activity via similar indirect interactions. 
The importance ofCdx2 in the maintenance of the intestinal phenotype has been 
demonstrated in knockout experiments (54,55). Ectopic expression ofCdx2 within the stomach 
epithelium results in the formation of intestinal metaplasia (56). The GATA-4 protein plays a 
role in the specification of the mouse gastric epithelium as demonstrated with the use of chimeric 
mice (57) and stimulates the differentiation of embryonic cells into extraembryonic endoderm 
(58). The possible role ofHNF-la in the formation and maintenance of the gastrointestinal tract 
has not been yet characterized carefully (59,60). The future challenge will be to investigate the 
combinatory roles ofHNF-la, GATA-4 and Cdx2 in the morphogenesis and differentiation of 
the intestinal epithelium during development. 
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FOOTNOTES 
1 The abbreviations used are: SI, Sucrase-isomaltase; SIF, Sucrase lsomaltase Footprint; Cdx, 
Caudal-related homeodomain protein; HNF-1, Hepatocyte Nuclear Factor-1; IPAL, intestinal 
phospholipase Allysophospholipase; PCR, polymerase chain reaction; hGH, human Growth 
Hormone; bp, base pairs; RNase, ribonuclease; DMEM, Dulbecco's modified Eagle's medium; 
NBT, nitroblue tetrazolium chloride; BCIP, 5-Bromo-4-chloro-3-indolyl-phosphate; HRl', 
horseradish peroxidase; PBS, phosphate-buffered saline; EMSA, electrophoretic mobility shift 
assay; GST, glutathione S-transferase; HDAC, histone deacetylase; CBP, CREB-binding 
rrotein; HAT, histone acetyltransferase; PCAF, CBP-associated factor. 
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ABSTRACT 
Cdx-2 is an intestine-specific homeodomain-containing transcription factor that activates 
the promoters of intestinal genes through specific interactions with the consensus sequence, 
TTTAT/C. Here, we demonstrate that Cdx-2 interacts with the lactase-phlorizin hydrolase (LPH) 
promoter at cis-element (CE)-LPH!a (-54 to -40 bp) as well as the LPH TATA-box. Introduction 
of a mutation (TATAtA) into the LPH TAT A-box that disrupts Cdx-2 binding, but not binding of 
the TAT A-binding protein, does not reduce Cdx-2-stimulated activation, suggesting that Cdx-2 
does not activate the LPH promoter through interactions at the T A TA -box. Characterization of 
CE-LPHl a using EMSAs revealed binding of a novel, non-Cdx-2 complex in multiple cell lines 
that is independent of the Cdx-2 binding site. Mutational analysis in transient transfection assays 
revealed a repressor fimction for this protein, and thus it was designated as nuclear factor-
LPHllrepressor (NF-LPH!/R). These data are consistent with the hypothesis that NF-LPHl/R 
represses LPH gene expression in non-Cdx-2-producing cells, and that this repression is released 
in cells that synthesize Cdx-2, such as those in the intestinal epithelium. 
Abbreviation: Lactase-phlorizin hydrolase, LPH; sucrase-isomaltase, SI; cis-element-LPHla, 
CE-LPHla; nuclear factor-LPHllrepressor, NF-LPHl/R; SI footprint!, S!Fl; TATA-box 
binding protein, TBP. 
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INTRODUCTION 
Cdx-2, a member of the homeobox gene family related to Drosophila caudal, is necessary 
for embryonic development, and may play an important role in intestinal differentiation. Mice 
homozygous for the Cdx-2 null mutation fail to implant, and die between embryonic day (E) 3.5 
and 5.5, whereas heterozygous mice develop adenocarcinoma of the small intestine and colon 
[!]. Cdx-2 is first detected at E3.5 in extra-embryonic tissue[!]. Within the embryo, Cdx-2 
expression first occurs at E8.5 in the posterior gut, tailbud, posterior region of the neural tube, 
and unsegmented paraxial mesoderm before the development of somites [1]. In adult mammals, 
Cdx-2 is highly expressed in small intestine and colon [2-5] and is also detected in pancreas [6]. 
In small intestine of adult mice, Cdx-2 is expressed in all epithelial cells in crypts and on villi, 
but only at low levels in Paneth cells at the bases of crypts [7, 6]. Stable transfection ofCdx-2 
into IEC-6 cells results in inhibition of cell gro\Vth and induction of marked morphological 
differentiation suggesting a role for Cdx-2 in cellular differentiation [8]. Together, these data 
suggest that Cdx-2 is important for development and maintenance of a differentiated intestinal 
epithelium. 
Originally shown to bind a conserved region in the sucrase-isomaltase (SI) gene called SI 
footprint 1 (SIFI) [5, 9, 10], Cdx-2 has now been demonstrated to bind to the consensus TTTAY 
(Y is Cor T) and regulate the activity of the promoters of several other intestinal genes, 
including lactase-phlorizin hydrolase (LPH) [11-16], clusterin [17], calbindin-D9K (CaBP9K) 
[18, 19], carbonic anhydrase 1 [20, 21], HOX C8 [9], the vitamin D receptor [22], guanylyl 
cyclase C [23], and human apolipoprotein B [24]. Cdx-2 has also been shown to activate the 
glucagon promoter in a pancreatic islet cell line [25]. In the human LPH gene, a Cdx-2 binding 
site, TTTAC, localized in a region called cis element (CE)-LPHl a at -54 to -40 bp, has been well 
characterized [26, 11-16]. Additional Cdx-2 binding sites, CE-LPHlb [27] and CE-LPHlc [28], 
have been identified in the pig LPH gene. 
Recently, it has been suggested that Cdx-2 may modulate the activity of the promoters of 
certain intestinal genes through interactions at their TATA-boxes. Rat clusterin, a glycoprotein 
that has been associated with apoptosis, and rat and human CaBP9K, a mammalian intestinal 
vitamin-D-dependent Ca2+-binding protein, both have been shown to bind Cdx-2 at their TAT A-
boxes using supershift and competition EMSAs [18, 19, 17]. These studies have suggested that 
Cdx-2 may activate or repress transcription at these sites. In addition, Xu et al. [29] have recently 
demonstrated that Cdx-2 binds to its own TAT A-box and represses Cdx-2 expression. Sequence 
analysis revealed that a Cdx-2 binding site is also present overlapping the rat and human LPH 
TAT A-boxes. Thus, we hypothesize that in addition to Cdx-2 regulation at CE-LPHla, Cdx-2 
may also modulate the activity of the rat and human LPH promoters by interaction at their 
TAT A-boxes. Furthermore, although it is widely known that Cdx-2 binds to CE-LPHla [ll, 13, 
15, 30], several reports have suggested that non-Cdx-2-proteins also bind to CE-LPHla [26, 12, 
28, 14-16]. In this report, we demonstrate that a non-Cdx-2-complex binds at CE-LPHla to a site 
that is independent of the Cdx-2 binding site. This complex is expressed in intestinal as well as 
non-intestinal cell lines, and may repress LPH gene transcription in the absence ofCdx-2. 
EXPERIMENTAL 
Electrophoretic mobility shift assays (EMSAs) 
To characterize specific protein/DNA interactions, EMSAs were carried out using probes 
and competitors as sho'Wll in Fig. 1. 
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Name Sequence Location (bp) 
r37/1 5'-TGTGCTCAT AAAGTI AGGATCCTICCACATGCTTCT -3' rLPH, -37 to -1 
h37/1 5' -GCAGTT AT AAAGT AAGGGTTCCACAT ACCTCCT AACA-3' hLPH, -37 to -1 
h37/1m1 5'-GCAGggcTMAGTAAGGGTTCCACATACCTCCTAACA-3' -----------
h37/1m2 5' -GCAGTT AgccAGT AAGGGTTCCACAT ACCTCCT AACA-3' -----------
h37/1m3 5' -GCAGTT AT AgAGT AAGGGTTCCACAT ACCTCCT AACA-3' -----------
h26/1 5' -GT AAGGGTTCCACAT ACCTCCT AACA-3' hLPH, -26 to -1 
r55/35 5'-ATGTTTTACAGCCTTGGCTGT-3' rLPH, -55 to -35 
h55/37 5' -T A TTTT ACAACCTCAGTTG-3' hLPH, -55 to -37 
h59/37 5' -T ACCT ATTTT ACAACCTCAGTTG-3' hLP H. -59 to -37 
h59/37m1 5'-TACCTATTTTgcAACCTCAGTTG-3' -----------
hSIF1 5'-GGGTGCAA T AAAACTTT ATGAGT A-3' hSI, -57 to -34 
Fig. l:Oligonucleotides used as probes and competitors in EMSAs. The names used in the present study, specific 
sequences (forward strand), and localization in their respective genes are indicated. Cdx-2 binding sites are in bold 
and TAT A-boxes are underlined. An 'm' indicates a mutation introduced into the oligonucleotide and the mutation 
itself is shown in lower case letters. The 'r' and 'h' indicate rat and human sequence, respectively. 
Probes were made by annealing a 10-fold molar excess of 10 base reverse strand oligonucleotide 
to the forward strand, and extending using the large fragment of DNA polymerase I (Klenow, 
Gibco-BRL, Gaithersburg, MD) and [32P] dATP (DuPont-New England Nuclear, Boston, MA) 
as previously described [13]. The specific activity of all probes exceeded l 06 cpmlpmol. EMSAs 
were carried out using 10,000 cpm of probe and 5 ~g of protein from nuclear extracts or in vitro 
transcribed and translated protein, labeled with e5SJ methionine (Redivue™, Amersham-
Pharmacia Life Science, Arlington Heights, IL). Nuclear extracts were prepared as previously 
described [13] and labeled proteins were synthesized using a reticulocyte lysate transcription-
translation system (TNT, Promega Biotech, Madison, WI) according to the manufacturer's 
instructions. In competition or supershift EMSAs, competitors (200-fold molar excess unless 
otherwise indicated) or antibodies (1 J..Ll, undiluted), respectively, were preincubated with the 
nuclear extract for 10 minutes prior to the addition of the probe. The Cdx-2 antibody used in 
supershift assays was a gift from Dr. D. Silberg (University of Pennsylvania) and was previously 
characterized [5]. 
Plasm ids 
The human growth hormone (hGH) gene was used as a reporter in co-transfection assays. 
Human LPH promoter-reporter constructs included h37wt, which contains the TAT A-box, and 
h59wt, which contains the TAT A-box and CE-LPHla (-54 to -40 bp). Specific mutations were 
also introduced into the human LPH promoter sequence of these two constructs. All plasmids, 
including those with introduced mutations, were constructed by PCR using a Kpni-Hindiii 
strategy, as previously described [13]. Heterologous promoter constructs were synthesized by 
inserting single (TK lx) and multiple (TK 4x) copies of wild type -59 to -37 bp sequence of the 
human LPH promoter upstream of the thymidine kinase (TK) promoter by PCR. All constructs 
were confirmed by sequencing. A previously described expression vector for mouse Cdx-2 [5] 
(gift ofr. Traber, U. Penn.) was employed in the present study. pRC-CMV (Invitrogen) served 
as a negative control expression vector for all co-transfection experiments. 
Cell culture and transient co-transfection assays 
Cells were maintained in DMEM (BioWhittaker, Walkersville, MD) supplemented with 5 
IJ.g/ml penicillin-streptomycin and containing 10% FCS. Transient co-transfection assays were 
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carried out by electroporation as previously described [13]. The amount ofhGH secreted into the 
media over 24 h was measured using an e25I] radio-immunoassay kit (Allegro hGH, Nichols 
Institute, San Juan Capistrano, CA). To control for transfection efficiency, all transcriptional 
activities were expressed relative to pXGH5, a constitutively active metallothionine-I promoter. 
Statistics 
The one-way analysis of variance (ANOV A) and Tukey-Kramer or Dunnett multiple 
comparisons tests were employed in all statistical analyses using InStat software (Graphpad 
Software, Inc., San Diego, CA). 
RESULTS 
A Cdx-2 binding site (TTTAT) was identified on the reverse strand overlapping the 
TATA-box of the rat and human LPH genes. To determine ifCdx-2 binds to sequence containing 
these sites, competition and supershift EMSAs were carried out using the -37 to -1 bp regions as 
probes. As shown in Fig. 2, a major complex with a similar mobility was identified with each 
probe using nuclear extracts from Colo-DM cells, which are enriched in Cdx-2 [5]. 
Probe: r37/1 h37/1 
A11ti-Cdx-2: - . - - . 
Competitor: s NS S NS 
sc-
1 2 3 4 5 6 7 8 9 10 
Fig. 2: Cdx-2 binds to the TAT A-box regions of the rat and 
human LPH genes. EMSAs using r37/l and h37/l as probes 
(indicated across the top of the figure) demonstrated a major 
protein-DNA complex (arrowhead) using 5 !lg of Colo-DM nuclear 
extracts. This complex was partially competed using a specific 
oligonucleotide (lanes 3 & 8), but was not competed using a non-
specific (NS) oligonucleotide (lanes 4 & 9), and also formed a 
supershift complex (SC) using a mouse Cdx-2 antibody (lanes 5 & 
10). 
These complexes competed specifically and were supershifted with a Cdx-2 antibody 
demonstrating that they contain Cdx-2. Thus, in addition to the known Cdx-2 binding site in CE-
LPH!a [26, 11, 13, 15, 30], Cdx-2 is also capable of binding to sequence near the LPH TAT A-
box. 
To characterize affinities of the different binding sites for Cdx-2, competition EMSAs 
were carried out using hSIFl as a probe (Fig. 3), which is a previously described test probe for 
Cdx-2 binding [13, 5]. Owing to the two Cdx-2 binding sites in this probe, two complexes, A and 
B, were observed, as previously described [5]. Using titrations of oligonucleotides containing 
each binding site under study, both r37/1 and h37/l revealed weaker affinities for Cdx-2 than the 
previously characterized upstream rat and human binding sites at CE-LPHla (r55/35 and h55/37) 
and hSlFI, with hS!Fl having the highest affinity for Cdx-2, as previously shown [13, 14]. 
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Fig. 3: Cdx-2 has a lower affinity for 
binding sites in the LPH TAT A-box regions 
than those in SIFl and CE-LPHla. EMSAs 
using hSIFI as a test probe and Colo-DM 
nuclear extracts (5 ).lg) revealed two major 
complexes (A and B, lane 1), as previously 
described [5]. Competition EMSAs using a 
20-, 50-, and 200-fold molar excess ofCdx-2 
binding sites LPH promoters (lanes 8-19) as 
well as a non-specific competitor (NS) (lanes 
5-7) revealed that r37/1 and h371l (lanes 14-
16 & 17-19, respectively) do not compete for 
Cdx-2 as well as rat and human CE-LPHla 
(r55/35 and h55/37.lanes 8-10 & 11-13, 
respectively) or hSIFl (lanes 2-4) 
To further localize Cdx-2 binding in the TATA-box region, competition EMSAs were 
carried out using the following probes: h37/l, which includes the human LPH TAT A-box; and 
h26/1, which does not contain the TAT A-box, but includes the first 26 bp of 5' -flanking region 
(Fig. 4A). A B 
Probe· h3711 h2611 Probe· 
Protein: Protein: 
Competitor: ~ ~ ~ ~ ~ ~ ~ ~ 2 ~ 2 Competitor: 
Cdx-21>-
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 
Fig. 4: Cdx-2 binds to the Cdx-2 consensus site overlapping the TAT A-box of the human LPH gene. A: Cdx-2 
binding is localized to -37 to -26 bp. EMSAs were canied out using h37/l (lanes 1-5), which includes the human 
LPH TAT A-box, and h26/1 (lanes 6-10), which does not include the TAT A-box, as probes, and Colo-DM nuclear 
extracts (5 )lg). The h37/1, h26/l, and non specific (NS) oligonucleotides were used as competitors as indicated 
across the top of the figure. Protein-DNA complexes formed with the h26/l probe (lane 7) do not coincide with the 
mobility of the Cdx-2-specific complex (arrowhead) indicating that this probe does not bind Cdx-2. B: Cdx-2 binds 
to the consensus sequence overlapping the TAT A-box. EMSAs were carried out using h37/1 (lane 1-5, 8 & 9), 
h37/lml (lane 6), and h37/lrn2 (lane 7) as probes and Colo-DM nuclear extracts (5 ).lg) or in vitro synthesized 
proteins (lanes 8 & 9). The Cdx-2 complex (arrowhead) formed with labeled h37/l (lane 2) was competed using 
hSIFl (lane 3) and h371l (lane 4), but not with a non-specific (NS) oligonucleotide. Probes with mutations 
introduced into the putative Cdx-2 binding site overlapping the TAT A-box do not bind Cdx-2 (lanes 6 & 7). In 
vitro-synthesized, radio labeled Cdx-2 binds h37/1 (lane 8), further demonstrating the mobility of the Cdx-2/DNA 
complex using a semi-purified protein rather than a nuclear extract. A negative control labeling reaction (ie, TNT 
reaction without template) demonstrates a non-specific signal near the top of the gel (lane 9), but not a Cdx-2-
specific complex. 
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Complexes that formed with the h37/1 probe (lane 2) were competed specifically using excess, 
unlabeled h37/1 oligonucleotide (lane 3), whereas none of the complexes were competed using 
h26/l or a non-specific oligonucleotide (lanes 4 and 5, respectively). In contrast, complexes that 
formed with the h26/l probe (lane 7) were competed specifically with a molar excess of both 
h3711 and h2611 oligonucleotides (lane 8 and 9, respectively). Protein-DNA complexes observed 
with the h26/l probe have different mobilities than those present using the h3711 probe (lanes 7 
and 2) and none form a supershift complex with a Cdx-2-specific antibody (not sho'NTI). These 
data demonstrate that Cdx-2 does not bind to the first 26 bp of the human LPH 5' -flanking 
region, but does bind to a sequence that includes an 11 bp region between -37 and -26 bp, which 
contains the human LPH TAT A-box and the putative Cdx-2 binding site. 
To localize Cdx-2 binding to the consensus sequence overlapping the TAT A-box, 
additional EMSAs were carried out using probes with mutations introduced into the consensus 
sequence (Fig. 4B). The h37/l probe forms multiple complexes, only one of which is competed 
by hSIFl (lane 3), suggesting that this protein-DNA complex (arrowhead) contains Cdx-2. The 
specific oligonucleotide, h37/l, competed all bands (lane 4). Probes containing mutations 
introduced into both the 3' and 5' regions of the Cdx-2 site overlapping the TAT A-box (h37/lml 
and h37/lm2, respectively) were unable to bind Cdx-2 (lane 6 and 7). In addition, in vitro-
synthesized, radiolabeled Cdx-2 demonstrated a single, specific Cdx-2 complex using h37/l as a 
probe (lane 8). These data show that Cdx-2 binds to the consensus sequence overlapping the 
TAT A-box in the human LPH promoter. 
Cdx-2 is known to bind and activate the LPH promoter at CE-LPHla[ll-16], but the 
interaction ofCdx-2 with the LPH TAT A-box is a novel finding. To characterize the function of 
the Cdx-2 binding sites at CE-LPHla and overlapping the TAT A-box, transient co-transfection 
assays were carried out in Caco-2 cells using wild type (h37wt and h59wt) and mutated human 
LPH promoter-reporter constructs and the pRC-CMV and Cdx-2 expression vectors. The h37m3 
construct has a mutation in the Cdx-2 binding site overlapping the TAT A-box that disrupts Cdx-
2 interactions as confirmed by competition EMSAs (not sho'NTI), but does not disrupt TBP-
TATA interactions [31]. The h59ml construct has a mutation in CE-LPH1 a that is known to 
disrupt Cdx-2 binding [15]. As shown in Fig. 5, h37wt, which does not contain CE-LPHla, was 
activated 8-fold over baseline by Cdx-2, suggesting that Cdx-2 may activate this construct 
through interactions at other sites, perhaps though the site overlapping the TAT A-box. 
:;:.0 081 
·;; 
~ 
• 0 
r:J 
0 
h37 wt h37 m3 h59 wt 
Constructs 
j 
h59 m1 
Fig. 5: Identification of Cdx-2 response elements in the 
human LPH promoter. Transient co-transfection assays were 
carried out using wild-type and mutated human LPH promoter 
sequence fused to the human gro\\ih hormone reporter, as 
described in Experimental. Transcriptional activities are 
expressed relative to that of the active metallothionine 
promoter. Values are mean± SEM ofn = 4. Values with the 
same letter are significantly different a, b, P < 0.01; c, P < 
0.001, using the Tukey-Kramer test. 
However, introduction of a mutation into this site, as revealed by h37m3, did not reduce the 
transcriptional response to Cdx-2, suggesting that an intact Cdx-2 binding site overlapping the 
TATA box does not mediate Cdx-2 activation. The h59wt construct was activated 24-fold by 
Cdx-2. The Cdx-2-stimulated transcriptional activity ofh59wt was significantly greater than that 
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ofh37wt (p < 0.01), suggesting that the addition ofCE-LPH-la results in a greater activation of 
the LPH promoter by Cdx-2. Introduction of a mutation into CE-LPH la (h59ml) that is known 
to disrupt Cdx-2 binding to DNA [15] resulted in a significantly reduced Cdx-2-mediated 
activation as compared to the wild type h59-wt construct (p < 0.001 ). This demonstrates that the 
presence of an intact Cdx-2 binding site at CE-LPHla mediates Cdx-2 activation. The Cdx-2-
stimulated transcriptional activity ofh59ml was also lower than that ofh37wt and h37m3 (p < 
0.01) suggesting the presence of a silencer between -59 and -37 bp of the human LPH promoter. 
Taken together, these data suggest that Cdx-2 activates the LPH promoter through interactions at 
CE-LPHla, but not through interactions with the Cdx-2 binding site overlapping the TAT A-box, 
and that a silencer may be present within human CE-LPHla. 
Although it is widely known that Cdx-2 binds to a in CE-LPHla [11-16], several reports 
have suggested that non-Cdx-2-proteins also bind to CE-LPHla [28, 15, 16]. To characterize 
such proteins, EMS As were carried out using CE-LPHla (h59/37) as a probe and nuclear 
extracts from different cell lines (Fig. 6A). Nuclear extracts from Caco-2 cells form a previously 
characterized protein-DNA complex (lane 2, arrowhead) [26, 11, 13, 15, 30]. Nuclear extracts 
from non-intestinal cells, including HeLa, Hep-G2, MDCK. and NIH/3T3 cells, each form a 
protein-DNA complex with a slower mobility (lanes 3-6) than that ofCdx-2. 
A 
Nuclear extract: -
NF-LPH1/R~ 
Cdx-211> 
B 
Protein: 
AnU-Cdx-2: 
sc-
NF-LPH1/R-
Cdx-2J~> 
Fig. 6: A novel complex binds CE-LPHla in 
multiple cell lines. A: Alternative binding to 
'l>cP"" ;;{;-<>:. CE-LPHla. EMSAs were carried out using 
1~ ~ h59/37 as a probe and nuclear extracts from 
- + - + multiple cell lines (indicated across the top of 
the figure). Nuclear extracts from Caco-2 cells 
show the Cdx-2/DNA complex (arrowhead, lane 
2). Nuclear extracts from HeLa, Hep-G2, 
MDCK, and NIH!3T3 cells reveal a 
proteinJDNA complex (arrow, lanes 3-6) with a 
slower mobility than that of the Cdx-2/DNA 
complex. This complex reveals repressor 
characteristics and is therefore called nuclear 
factor LPH-1/repressor (NF-LPHl/R). B: 
Alternative complex does not contain Cdx-2. 
Supershift EMSAs were carried out using 
h59/37 as a probe and nuclear extracts Caco-2 
and NIH/3T3 cells. Addition of a Cdx-2 
antibody revealed a supershift complex (SC) 
with Caco-2 nuclear extracts (lane 3), but not with NIHI3T3 nuclear extracts (lane 5) indicating that the alternative 
complex does not contain Cdx-2. 
This complex does not contain Cdx-2, as revealed by supershift EMSAs using NIH/3T3 nuclear 
extracts and a Cdx-2 antibody (Fig. 6B). These data suggest an alternative binding activity 
occurring at CE-LPHla in multiple cell lines that is distinct from Cdx-2. As shown below, this 
complex reveals repressor characteristics and is therefore called nuclear factor LPH-1/repressor 
(NF-LPHl/R). 
To characterize the DNA binding characteristics ofNF-LPHl/R, competition EMSAs 
were carried out using Caco-2 and NIH/3T3 nuclear extracts (Fig. 7). Caco-2 cells were used as a 
source ofCdx-2 in order to define the mobility of the Cdx-2 complex, and NIH/3T3 cells were 
chosen because these cells demonstrate abundant NF-LPHl/R and do not synthesize Cdx-2 (Fig. 
6). 
Protein: 
Competitor: 
NF-LPH1/R-
Cdx-2 .. 
Caco-2 NIH/3T3 
1 2 3 4 5 6 7 8 9 10 11 
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Fig. 7: NF-LPHl/R does not bind to the consensus Cdx-2 site. 
EMSAs were carried out using h59/37 as a probe and nuclear 
extracts from Caco-2 or NIH/3T3 cells. Nuclear extracts from Caco-2 
cells (lane 2) revealed binding ofCdx-2 (arrowhead, lane 2). The 
h59/37 and hSIFI oligonucleotides competed for Cdx-2, but h59/37ml 
and a non-specific (NS) oligonucleotide did not compete for Cdx-2 
(lanes 3-6, respectively). Nuclear extracts from NIH/3T3 cells (lane 7) 
revealed binding ofNF-LPHl/R (arrow). The oligonucleotides h59/37 
(lane 8) and h59/37ml (lane 10) competed for NF-LPHI/R, but the 
hSIF l (lane 9) and NS (lane II) oligonucleotides did not compete for 
NF-LPHl/R. 
Nuclear extracts from Caco-2 cells demonstrated a Cdx-2 complex that was competed by h59/37 
and hSIFl, but not by h59/37ml, which does not bind Cdx-2 [15], or a non-specific 
oligonucleotide (NS). In contrast, NF-LPHI!R was competed away by h59/37 and h59/37ml, but 
not by hSIFl or a non-specific competitor. These data demonstrate that NF-LPHl!R binds to a 
different sequence than that ofCdx-2. 
Data from co-transfection assays described in Fig. 5 are consistent with silencer activity 
associated with CE-LPHla. To determine ifNF-LPHl/R is a candidate repressor that binds CE-
LPHla, the -59 to -37 bp region was transferred upstream of the active thymidine kinase (TK) 
promoter, and transient transfection assays were carried out in NIH/3T3 cells, which synthesize 
NF-LPHl/R, but not Cdx-2. As shown in Fig. 8, CE-LPHla was transferred in single (TKlx) 
and multiple (TK4x) copies. 
Transcriptional activation 
f 0,2. 0.4 
~ TK 111111111111111111111111111111111--
TK 1x ~~~~~~~~~~~~~~--
1\Wiiljji &M'i\iliiji ~ TK 4x 11111111111111111--* 
Fig. 8: NF-LPHl/R has repressor activity that is transferable to a heterologous promoter. Transient 
transfection assays were carried out using NIH/3T3 cells, which synthesize NF-LPHl/R, but not Cdx-2. A schematic 
representation of the promoter-reporter constructs is shown on the left. An open box indicates the TK promoter; a 
grey box indicates the h59/37 region; and the solid line indicates the human growth honnone (hGH) reporter. 
Transcriptional activity is expressed relative to pXGH-5 as described in Experimental. Data are mean± SEM of n = 
4. * p<0.05 compared to TK, using the Dunnett test. 
TKlx demonstrated a consistently lower transcriptional activity than that of the TK promoter 
alone, but failed to demonstrate statistical significance. However, TK4x, which contains four 
copies of the -59 to -37 bp region, was significantly lower than that ofTK alone (p < 0.05) 
demonstrating an approximate 50% reduction. These data revealed that in the absence ofCdx.-2, 
but in the presence ofNF-LPHl/R, CE-LPHla mediates silencer activity. These data are 
consistent with the hypothesis that NF-LPHl/R represses the LPH promoter in cells that do not 
produce Cdx-2. 
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DISCUSSION 
Cdx-2 is an intestine-specific homeodomain transcription factor that regulates the 
promoters of intestinal genes through specific interactions with the consensus sequence TTTA Y. 
Here, we show that Cdx-2 not only activates the promoter of the intestinal LPH gene through 
interactions with the consensus site within CE-LPHla at -54 to -40 bp, as previously 
demonstrated by us [13] and others [11-16], but also that Cdx-2 associates with a binding site 
overlapping the LPH TAT A-box. We further show that a non-Cdx-2 protein also interacts with 
CE-LPHla. Our data are consistent with the hypothesis that this protein, termed NF-LPHlJR, 
which is expressed in multiple cell lines, represses the human LPH promoter. 
Our data demonstrate that Cdx-2 is capable of binding to the TAT A-boxes of both the rat 
and human LPH genes. This finding is consistent with previous reports that have shown that 
Cdx-2 binds also to Cdx-2 sites overlapping the TAT A-boxes of other genes, including those of 
rat clusterin [17] and rat and human CaBP9K [18, 19]. For the rat clusterin gene, Cdx-2 activates 
a promoter-reporter construct containing rat clusterin 5 '-flanking and untranslated sequence in 
which a single Cdx-2 binding site overlapping the TAT A-box is present [17]. For the CaBP9K 
genes, which also contain Cdx-2 binding sites overlapping their TAT A-boxes, Cdx-2 both 
activates and represses a reporter fi.rsed to the CaBP9K promoter depending on the promoter (rat 
vs. human) and cell line used for transfection [18, 19]. Cdx-2 may repress the Cdx-2 promoter at 
its own TAT A-box [29]. However, none of these studies [18, 19, 17] introduced a mutation into 
the Cdx-2 consensus binding site overlapping their respective TAT A-boxes, and thus the 
importance of this site for Cdx-2 regulation is unknown. 
In the present study, we introduced a novel mutation into the human LPH TAT A-box that 
disrupts Cdx-2 binding, but not TBP binding. This mutation is based on a study by Wu et. al., 
[31] which showed that the TAT A-box (TATAAA) of the adenovirus major late promoter 
(AdMLP) containing a mutation (TATAtA) binds TBP at a higher affinity than that of the wild 
type sequence, but demonstrates a lower transcriptional activation of the AdMLP promoter. 
Interestingly, a parallel mutation introduced into the TAT A-box of the human LPH gene, which 
disrupts Cdx-2 binding (confirmed by EMSAs), was activated by Cdx-2 to a mean value that was 
not decreased from that ofthe wild type promoter. Since no other Cdx-2 binding sites are present 
within the first 37 bp of the LPH 5' -flanking sequence, Cdx-2 activation of the human LPH 
construct containing only 37 bp of 5' -flanking region is most likely due to direct protein-protein 
interaction with the TBP complex. Similar mechanisms have been reported for the transcriptional 
activation of this construct by GATA and HNF-1 transcription factors [13]. Our data are 
consistent with the hypothesis that Cdx-2 is capable of binding to the Cdx-2 consensus site 
overlapping the LPH TAT A-box, and may even compete with TBP for binding to this site. 
Support for this mechanism is given by a report that suggested competition by Cdx-2 with TBP 
at the TAT A-box of its own promoter [29], and a report that demonstrated competition by PRH, 
a homeodomain protein, with TBP for binding at the TAT A-box of genes expressed in 
hematopoietic cells [32]. The importance ofCdx-2/TATA interactions in vivo is unknovm at this 
time. 
Although it is widely known that Cdx-2 binds to CE-LPHla [11-16], several reports have 
suggested that non-Cdx-2-proteins also bind to CE-LPH!a [28, 15, 16]. Using EMSAs, several 
studies reveal the presence ofnon-Cdx-2 complexes interacting at CE-LPH1a, but none report a 
function associated with this binding activity [26, 11, 12, 14]. Mitchelmore et. a!. [28] suggested 
that a homeodomain protein, HOXCll, interacts at CE-LPH1a and potentiates HNF-1a-
dependent transcription ofthe LPH promoter, but did not report direct protein binding to this 
site. Further, Troelsen et al. [15] reported that a specific mutation outside ofthe Cdx-2 binding 
site at CE-LPHla demonstrated a higher transcriptional activity than that of the wild type 
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promoter suggesting the presence of a silencing element within CE-LPHla, but did not report an 
alternative complex forming at CE-LPHla by EMSAs. The present report links for the first time 
binding of a non-Cdx-2-complex (NF-LPHI/R) to CE-LPHla with repression of the human LPH 
promoter. NF-LPH1!R binds to a site different from that ofCdx-2, and is produced in multiple 
cell lines. Binding ofNF-LPHl/R to CE-LPHla was consistently associated with a decrease in 
transcriptional activity, both in the wild type context (Fig. 5) and as a heterologous promoter 
(Fig. 8), supporting a repressor role for this protein complex. 
The close proximity ofCdx-2 and NF-LPHI/R binding within CE-LPH!a suggests that 
the binding of these proteins is mutually exclusive. The complex that binds to CE-LPH1a (Cdx-
2 and NF-LPHl!R) would therefore depend on the relative abundance and affinity of each 
protein for their respective consensus binding sites. Accordingly, NF-LPHl!R could act as a 
general repressor ofLPH gene transcription in multiple tissues, but in the presence ofCdx-2, 
such as in intestinal epithelium, Cdx-2 could preferentially bind CE-LPHla and activate the LPH 
promoter in a tissue-specific manner. We have previously sho-wn that GATA and HNF-1 
transcription factors synergistically activate an LPH promoter-reporter construct containing 118 
bp of 5'-flanking sequence, which includes GATA and HNF-1 binding sites [13, 33]. This and 
the present study support a model in which NF-LPHl!R acts as a repressor ofLPH transcription 
in non-Cdx-2 producing cells (i.e., non-intestinal cells), that this repression is released by Cdx-2, 
and that overlapping expression of GAIA factors with HNF-1a. results in high levels of 
intestine-specific LPH gene expression. 
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ABSTRACT 
GATA-4, -5, and -6 zinc finger and HNF-la homeodomain transcription factors are 
expressed in the intestinal epithelium and synergistically activate the promoter of intestinal 
genes. Here, we demonstrate that GATA-5 and HNF-la physically associate both in vivo and in 
vitro, and that this interaction is necessary for cooperative activation of the lactase-phlorizin 
hydrolase (LPH) promoter. Further, physical association is mediated by the C-terminal zinc 
finger ofGATA factors and the homeodomain ofHNF-la. Deletion ofHNF-la activation 
domains or interruption ofHNF-1 binding sites in the LPH promoter results in a complete loss of 
cooperativity, whereas deletion ofGATA-5 activation domains or interruption ofGATA binding 
sites results in a reduction, but not an elimination of cooperativity. We hypothesize that 
GATA!HNF-la:-cooperativity is mediated by HNF-la through its activation domains which are 
oriented for high levels of activation through binding to DNA and physical association with 
GAIA factors. These data suggest a paradigm whereby intestine-specific gene expression is 
regulated by unique interactions among tissue-restricted transcription factors co-expressed in the 
intestine. Parallel mechanisms in other tissue as well as in Drosophila suggest that zinc 
fingerlhomeodomain interactions are an efficient pathway of cooperative activation of gene 
transcription that has been conserved throughout evolution. 
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INTRODUCTION 
The intestinal epithelium is a dynamic structure that undergoes a highly regulated process 
of cell division, migration, cell fate determination, and differentiation (l-3). During intestinal 
development, interactions bet\veen visceral endoderm and mesoderm at E8 in mice result in the 
formation of a primitive foregut that rapidly undergoes cytodifferentiation so that by El9, an 
epithelial monolayer overlies nascent villi. During the first two weeks of postnatal life, a 
proliferating compartment develops into the crypts ofLieberktihn. Stem cells located near the 
base of crypts rapidly divide and give rise to four terminally differentiated cell types, which 
migrate both basally and apically. Cells migrating to the base of crypts become Paneth cells, 
whereas those migrating up the crypt toward villi become absorptive enterocytes, goblet cells, 
and enteroendocrine cells. At the crypt-villus junction, the proliferative phase ends and cells 
acquire a differentiated phenotype characterized by the synthesis of functionally relevant 
proteins. The cells continue to migrate up the villi, enter an apoptotic cycle, and are shed into the 
intestinal lumen approximately three days after their initial appearance on villi. The molecular 
mechanisms underlying the dynamic processes of intestine-specific gene expression and cellular 
differentiation during development are poorly understood. 
Absorptive enterocytes comprise ~95% of epithelial cells on villi and are the cells 
responsible for the terminal digestion and absorption of nutrients. Lactase-phlorizin hydrolase 
(LPH), the enzyme critical for the digestion of milk lactose, is an absorptive enterocyte-specific 
protein that serves as a marker for intestine-specific gene expression and intestinal differentiation 
(4,5). In rats, LPH mRNA is detected as early as E18 in the proximal intestine when primitive 
villi are formed (6). LPH expression is highest at birth and continues to be highly expressed 
throughout the suckling period. After weaning, LPH expression per enterocyte is reduced and is 
also restricted to the jejunum and proximal ileum ( 4,5). This developmental decline also occurs 
in humans at around age 5, although a subset of the human population continues to synthesize 
high levels ofLPH throughout adulthood (7,8). The close correlation between the lactase activity 
and its mRNA in rats ( 4,9), and humans (10, 11 ), and transcription rate experiments (4) indicate 
that LPH is regulated mainly by gene transcription. 
Transgenic studies indicate that information for enterocyte-specific LPH gene expression 
in vivo is contained in the 5'-flanking region (12-14). Identification of specific binding sites 
within the first 100 bp of 5'-flanking region in the LPH genes of several species has led to the 
demonstration that GATA, hepatocyte nuclear factor-lex. (HNF-la), and Cd.x-2 transcription 
factors are activators of the LPH promoter (15-21). Due to the close proximity ofGATA and 
HNF-1 sites on the LPH promoter, and the near-exclusive co-expression of these two families of 
transcription factors in intestinal epithelium (22-29), we hypothesized that members of the 
GATA and HNF-1 families of transcription factors interact to modulate LPH gene expression. 
The GATA family of transcription factors has been implicated in cell lineage 
differentiation during vertebrate development. Defined by two evolutionarily conserved zinc 
fingers of the motifCys-X2-Cys-X17-Cys-Xz-Cys that mediate binding to the consensus DNA 
sequence WGATAR (W ~A or T, R ~A or G), the GATA family is generally categorized into 
two classes based on expression patterns and amino acid homologies. GATA-1, -2, and -3 are 
expressed in developing bone marrow cells and are critical for hematopoiesis (30), whereas 
GATA-4, -5, and -6 have a more diverse pattern of expression that includes small intestine, 
heart, liver, lung, and gonad (22-24,31-33). The GATA-4, -5,-6 subfamily has been shown to 
modulate promoter function of intestinal genes including the rat and human LPH (16,17,21 ), 
human sucrase-isomaltase (SI) (21 ), and Xenopus intestinal fatty acid binding protein (I-F ABP) 
(25) genes. Although the wide-ranging expression patterns ofGATA-4, -5, and -6 argue against 
these proteins as being master regulators of tissue- or cell-type-specific gene expression, there is 
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increasing evidence that this subfamily might be critical in regulating cell-specific gene 
expression through unique interactions with other semi-restricted transcription factors and co-
factors (34). 
HNF-la is a member of a transcription factor family that contains a modified 
homeodomain and binds as dimers to the consensus sequence, GTTAATNATTAAC (35,36). 
Originally thought to be liver-specific, HNF-la is expressed in the intestinal epithelium (26-
29,37), and has been shown to modulate the promoter of many genes expressed in the intestine 
(18,20,21,38-45). We have recently shown that GATA subfamily members and HNF-la 
synergistically activate the LPH and SI promoters (21), suggesting that members of these t\vo 
transcription factor families interact to produce high levels of enterocyte-specific gene 
expression. 
The goal of the present experiments was to characterize the role that GAIA and HNF-la. 
transcription factors play in regulating intestine-specific gene expression by defining the 
mechanism by which these two transcription factors function to synergistically activate the 
human LPH promoter. In these studies, the importance of critical structures in GAIA factors and 
HNF-la, including domains responsible for protein-protein interaction, DNA-binding domains, 
and activation domains, for cooperative activation was determined. Using GATA-5 as a model, 
the results of this study reveal that physical association bet\veen GATA-5 and HNF-la is 
required for the synergistic activation of the human LPH promoter, and that this interaction 
occurs through the C-terminal zinc finger and basic region ofGATA-5 and the horneodomain of 
HNF-la. Identification of parallel mechanisms of protein-protein interaction between zinc finger 
and homeodomain proteins in other vertebrate tissue (46-48) as well as in Drosophila (49,50) 
suggest that zinc fingerlhomeodomain interactions are an efficient mechanism for synergistic 
activation of gene transcription that has been conserved throughout evolution. 
MATERIALS AND METHODS 
Plasmids~Previously characterized expression vectors for mouse GATA-4 (G4-CMV), 
(51), GATA-5 (G5-CMV), (24) (gifts ofM. Parmacek, University of Pennsylvania) and HNF-
la (27) (gift of G. Crabtree, Stanford University) were obtained for these studies. Since the 
original HNF-la expression vector replicates inefficiently during bacterial amplification, the 
HNF-la coding region was PCR-amplified (5'-
ATACGGATCCATGGTTTCTAAGCTGAGCCAGCTG-3' and 5'-
GTATGAATTCCTTACTGGGAAGAGGAGGCCATCTG-3') and subcloned into the BamHI 
and EcoRJ sites of pcDNAl (called Hla-CMV). This plasmid was amplified efficiently in E. coli 
DH5a cells. 
For in vivo protein-protein interaction studies, an expression vector for FLAG-tagged 
GATA-5 (G5-FLAG) was constructed by fusing the GATA-5 coding region to that of FLAG in 
the pFLAG-CMVTM_2 expression vector (Sigma). This was done using site-directed mutagenesis 
(52) by inserting a second EcoRI site at the 5' side of the GATA-5 coding region (mutagenic 
oligonucleotide, 5'-CTTTGGTACATGGAA TTCGAGAGCTCCCAAC-3') resulting in EcoRJ 
sites flanking the open reading frame. The GATA-5 coding region was then subcloned in-frame 
into the EcoRI site of pFLAG-CMV™-2, oriented by restriction digests, and confirmed by 
sequencing. 
For in vitro protein-protein interaction studies, glutathione S-transferase (GST) fusion 
vectors were constructed for GATA-5 (GST-G5) and HNF-la (GST-Hla). GST-G5 and GST-
Hla were made by site-directed mutagenesis and PCR amplification, respectively, by 
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introducing Bamm and EcoRI sites adjacent to the start and stop codons: GATA-5, 5'-
CAAGCTTTGGTACATGGATCCTCCCCGCGCGA-3', 5'-
GGTGACAGTTTCCGAATTCCCTAGGCCAAG-3'; HNF-la, 5'-
ATACGGATCCATGGTTTCTAAGCTGAGCCAGCTG-3', 5'-
GT ATGAATTCCTTACTGGGAAGAGGAGGCCATCTG-3'. Both constructs were 
subsequently subcloned in-frame into the BamHI and EcoRI sites ofpGEX-2TK (Promega). The 
constructs were confirmed by sequencing. 
For transfection studies, the human LPH promoter containing 118 bp of 5' -flanking 
region was fused 5' to the human growth hormone reporter (called h118wt), as previously 
described (21). This region contains two GAIA sites and an HNF-1 site as previously described 
(21). Transcription factor-DNA interactions were characterized, in part, using human promoter-
reporter constructs containing mutations in the two GATA sites (hll8mG 1G2), in the HNF-1 
site (hll8mH), and in all three sites together (hll8mGlG2H). Mutations introduced into these 
sites, have been previously shovro to disrupt specific protein-DNA interactions (21). pRC-CMV 
(Invitrogen) served as a negative control expression vector for all co-transfection experiments. 
Immunoprecipitation of FLAGTM..tagged protein-In vivo GA TA-5/HNF-la interactions 
were determined by supershift EMSA detection ofHNF-la in proteins from Cos-7 cells co-
transfected with G5-FLAG and Hla-CMV and immunoprecipitated with anti-FLAG antibodies. 
Cos-7 cells were co-transfected at 70% confluence with G5-FLAG and H1a-CMV using 
Effectene™ reagent (Qiagen) according to the manufacturer's protocol. After two days, 
confluent 100 mm plates were washed using 10 ml of cold PBS and scraped in 1 ml PBS. Cells 
were then pelleted in a microfuge at 4° C and supernatants were discarded. The pelleted cells 
were resuspended in 150 ~1 oflysis buffer (10 mM HEPES pH 7.0, 1 mM EDTA, 60 mM KCl, 
0.5% Nonidet P-40, 1 mM DTT, and 1% proteinase inhibitor [Sigma]), incubated on ice for 5 
min, and centrifuged for 5 min at 4° C. The supernatants were discarded and the pelleted nuclei 
were resuspended in 650 ~1 of Buffer A (150 mM NaCl, 40 mM Tris pH 8, 10% glycerol, 0.3% 
Nonidet P-40, and 1% proteinase inhibitor) and incubated on ice for 20 min. After centrifugation 
for 1 0 minutes at 4 ° C, the supernatants were transferred to a new tube and incubated for 1 hour 
with protein A/G PLUS-Agarose beads (Santa Cruz Biotechnology) to clear non-specific 
proteins. Beads were pelleted and supernatants were transferred to a fresh tube. Anti-FLAG™ 
M2 affinity gel (Sigma), which is a purified murine anti-FLAG IgG1 monoclonal antibody 
attached to agarose, was gently mixed with nuclear extracts for 5 hours at 4° C. The agarose was 
then washed 3 times in Buffer A followed by 3 washes in lx EMSA buffer (20 mM HEPES pH 
7.5, 60 mM KCl, 1 mM MgC12, 0.5 mM DTT, 0.1 mM EDTA, 12.5% glycerol). GATA-5-
FLAG!HNF-1a complexes were than released by incubating the agarose in 40 ).11 0.8% 
deoxycholic acid (Sigma) on ice for 15 min. After adding 10% Nonidet P-40 to final~ 1%, the 
agarose was pelleted and 12 ~1 were analyzed by EMSAs. 
Electrophoretic mobility shift assays (EMSAs)-EMSAs were carried out as previously 
described (21) using previously characterized GATA and HNF-1 binding sites as probes and 
competitors. These sites included the GAIA site from the Xenopus intestinal-fatty acid binding 
protein gene (x!FABP) (25) and the HNF-1 site in the ratbeta-fibinogen gene (r~-Fib) (53). 
Probes were made by annealing single-stranded oligonucleotides and extending with e2P] dA TP 
(DuPont-New England Nuclear) using the large fragment of DNA polymerase I (Klenow, Gibco-
BRL) as previously described (21 ). The specific activity of all probes exceeded 106 cprn/pmol. 
Proteins were incubated with 10,000 cpm of probe for 20 min at R T and separated in 8% non-
denaturing polyacrylamide gels. For competition or supershift EMSAs, competitors (200-fold 
molar excess) or antibodies (1 ).11, undiluted), respectively, were pre-incubated with the nuclear 
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extract for 10 minutes prior to the addition of the probe. All antibodies were purchased from 
Santa Cruz Biotechnology. 
Site-directed mutagenesis-Site-directed mutagenesis was carried out using the method of 
Kunkel et. a!. (52). To delete or disrupt specific structures within GATA-5 and HNF-la, 
mutations were introduced into 05-pGEM, which contains the GATA-5 coding region oriented 
for efficient transcription from the SP6 RNA polymerase site in pGEM-7Zf(-) (21 ), and HNF-
la-CMV. The G5-pGEM vector was used because mutagenesis with 05-CMV was not achieved. 
DNA containing GATA-5 mutants synthesized from the 05-pGEM uracil template were re-
inserted into the pcDNA-3 expression vector for transient transfection studies using a 
Bamffi!EcoRI subcloning strategy. Fig. 1 shows the mutagenic oligonucleotides used in this 
study. The oligonucleotides were phosphorylated using T4 polynucleotide kinase and ATP, and 
annealed to the uracil templates by incubation for 2 minutes at 70°C, followed by slow cooling to 
40° C. Uracil templates for both G5-pGEM and Hla-CMV required the use of reverse strand 
oligonucleotides. After annealing, a double-stranded hybrid was synthesized using T7 DNA 
polymerase and T4 DNA ligase, and used to transform competent E. coli cells. After an 
overnight incubation at 37°C, plasmids were isolated using a mini-prep kit (Qiagen) and tested 
with Bamffi or EcoRl digest. The identities of the mutant clones were confirmed by DNA 
sequencing. 
Name Oligonucleotide Mutation 
GATA mutations 
mut 1 
mut2 
mut3 
mut4 
mut5 
5'-GGTGTTTGCTGTGAATTCTTAGGAGCCCTTGAT-3' Stop,EcoRI 
5'-TGTCTGGATACTCTGAATTCACATTGCCAGTGGC-3'Stop,EcoRJ 
5'-GAAGGCTCCGGACATGGATCCAGGGGCTACGTC-3' Bamlll Start 
5'-TTGACCCCGTTCATGGATCCATAGAGGCCGCAG-3' Baml!I Start 
5'-GCCACAGGCGTTAGACACTGGTTCGCC-3' C270S 
HNF-1 a mutations 
Effect 
Deletion of C-terminal domain 
Deletion of C-terminal domain, 
basic region 
Deletion of activation domains 
Deletion of activation domains, 
Zn fmger I 
Cysteine to serine substitution 
in Zn finger II 
mut I 5' -GGTGGAGGTCCGAATTCTCAGTCCATGGCCAAC-3' Stop, EcoRl Deletion of activation domains 
mut 2 5 1 -GTAGACACGCACGAATTCTCAAAGGTTGGAGCC-3 I Stop, EcoRI Deletion of activation domains 
and partial deletion of the 
homeodomain 
Fig. 1: Oligonucleotides used for the introduction of mutations in GAT A-5 and HNF -la. The name, 
oligonucleotide sequence, type of mutation, and effect of the mutation are indicated. Uracil templates for both GS-
pGEM and Hla-CMV required the use of reverse strand oligonucleotides. 
In vitro transcription and translation-Unlabeled and labeled wild-type and mutant 
GATA-5 and HNF-lo. proteins were synthesized using the TNT™ transcription/translation kit 
(Promega) according to the manufacturers instructions. G5-pGEM and Hla-CMV utilized SP6 
and T7 RNA polymerases, respectively. Labeled proteins were synthesized using e5SJ-
methionine (Redivue, Amersham-Pharrnacia Biotech). 
GST pull-down assays-To characterize in vitro protein-protein interactions, GST pull-
down assays were carried out. GST fusion proteins were expressed in E. coli DH5a and purified 
using GSH-Sepharose (Amersham Pharmacia Biotech) beads according to standard protocols 
GATA-5 and HNF-la synergistically activate LPH promoter 103 
(54). Beads coated with glutathione were incubated in 160 ~I of binding buffer (20 mM HEPES 
pH 7.5, 100 mM KCI, 5 mM EDTA, 5 mM EGTA, 0.5% BSA) and mixed for 2 hours at4'C. 
The beads were then washed 5x with PBS and bound proteins were released by boiling in SDS-
sample buffer and resolved by SDS/PAGE. The gels (10% polyacrylamide) were run at constant 
voltage (l50V) for 40 minutes, dried, and exposed to film. 
Cell culture and transient co-transfection assays-HeLa cells were used for transient co-
transfection assays because GAT A-specific and GATA/HNF-la cooperative activation can be 
distinguished in cells that do not synthesize endogenous HNF-la. Transient co-transfection 
assays were carried out by electroporation as previously described (21). The amount of human 
grovvth hormone reporter secreted into the media over 24 h was measured using an [1251] 
radioimmunoassay kit (Allegro hGH, Nichols Institute). To control for transfection efficiency, all 
transcriptional activities were expressed relative to pXGH5, a constitutively active 
metallothionine-1 promoter fused to the human growth hormone gene. 
Statistics-The t test or the one-way analysis of variance (ANOVA) was employed in all 
statistical analyses using InStat sofuvare (Graphpad Software, Inc.). Multiple comparisons were 
carried out by the Dunnett multiple comparison test. 
RESULTS 
GATA-5 and HNF-la synergistically activate the human LPH promoter (21) suggesting 
that these two transcription factors physically associate. To test the hypothesis that GATA-5 and 
HNF-la physically associate in vivo, Cos-7 cells were co-transfected with G5-FLAG and Hla-
CMV, and FLAG-associated proteins were immunoprecipitated from nuclear extracts using 
beads coated with anti-FLAG antibodies. Detection ofHNF-la. in the 05-FLAG 
immunoprecipitate indicates GATA-5/HNF-la. interactions. 
As shown by EMSAs using an HNF-l binding site as a probe (Fig. 2), a protein/DNA complex 
was identified that supershifts with an HNF-la antibody demonstrating that HNF-la was 
present in the anti-FLAG irnmunoprecipitate from G5-FLAG-transfected cells. 
G5-FLAG: 
FLAG-CMV: 
H1a-CMV: -
Fig. 2: GATA-5 and HNF-la physically associate in vivo. EMSAs using the 
rP-Fib probe (53) were carried out on nuclear extracts from Cos-7 cells that were 
co-transfected with the G5-FLAG and Hla, and immunoprecipitated using 
beads coated with anti-FLAG antibodies. A major protein!DNA complex 
(arrowhead) was detected (lane 2) that forms a supershift complex (SC) using an 
HNF-lo: antibody (lane 3). Nuclear extracts from Cos-7 cells co-transfected 
with FLAG-CMV and Hla were used as a negative control (lane 4). 
HNF-la was not detected in nuclear extracts from Cos-7 cells co-transfected with FLAG-C:MV 
and Hl a-CMV indicating that HNF-la does not bind to FLAG alone. These data demonstrate 
that HNF-la physically associates with GATA-5 in vivo. 
To characterize critical domains in GATA-5 necessary for physical association and 
functional cooperativity with HNF-1 a, mutations were introduced into GATA-5 to delete or 
disrupt specific structures (Fig. 3A). The capacity of wild type and mutant GATA-5 proteins to 
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associate physically with HNF-la. in vitro was then tested by GST pull-down assays using GST 
fused to HNF-1 a. As indicated by the presence of a labeled protein on SDS-polyacrylamide gels 
(Fig. 3B, upper panel), GATA-5 proteins that have intact C-terminal zinc finger and basic 
regions (GATA-5 wild type, mut I, mut 3, and mut 4) are pulled down by GST-Hla. In contrast, 
GA TA-5 mut 2, in which the basic region and C-terminal domain are deleted, and GATA-5 mut 
5, in which the structure of the C-terrninal zinc finger is disrupted, are not pulled down by GST-
Hla. 
A 
AD I AD II 
Wild type (wt) I I I I 
mut1 
mut2 
mut3 
mut4 
mut5 
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Fig. 3: C-terminal zinc finger and basic regions of 
GAT A-5 are necessary for physical association 
with HNF-la and binding to DNA. A: Schematic 
representation of wild type and mutant GATA-5 
proteins. GAT A-5 contains two N-terminal activation 
domains (AD I and AD II), two zinc fingers (Zn I, N-
tenninal zinc finger; Zn II, C-tenninal zinc finger). 
and a basic region (B) near the C-tenninus (24). The 
C C-terminal domain is deleted in mut l, whereas the 
competitor:-- 5 N _ _ _ _ _ C-terminal domain and basic region are deleted in 
mut 2. Both activation domains are deleted in mut 3, 
whereas both activation domains and the N-tenninal 
zinc finger are deleted in mut 4. GATA-5 mut 5 is a 
I 
•t·+M'*' 
123456789 
cysteine-to-serine substitution in the C-terminal zinc 
finger at amino acid 270. B. The C-terminal zinc 
finger and basic region ofGATA-5 are necessary for 
physical association with HNF-1 a 
GST pull-down assays (upper panel) were carried out 
using GST-Hla incubated with labeled in vitro 
transcribed and translated wild type (lane I) and 
mutant GATA-5 (lanes 2-6). GATA-5 wild type, mut 
I, mut 3, and mut 4, were pulled down by GST-Hla 
whereas GATA-5 mut 2 and mut 5 were not. GATA-
5 was not pulled down by GST alone (lane 7). All 
proteins used in GST pull-down assays were 
synthesized as shown by direct loading of TNT 
products (lower panel). C. The C-terminal zinc finger and basic region are critical/or binding to DNA. EMSAs 
were carried out using the xiFABP probe (25) and wild type and mutant GAT A-5 proteins as indicated across the 
top of the figure (lanes 2-8). GATA-5 wild type forms a complex with (lane 2) that is competed with a specific 
oligonucleotide (S, lane 3) but not with a non-specific oligonucleotide (N, lane 4). GATA-5 wild type, mut 1, mut 3, 
and mut 4 all bind to DNA, whereas GATA-5 mut 2 and mut 5 do not bind to DNA. 
GST alone does not pull down wild type GATA-5 indicating that GST does not interact with 
GA TA-5. Direct loading of labeled TNT products (Fig. 3B, lower panel) indicates that proteins 
of predicted sizes were synthesized. These data demonstrate that the C-terminal zinc finger and 
basic regions of GATA-5 are required for physical association with HNF-1 a. 
To map DNA binding domains in GATA-5, EMSAs were carried out using a GATA 
binding site as a probe and in-vitro synthesized wild type and mutant GATA-5 proteins (Fig. 
3C). A protein/DNA complex is formed with wild type GA TA-5 that is competed away by a 
specific oligonucleotide but not by a non-specific oligonucleotide, indicating that the GATA-5 
binds the DNA specifically. GATA-5 mut I, mut 3, and mut 4 bind DNA but GATA-5 mut 2 and 
mut 5 do not. These data are parallel to the GST pull-down experiments demonstrating that the 
domains critical for GATA-5/DNA interaction also map to the C-terminal zinc finger and basic 
region. Thus, regions in GATA-5 that mediate protein-protein interaction with HNF-la and 
DNA binding are co-localized to the C-terminal zinc finger and basic regions. 
The functional importance of specific structures in GATA-5 for synergistic GATA-
5/HNF-la activation of the human LPH promoter was tested by transient co-transfection assays 
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using wild type or mutant GATA-5, and wild type HNF-la expression vectors (Fig. 4). To test 
specific effects oftransfected wild type and mutant GATA-5 and HNF-1a, a model system 
utilizing cells that do not synthesize appreciable amounts of these factors was necessary. HeLa 
cells provided such a model system (15,16,25,55) and were used throughout the remainder of 
this study. pRC-CMV was used as a negative control. The human LPH promoter (h118wt) was 
independently activated by HNF-1a, as previously described in Caco-2 cells (21), whereas 
GA TA-5 alone only minimally activated this promoter. The human LPH promoter was 
synergistically activated by the combination ofGATA-5 plus HNF-la together, as indicated by a 
GATA-5 
II !MNd 
II .... 
Expression Transcriptional activity 
vector o 12 24 
pRC-CMV 
Fig. 4: C-terminal zinc finger and basic 
regions of GAT A-5 are required for 
synergistic activation with HNF-la. 
Transient co-transfection assays were 
carried out in HeLa cells using the hll8wt 
promoter co-transfected with pRC-C:MV 
(negative control expression vector) or 
with wild type or mutant GAT A-5, and 
wild type HNF-la. GATA-5 mutants are 
+ HNF-1a as indicated in Fig. 2A. The dotted line 
indicates the sum of the transcriptional 
activities of wild type GATA-5 and HNF-
la co-tmnsfected individually with 
h118wt. The transcriptional activities that 
extend to the right of the dotted line 
indicate synergistic activation. Data are mean± SEM ofn = 5. * p<0.05 compared to hll8wt co-transfected with 
GATA-5 andHNF-la. 
transcriptional activity that was -3 fold greater than the sum of the individual transcriptional 
activities ofGATA-5 and HNF-la alone (indicated by the dotted line). GATA-5 mut I, mut 3, 
and mut 4 all demonstrate synergistic activation of the human LPH promoter when co-
transfected with HNF-la as indicated by a mean activation that extends to the right of the dotted 
line. Noteworthy, however, is that synergy, although present, is greatly reduced with muts 3 and 
4, which do not contain GATA-5 activation domains. GATA-5 mut 2 and mut 5, which do not 
physically associate with HNF-1a or bind to DNA: fail to show synergistic activation of the 
human LPH promoter. These data suggest that the C-tenninal zinc-finger and basic region of 
GATA-5 are required for synergistic activation of the human LPH promoter. 
To characterize functional domains in HNF-la, mutations were introduced into wild type 
HNF-1a that result in C-tenninal deletions (Fig. 5A). The capacity of these proteins to 
physically associate with GATA-5 in vitro was assessed by GST pull-down assays using GST 
linked to GATA-5 (Fig. 5B, upper panel). As indicated by the presence of labeled protein on 
SDS polyacrylamide gels (Fig. 5B, upper panel), wild type HNF-la (filled arrowhead) and 
HNF-1a mut 1 (open arrowhead), in which the activation domains are deleted, physically 
associate with GST-G5 (lanes 1 and 2, respectively). However, HNF-1a mut 2, in which the 
activation domains plus a segment ofthe C-terminal side of the homeodomain are deleted, does 
not physically associate with GST -G5. All proteins were synthesized as shown by direct loading 
of the TNT reactions (Fig. 5B, lower panel). 
DNA binding domains in HNF-la were mapped by EMSAs using wild type and mutant 
HNF-la synthesized in vitro (Fig. 5C). Wild type HNF-la forms a protein!DNA complex which 
supershifts using an HNF-1a antibody, indicating that the complex contains HNF-la. HNF-la 
mut I binds DNA (lane 4), but HNF-la mut 2 does not bind DNA (lane 5). These data 
demonstrate that an intact homeodomain in HNF-1a is critical for HNF-1a/DNA binding to 
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DNA. Thus, regions in HNF-la that mediate protein-protein interaction with GATA-5 and DNA 
binding are co-localized to the homeodomain. 
A HNF-1a 
Wild type (wt)ii E81 1 AD II AD I 
21 AA loop 
mut 1 -:~~~=~~t.-~~l 
mut2 - 4 eo 
B C Anti-H1oc - - . 
- N G~-GS R 
HNF-1o;: WT ~ ~ WT HNF-1o;: -~ ~ ~ 
75 sc ,· 
• 
_37 
Fig. 5: An intact homeodomain in HNF-lais 
necessary for physical association with GAT A-5 and 
binding to DNA. A. Schematic representation of wild 
type and mutant HNF-1 a proteins. HNF-1 a contains an 
N-terminal dimerization domain (DD), a POU domain 
(POU), ahomeodomain (HD) that has a unique 21-amino 
acid loop (21 AA loop), and two C-terrninal activation 
domains (AD I and AD II). The activation domains are 
deleted in HNF-la mut I, and the activation domains 
plus a segment of the C-terminal side of the 
bomeodomain are deleted in HNF-la mut 2. B. An intact 
homeodomain of HNF-1 a is requiredfor 
physical association with GATA-5. GST pull-down assays 
were carried out using GST -GS incubated with in vitro-
labeled wild type and mutant HNF-lcx proteins (upper 
panel). HNF-lcx wild type (filled arrowhead, lane 1) and 
HNF-la mut I (open arrowhead, lane 2) physically 
associate with GATA-5, whereas HNF-Icx mut 2 does 
not (lane 3). HNF-la does not interact with GST alone 
(lane 4). All wild type and mutant HNF-la proteins were 
synthesized as indicated by direct loading of labeled 
products (lower panel). HNF-lcx mut 2 is indicated by 
the shaded arrowhead. C. An intact homeodomain is 
required for HNF-labinding to DNA. EMSAs were 
carried out using the rP-Fib probe (53) incubated with wild type and mutant Hl\IF-la proteins. Probe alone is 
indicated in lane 1. Wild type HNF-lcx forms a protein/DNA complex (filled arrowhead, lane 2) that is supershifted 
(SC) using an HNF-la antibody (lane 3). HNF-lcx mut 1 (open arrowhead, lane 4) is capable of forming a complex 
with DNA with faster mobility than that of wild type HNF-1 a. HNF -1 a mut 2 does not form a protein/DNA 
complex (lane 5). 
The role ofHNF-la. activation domains in the cooperative activation of the human LPH 
promoter were characterized by transient co-transfection assays using h118wt and wild type and 
mutant HNF-la (mut 1). For comparison, wild type GATA-5 and GATA-5 mut 3, which 
contains a deletion of the GATA-5 activation domains, were also used. This allowed 
comparative analyses of the activation domains ofGATA-5 and HNF-la together (Fig. 6). 
Expression 
vectors 
pRC-CM 
~ CcLILI:ii="'I£B00.C======~i G5wt 
ouoow~·c==;::c=l G5 m3 
,..00....., O:~IE:=I::i==IJ==JH1aw1 
G5 wt + H1o: m1 
Transcriptional activity 
1 2 3 
G5m3+H1am1 * 
Fig. 6: Activation domains ofHNF-la are 
required for synergistic activation of the human 
LPH promoter. Transient co-transfection assays 
were carried out in HeLa cells using hll8wt, and 
wild type and mutant expression vectors for GATA-5 
and HNF-lo:. pRC-CMV was used as a negative 
control. Wild type and mutant GATA-5 and HNF-la 
proteins are as indicated in Fig. 2A and SA, 
respectively. The dotted lines indicate the sum of the 
transcriptional activities of wild type and mutant 
GATA-5 and HNF-lo: expression vectors 
individually co-transfected with hll8wt for that 
specific combination of expression vectors. 
Transcriptional activities that extend to the right of 
the dotted lines indicate synergistic activation of the 
hll8wt promoter. Data are means± SEM ofn = 4. * 
p<0.05 compared to hll8wt co-transfected v.ith wild 
type GATA-5 and HNF-la. 
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Consistent with previous data (Fig. 4), deletion of GATA-5 activation domains reduces, but does 
not eliminate functional synergy. In contrast, deletion of the HNF-la activation domains 
eliminates independent as well as cooperative activation of the human LPH promoter. Lack of 
activation by HNF-la mut 1 is not due to the inability to associate with GATA-5 or to inefficient 
DNA binding because these functions remain intact (Fig. 5). 
Since domains in GATA-5 and HNF-1 a that confer physical association are co-localized 
with DNA binding domains, it is not possible by mutagenesis ofGATA-5 or HNF-la to 
differentiate the importance ofGATAJHNF-la interaction from DNA binding. However, it is 
possible to independently determine the importance of protein-DNA interaction by introducing 
mutations that disrupt DNA interaction into the binding sites in the human LPH promoter. As 
shown in Fig. 7, transient co-transfection assays were carried out using wild type and mutant 
hl18 promoter-reporter constructs that have the GATA and HNF-1 binding sites either intact or 
mutated. 
h118 
;, 
Expression 0 
vector: u.. 
~ 
," 
u_ 
z 
:r: GATA-5 + HNF-1o: 
Fig. 7: GATA!HNF-la synergistic activation of the 
human LPH promoter requires intact HNF-1 binding 
sites on the DNA. Transient co-transfection assays were 
carried out in HeLa cells using wild type GATA-5 and 
HNF-la expression vectors co-transfected with wild type 
and mutant promoter-reporter constructs. The hll8mG 102 
promoter-reporter construct contains mutations in both 
GAT A sites, whereas h 118mH contains a mutation in the 
HNF-1 binding site. The hll8mGlG2H construct contains 
mutations in all three binding sites. The dotted line 
indicates the sum of transcriptional activities of GAT A-5 
and HNF-la expression vectors co-transfected 
individually with hll8wt. Transcriptional activities that 
extend above the dotted line indicate synergistic activation. 
Data are mean± SEM ofn = 5. * p<0.05 compared to 
hll8wt co-transfected with GATA-5 and HNF-la. 
As shovm by the middle bar, the wild type human LPH promoter co-transfected with GATA-5 
and HNF-la demonstrates synergistic activation. GATA-5 and HNF-la co-transfected with 
hll8mGIG2 demonstrate synergistic activation, although the transcriptional activity is reduced 
from that of the wild type promoter. However, constructs containing mutations in the HNF-1 
binding site alone (hll8mH) or together with the mutated GATA binding sites (hll8mG 1 G2H), 
do not show synergistic activation and are significantly lower than that of the wild type promoter 
(p < 0.05). These data demonstrate that HNF-1 binding sites in the promoter are necessary for 
GATA-5/HNF-la cooperative activation. 
Sequence alignment ofGATA-4 and GATA-5 reveals 85% homology in the C-terminal 
zinc finger and basic regions (24), which are the domains responsible for interaction with HNF-
lo:. To test the hypothesis that GATA-4 and HNF-la are also capable of physically associating 
and cooperatively activating the human LPH promoter, GST pull-do'N!l and transient co-
transfection assays were carried out. As indicated by the presence of a labeled protein in SDS-
polyacrylamide gels (Fig. SA, upper panel), GATA-4 is pulled down with GST-Hla similar to 
that ofGATA-5. 
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~ Expression vectors 
Fig. 8: GATA~4 physically associates with HNF~ 
la and synergistically activates the human LPH 
promoter. A. GAT A-4 physically interacts with 
HNF-1 a. GST pull-down assays were carried out 
using GST linked to HNF -1 a and in vitro 
synthesized, labeled GATA-4 and GATA-5 (upper 
panel). Labeled GATA-4 and GATA-5 (lanes 1 and 
2, respectively) were pulled down by GST-Hlo.: 
demonstrating that GAT A-4 physically associates 
with HNF-Ia similar to that ofGATA-5. GST 
alone does not physically associate with either 
GATA-4 or GAT A-5 (lanes 3 and 4, respectively). 
Loading ofGATA-4 and GATA-5 
immunoprecipitated with specific antibody (lanes 1 
and 2) or non immune serum (NI) (lanes 3 and 4) 
indicates that the TNT™ products are authentic 
GATA-4 and GATA-5 (lower panel). B. GATA-4 
and HNF-1 a synergistically activate the human 
LPH promoter. Transient co-transfection assays 
were carried out in HeLa cells using hll8wt and 
GAT A-4 and HNF-la co-transfected separately or together. pRC-CMV is used as a negative control. 
Transcriptional activities above the dotted line indicate synergistic activation. Data are means± SEM ofn = 5. 
Immunoprecipitations were carried out using antibodies for GATA-4 and GATA-5 
demonstrating that the TNT reactions resulted in the synthesis of authentic GATA-4 and GATA-
5 proteins (Fig. SA, lower panel). These data suggest that GATA-4, like GATA-5, physically 
associates with HNF-la. Transient co-transfection assays carried out in Hela cells (Fig. 8B) 
demonstrate that GATA-4 and HNF-la independently and synergistically activate the human 
LPH promoter. These data suggest that GATA-4 is capable of interacting with HNF-la by 
mechanisms similar to those described for GATA-5. 
DISCUSSION 
The GATA zinc finger and HNF-1 homeodomain families have been implicated as 
regulators of tissue-specific gene expression (34,37). The mRNAs of members of both of these 
transcription factor families are detected in the foregut as early as E9 .5 for GATA factors and 
El0.5 for HNF-la. Both are expressed in the intestinal epithelium throughout adulthood, 
suggesting a critical role for these two families of transcription factors in intestinal function 
(29 ,34,56). This report shows for the first time that physical association between members of 
each of these transcription factor families, namely GATA-4 or GATA-5 and HNF-la, results in 
the cooperative activation of the promoter of an intestine-specific gene, LPH, suggesting 
functional convergence of two critical intestinal transcriptional regulatory pathways to maintain 
high levels of intestine-specific gene expression. 
We have previously shown that GATA-5 and HNF-la synergistically activate the human 
LPH promoter in the Caco-2 intestinal cell line (21). In the present report, we demonstrate that 
this synergistic activation requires physical association between GATA-5 and HNF-lo:, and that 
this interaction is mediated by the C-terminal zinc finger and basic region ofGATA-5 and 
homeodomain of HNF-1 a. Our data further demonstrate that HNF-1 a activation domains are 
necessary not only for independent HNF-la activation, but also for synergistic activation with 
GATA-5. Deletion ofGATA-5 activation domains however, results in a reduction, but not an 
elimination of synergy, suggesting that the GATA-5 activation domains are not necessary, but 
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serve as additional activators for maximal synergy. Mutational analysis of the human LPH 
promoter further revealed that intact HNF-1 binding sites, but not GATA binding sites, are 
necessary for synergistic activation (Fig. 7), suggesting that binding ofHNF-la to the LPH 
promoter is a critical component of synergy. Although GATA-5 binding sites may not be directly 
necessary for cooperative activation, the presence ofGATA binding sites adjacent to the HNF-1 
site might recruit GATA factors in close proximity for HNF-la interaction resulting in maximal 
levels of synergistic activation. 
The requirement for physical association between GATA-5 and HNF-la is demonstrated 
by mutational analysis ofGATA-5 (Fig. 3 and 4) and ofthe human LPH promoter (Fig. 7). As 
shown in Fig. 3 and4, GATA-5 mut 5 (C270S) fails to associate with HNF-la, bind DNA, and 
synergistically activate h118wt. However, promoter mutation experiments (Fig. 7) reveal that 
GATA binding to DNA is not necessary for functional synergy. Thus, failure to synergistically 
activate the LPH promoter by GATA-5 mut 5 must be due to its inability to physically associate 
with HNF-la, rather than its inability to bind DNA. Taken together, these data demonstrate that 
physical interaction is required for functional synergy. Based on these data, we hypothesize that 
GATAIHNF-la synergy is mediated by HNF-la through its activation domains which are 
oriented for high levels of activation through a combination of binding to DNA and physical 
association with GATA factors (Fig. 9). GAT AIHNF-la interactions might unmask the HNF-1 a 
activation domains either by a conformational change or by recruitment of additional proteins 
that modulate transcriptional activity. Interaction between zinc fingers and homeodomains may 
be a critical biological mechanism for gene regulation. 
HNF-1a-independent activation 
~ GATA~ 
GATAIHNF-1a cooperative activation 
Fig. 9. Schematic representation of a model for GATA/HNF-la cooperative activation of the human LPH 
pro-moter. AD, activation domains; HD, homeodomains; Znii, C-terminal zinc finger of GAT A factors; G, GAT A 
binding site at the LPH promoter; H, HNF-1 binding site; TATA, is the TAT A-box binding site for TBP. 
For example, similar to the model presented here is the well-characterized model for the 
synergistic activation of cardiac promoters by GATA-4 and Nkx2.5 (47,48,57-60), a 
homeodomain-containing transcription factor like HNF-la. In this model, the C-terminal zinc 
finger and basic region ofGATA-4 and the homeodomain ofNkx2.5 are required for physical 
association which, in tum, is necessary for synergistic activation of several genes (47 ,48,57). 
Furthermore, intact Nkx2.5 binding sites on cardiac promoters are required for synergistic 
activation (47,48,57). HNF-la cooperatively activates the sodium-glucose transporter (SGLTI) 
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with SP-1, a zinc finger-containing protein (44). In Drosophila, interactions between the zinc 
finger ofFtz-Fl, a member of the nuclear receptor superfamily, and the homeodomain of the 
fushi tarazu FTz protein result in the cooperative activation of the engrailed gene (49,50). These 
findings are parallel to the GATA-5/HNF-la model proposed here, and suggest an evolutionarily 
conserved structure/function relationship that preserves a mechanism of cooperative activation of 
multiple genes in diverse tissues. 
HNF-la has been sho\Vll to interact through its homeodomain with other transcription 
factors in the intestine. A report by Sakaguchi et al. (45) suggested that HNF-la was able to 
enhance claudin-2 promoter activity only in the presence of another member of the 
homeodomain transcription factor family, Cdx-2. In addition, Michelmoore et. al. (20) 
demonstrated that HNF-la physically interacts with Cdx-2, to cooperatively activate the pig 
LPH promoter. Interestingly, similar to the GATA-5/HNF-la model presented in this study, 
HNF-la, but not Cdx-2, must bind to the DNA for cooperative activation. Since HNF-la binds 
to the DNA as a dimer (35,36), it remains possible that for the specific regulation of the LPH 
gene in vivo, all three factors form a tri-molecular complex whereby the HNF-la dimer binds 
GATA factors, Cdx-2, or a combination of both. This hypothesis is consistent with our previous 
studies (21 ), which show that the human LPH and SI promoters demonstrate synergistic 
activation when co-transfected with GATA-5, HNF-la, and Cdx-2 together. A similar 
mechanism has also been reported for the cardiac a-actin ( aCA) promoter, which is up-regulated 
through combinatorial interactions of at least three cardiac tissue-enriched transcription factors, 
GATA-4, Nkx2.5, (which also forms dimers, like HNF-la), and serum response factor (SRF) 
( 48). HNF -1 a may also recruit co-activators such as CREB-binding protein and p300/CBP-
associated factor, forming a tri-molecular complex that activates transcription by coupling 
nucleosome modification with recruitment of proteins for the general transcription machinery 
(61). Together, these data suggest that HNF-la has the ability to physically associate with 
diverse proteins, and act as a linker to the DNA in order to synergistically activate intestinal gene 
promoters. The magnitude of cooperative activation may be altered by the abundance of different 
transcription factors and their affinity for HNF-la. 
Physical association between GATA family members and HNF-1 a is necessary for the 
synergistic activation of the human LPH promoter providing a mechanism by which tissue-
restricted transcription factors can interact to attain high levels of tissue-specific gene expression. 
However, although GATA (22,24) and HNF-la (29) transcription factors are co-localized in the 
intestinal epithelial where LPH expression is high (5,6), they are also co-expressed in primitive 
intestinal epithelial cells prior to the onset ofLPH gene expression (23,24,32,37). We therefore 
hypothesize that co-expression of GATA factors and HNF-1 a is necessary but not sufficient for 
high levels of cell-specific LPH gene expression. Interaction with other tissue-restricted 
transcription factors and co-factors, such as SP-1 (44), FOG-2 (62,63), Cdx-2 (20) and 
dimerization co-factor of HNF -1 a ( 64) as well as other information further upstream in the LPH 
p:omoter (18,65) must be considered when characterizing specific expression of the LPH gene in 
VIVO. 
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ABSTRACT 
In the recent study, the importance ofGATA elements in the LPH promoter, the critical 
structures in GATA factors, including domains responsible for DNA-binding, protein-protein 
interaction, and activation domains, for GATA-4-specific as well as GATA-4/HNF-la 
cooperative activation were determined. Using wild type and mutated human LPH constructs and 
wild type and mutated GATA-4 proteins, the results of this study revealed that the two GATA 
elements in the human LPH promoter and the GATA-4 activation domains are critical for the 
GATA-4 independent activation, but not for GATA-4/HNF-la synergy. The physical interaction 
between GATA-4 and HNF-la is mediated through the C-terminal zinc finger of GATA-4 and is 
important for the GATA-4/HNF-la cooperative activation of human LPH gene. The GATA 
elements in the human LPH promoter and the GATA-4 activation domains are not important for 
the GATA-4/HNF-la cooperative activation of human LPH gene. As is described above GATA-
4 and GATA-5 demonstrated distinct as well as redundant mechanisms for the regulation of 
human LPH promoter (1), we used GATA-4 and GATA-5 as models in the comparisons for 
DNA binding affinities among the GATA elements of the human LPH promoter. Therefore, this 
report suggests that the human LPH promoter is activated by GATA-4 using a dual mechanism 
defined by GATA-4-specific as well as GATA-4/HNF-la cooperative activation. Also the 
distinct GATA-4-specific activation over that from GATA-5 is due, in part, to a higher affinity 
of GATA-4 for a GATA element in the human LPH promoter. Since the GATA-4 horizontal 
expression of GATA-4 coincides with that of LPH in intestine of adult mice, it is hypothesized 
that GATA-4 together with HNF-la is important for adult levels ofLPH expression. 
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INTRODUCTION 
The GATA family of transcription factors is a group of evolutionarily conserved 
transcriptional regulator that are defined by two zinc fingers of the motifCys-X2-Cys-X17-Cys-
Xz-Cys that mediate binding to the consensus DNA sequence WGATAR (W =A or T, R =A or 
G). The GATA family is generally categorized into two classes based on expression patterns and 
amino acid homologies. GATA-1, -2, and -3 are expressed in developing bone marrow cells and 
are critical for hematopoiesis (2), whereas GATA-4, -5, -6 are expressed in individually, or in 
overlapping patterns in cardiac tissue, small intestine, stomach, liver, lungs, spleen, ovary, testis, 
and bladder (3-8). Expression of all three intestinal GAIA mRNAs is detected as early as E9.5 in 
the primitive gut and continues to be expressed in intestinal epithelium throughout 
embryogenesis (3,5-7,9). In both mouse (3) and chicken (9) intestine, GATA-4 transcripts are 
distributed in epithelial cells all along the villus, with increasing levels accumulating toward the 
villus tips. In chicken intestine (9), GATA-5 mRNA is localized to differentiated cells of the 
villi, whereas GAT A-6 transcripts are localized to cells of the upper crypt and lower villus. 
Although the small intestine of adult mice is the only tissue in which all three GATA-4, -5, and -
6 mRNAs are expressed (10), independent and overlapping functions of this GATA subfamily 
are unkno"Wll. 
Targeted disruption of the GATA-4, -5, -6 genes demonstrate phenotypes that are 
consistent with their individual expression patterns. Mice homozygous for the GATA-4 null 
allele die by E9.5 and lack both a primitive heart tube and foregut (11,12). GATA-5 knockout 
mice survive and reproduce despite pronounced genitourinary abnormalities in females (13), but 
show no gross abnormalities in intestinal structure or histology (intestinal gene expression was 
not reported). GA TA-6 null mice die before gastrulation (14, 15) and therefore provide little 
information regarding intestinal development. Interestingly, a GATA-5 null mutation in 
zebrafish resulted in embryonic lethality with an identical phenotype to that observed in GAT A-
4 null mice, suggesting a similar role for GATA-5 in zebrafish to that of GATA-4 in mice (16). 
In Drosophila and C. elegans, GAIA homologs have been implicated in gut development (17-
19). These studies, however, demonstrate independent functions for individual GA TA 's, 
although functional redundancy among GAT A subfamily members has been reported (20,21 ). 
The GATA-4, -5, -6 subfamily has been shovm to modulate promoter function of 
intestinal genes including the rat and human lactase phlorizin hydrolase (LPH) (1,22-24), human 
and mouse sucrase-isomaltase (SI) (24,25), and Xenopus intestinal fatty acid binding protein (I-
FABP) (9) genes. We have recently shown that GATA-4 or -5 together with hepatic nuclear 
factor-! a (HNF-1 a) synergistically activate the LPH and SI promoters (I ,24,25). Similar to these 
data, Durocher et. a!. have shown that GA TA-4 or GATA-5 together with Nkx-2.5 
synergistically activate the atrial natriuretic factor (ANF) promoter (26) demonstrating that 
GATA factors display redundant roles, suggesting fundamentally important pathways in the 
regulation of gene transcription. Identification of parallel mechanisms of protein-protein 
interaction between zinc finger and homeodomain proteins in other vertebrate tissue (26-28) as 
well as in Drosophila (29,30) suggest that zinc finger!homeodomain interactions are an efficient 
mechanism for synergistic activation of gene transcription that has been conserved throughout 
evolution. 
As we have recently reported (I), that GATA-4, in contrast to GATA-5, is capable of 
activating the human LPH promoter independently ofHNF-la. The present report defines the 
dual mechanisms ofGATA-4 activation, characterized by GATA-4 specific and GATA-4/HNF-
1 a cooperative activation, for the transcriptional regulation of the human LPH promoter. These 
mechanisms are characterized by: (1) HNF-la-independent activation (in contrast to GATA-5), 
in which the DNA binding and activation domains are required, and (2) HNF-la-dependent 
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cooperative activation (similar to GATA-5), in which physical association is required but not the 
GATA-4 activation domains or GATA-4/DNA binding. This study is the first to demonstrate 
distinct regulatory mechanisms for activation of the human LPH promoter by two conserved 
GATA factors. 
MATERIALS AND METHODS 
Plasm ids- To construct plasmids templates for the synthesis of RNA probes for RNase 
protection assays, mouse eDNA sequence (GATA-4, bp 456 to 736; GATA-5, bp 253 to 707; 
HNF-la, bp 2936 to 3174) was amplified and subcloned into pBluescript II KS(+). Templates 
for antisense and sense probes were linearized and transcribed accordingly: GA TA-4 antisense, 
EcoRI, T3; GATA-5 antisense, Aatll, T7; HNF-Ja antisense, Kpnl, T7; HNF-Ja sense, HinD III, 
T3. A previously described template was used to synthesize a probe for the identification of 
mouse LPH mRNA (31 ). 
Previously characterized expression vectors for mouse GATA-4 (G4-CMV), (11), 
GATA-5 (05-CMV), (7) (gifts ofM. Parmacek, University ofpennsylvania) and HNF-la (32) 
(gift of G. Crabtree, Stanford University) were obtained for these studies. Since the original 
HNF-1a expression vector replicates inefficiently during bacterial amplification, the HNF-1a 
coding region was PCR amplified and subcloned into the Bamffi and EcoRI sites of pcDNA1 
(called Hla-CMV), as previously described (l). This plasmid was amplified efficiently in E.coli 
DH5a cells. 
For transfection studies, the human LPH promoter containing 118 bp of5'-flanking 
region was fused 5' to the human growth hormone reporter (called h118wt) (24). This region 
contains two GATA sites, an HNF-1 site, and a Cdx-2 site as previously described (24). 
Transcription factor-DNA interactions were characterized, in part, using human promoter-
reporter constructs containing mutations in the two GATA sites (h118mGlG2), in the HNF-1 
site (hllSrnH), and in all three sites together (h118mGIG2H). Mutations introduced into these 
sites, have been previously shown to disrupt specific protein-DNA interactions (24). pRC-CMV 
(Invitrogen) served as a negative control expression vector for all co-transfection experiments. 
For in vitro protein-protein interaction studies, a glutathione S-transferase (GST) fusion 
vector was constructed for HNF-1 a (GST -HI a) as previously described (l ). 
RNase protection assays-The quantitative pattern ofGATA and HNF-1a expression was 
compared to that ofLPH using RNase protection assays as previously described (31,33). Total 
RNA was isolated from mouse tissues using Trizol Reagent™ (Invitrogen), quantified by optical 
density at A260 nm, and checked on an agarose geL e2P]-labeled probes were hybridized at 
68°C in 50% formamide overnight, digested with RNase A and Tl, and the protected fragments 
were separated on 6% denaturing polyacrylamide gels and revealed by autoradiography. 
Site-directed mutagenesis-To delete or disrupt specific structures within GATA-4 and 
GATA-5, site-directed mutagenesis (34) was carried out on the GATA-4 and GATA-5 coding 
region using mutagenic oligonucleotides. The oligonucleotides were phosphorylated using T4 
polynucleotide kinase and ATP, and annealed to the uracil templates by incubation for 2 minutes 
at 70°C, followed 20 minutes incubation at 40° C. The protocol was continued according to 
previously described method (I). All uracil templates required the use of reverse strand 
oligonucleotides. GATA-4 mutl was constructed using the oligonucleotide 5'-
GAGGCGGCAGCCATGGATCCCCAGGA TGCTC-3' which introduced a Bamm (underlined) 
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and a start codon (bold), and resulted in a deletion of the GATA-4 activation domains. GATA-4 
mut2 was constructed using the oligonucleotide 
5' -GCCGCAGGCATTAGATACAGGCTCACC-3', the mutation is indicated in bold, which 
resulted in a cysteine-to-serine substitution in the C-terminal zinc finger at amino acid position 
290. The identities of the mutant clones were confirmed by DNA sequencing. 
In vitro transcription and translation-Unlabeled and labeled wild-type and mutant 
GATA-4 and GATA-5 proteins were synthesized as previously described (1) using the TNT™ 
transcription/translation system (Promega). Labeled proteins were synthesized using e5S]-
methionine (Redivue, Amersham-Pharmacia Biotech). 
GST pull-down assays-To characterize in vitro protein-protein interactions, GST pull-
down assays were carried out as previously described (1). GST fusion proteins were expressed in 
E. coli DH5a and purified using GSH-Sepharose (Amersham Pharmacia Biotech) beads 
according to standard protocols (35). 
Electrophoretic mobility shift assays (EMSAs)- To define the capability of wild type and 
mutated proteins to bind DNA, EMSAs were carried out as previously described (24). A test 
oligonucleotide that contains a GATA site from Xenopus intestinal-fatty acid binding protein 
gene (xiF ABP) was used as a probe (9). Specific and non-specific oligonucleotides, and the two 
GATA sites located in the human LPH promoter (24) were used as competitors. The 
oligonucleotides are listed below, Specific competitor (S), 5'-
GGAGATCCCTGTACAGATATGGGGAGAC-'3, non-specific (S!Fl), 5'-
GGGTGCACTAAAACTTTATGAGTA-'3, GATA element (hGl, -95 10-88 bp), 5'-
GTGATCATAGATAACCCAGTTAAA-'3, and GATA element (hG2, -67 to -61 bp) 5'-
ATACTAAGTGATAATTAAGACTTA-'3 as previously characterized (24). For competition or 
supershift EMSAs, competitors (200-fold molar excess) or antibodies (I f!l, undiluted), 
respectively, were pre-incubated with the nuclear extract for 10 minutes prior to the addition of 
the probe. All antibodies were purchased from Santa Cruz Biotechnology. 
Cell culture and transient co-transfection assays-To characterize the functional role of 
GATA on the LPH promoter, transient co-transfection assays were carried out using HeLa cells 
because GAT A-specific and GATA/HNF-la cooperative activation can be distinguished in cells 
that do not synthesize endogenous HNF-la as previously described (1). Cells were transfected 
using Effectene™ reagent (Qiagen) according to the protocol provided by the manufacturer. 
Optimal conditions for both cell lines were: 1 ].lg total DNA (0.4 ].lg of promoter/reporter 
construct and 0.2 ].lg of expression vector) and 4 f.ll ofEffectene™ reagent. Media were replaced 
after 24 h, and the experiment was concluded after an additional 24 h, as previously described 
(24). The amount of human growth hormone reporter secreted into the media over 24 h was 
measured using an [1251] radioimmunoassay kit (Allegro hGH, Nichols Institute). To control for 
transfection efficiency, all transcriptional activities were expressed relative to pXGH5, a 
constitutively active metallothionine-I promoter fused to the human growth hormone gene. 
Densitometry quantification-The films of EMSAs were scmmed under epi-white light 
using the Gel Doc 2000TM (Bio-Rad, Hercules, CA). The relative density ofbands form film 
were determined by densitometry using the Quantity One software (Bio Rad, Hercules, CA). 
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Statistics-The t test or the one-way analysis of variance (ANOV A) was employed in all 
statistical analyses using InStat software (Graphpad Software, Inc.). Multiple comparisons were 
carried out by the Dunnett test. 
RESULTS 
To define the regulation ofLPH gene expression in adult mice expression patterns along 
the horizontal gradient ofGATA factors in small intestine, RNase protection assays were carried 
out (Fig. I). 
GAT A-S 
HNF-1a 
LPH 
GATA-41 
Ribosomal 
RNA 
Fig. I: The horizontal patterns of expression ofGATA-4 mRNA in 
adult mice coincides with that of LPH. RNase protection assays were 
carried out using probes for GATA-4, GATA-5, HNF-la, and LPH (lane 
1) incubated with RNA isolated from duodenum, jejunum, ileum, colon, 
heart and lung (lanes 2-7, respectively). The quality of RNA is 
demonstrated by intact ribosomal bands in an agarose gel (bottom panel). 
RNA was isolated from duodenum, mid-jejunum, ileum and 
colon as well as liver and lung of adult mice. GATA-4 mRNA 
was detected in mid-jejunum, whereas GATA-5 mRNA was 
detected in duodenum, mid-jejunum, and ileum, but was not 
detected in colon. Both liver and lung express GATA-5 
mRNA, as previously shown (10). HNF-la mRNA was 
detected in every tissue with liver being the most abundant, as 
previously shown (32). LPH mRNA was detected in small intestine with highest levels in mid-
jejunum, as previously shown (31 ). The quality and quantity of RNA is demonstrated by distinct 
ribosomal RNA bands on agarose gel (bottom panel). These data indicate that the horizontal 
expression ofGATA-4 mRNA parallels that ofLPH mRNA in adult mice suggesting that 
GATA-4 is an activator ofLPH along the horizontal gradient in vivo. 
To define the potential importance ofGATA-4 and HNF-la in the regulation ofLPH 
'•i~:"'-'->'J": gene expression along the vertical gradient in 
GATA-4 HNF-1<l 
Fig. 2: GATA-4 and HNF-lo: are both expressed in epithelial 
vivo, immunohistochemistry was carried out using 
serial sections of mid-jejunum from adult mice 
and mouse GATA-4 and HNF-la antibodies (Fig. 
2). GATA-4 and HNF-la are both expressed on 
villi and are not detected in goblets (arrows) or 
crypts. The vertical expression patterns of GA TA-
4 and HNF-la coincide with the villus-specific 
expression of LPH, suggesting that GATA-4 and 
HNF-la might act together to cooperatively 
activate the human LPH promoter. 
cells on villi of adult mice. Immunohistochemistry was carried T 0 define potential similarities and out on serial sections of mid jejunum of adult mice using mouse 
antibodies for GATA-4 and HNF-Ju. Goblet cells (arrows) do differences in the function of intestinal GATA 
not demonstrate staining for either GAT A-4 or HNF-1 a. factors, transient co-transfection assays were 
carried out using the wild type human LPH promoter (hl!Swt) and GATA-4, GATA-5, and 
HNF-la expression vectors co-transfected singly and in combination (Fig. 3). HeLa cells were 
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used since these cells do not synthesize endogenous HNF-la (24). An empty expression vector 
(pRC-CMV) was used as a control for background activation of the human LPH promoter. As 
recently reported (1), GATA-4 independently activated the human LPH promoter as compared to 
GATA-5 which is known not to activate the human LPH promoter in the absence ofHNF-la 
(24). 
~ ~ 
HNF-1a 
Expression vector 
Fig. 3: GATA-4 activates the human LPH promoter by 
distinct mechanisms that are independent and dependent on 
HNF-la. Transient co-transfection assays were carried out in 
HeLa cells using the hll8wt promoter co-transfected with pRC-
CMV (negative control expression vector) or wild type GATA-
4, GAT A-5, and HNF-la, singly and in combination. The dotted 
line indicates the sum of the transcriptional activities of wild 
type GAT A and HNF-1 a co-transfected individually with 
hllSwt. The transcriptional activities above the dotted line 
indicate synergistic activation. Data are mean± SEM ofn = 5. 
HNF-la activated the human LPH promoter independently, as previously described (1,24). Both 
GATA-4 and GA TA-5 synergistically activated the human LPH promoter with HNF-la, as 
previously shown (1 ). These data suggest that GA TA-4 activates the human LPH promoter by 
dual mechanisms that are both independent and dependent on HNF-1a. 
To determine the importance of the binding sites in the proximal LPH promoter for the 
dual mechanisms ofGATA-4 activation, transient co-transfection assays were carried out in Hela 
cells using wild type and mutated hll8 constructs (Fig. 4A), and pRC-CMV and GATA-4 
expression vectors (Fig. 4B top panel). 
GATA-4 promoter are necessary for GATA-4-specific and 
h11 Bwt GAT A-4/HNF -1 a cooperative activation. A 
"lL Fig. 4: Different binding sites in the human LPH 
~ >- 0·5 schematic representation of wild type and mutant 
h11BmG.G, ~ hilS LPH constructs. Wild type (hilS wt) construct 
ro 0 , containsthefirstllSbpofhumanLPH5'-flanking 
h118 mH ·! 5.0 sequence. The mutated hll8mG1G2, hllSmH, and ~~ hll8 mG1G2 constructs contain mutations introduced ~ GATA-4+HNF-1"' into both GAT A-binding sites, the HNF-1 site, and in 
h11B m~ 'lo.-7!' .,._,.. r=-=-:-1 r+ ~ 
2
_
5 
all three sites together, respectively. B. GATA-4-
specific activation requires intact GATA binding 
sites in the human LPH promoter (top panel), 
whereas GAT A-4/HNF -1 a cooperative activation 
-;: 6 requires an intact HNF-1 site and not intact GATA 
~ sites (bottom panel). Transient co-transfection assays 
h118 were carried out in HeLa cells using wild type and 
constructs mutated hll8 constructs and the GATA~4 expression 
vector. pRC-CMV was used as a negative control. Data are means ± SEM of n = 5. 
The wild type h118 construct and the h118rnH construct, which contains a mutation in the HNF-
1 binding site, were similarly activated by GATA-4. However, constructs containing mutations 
introduced into both GATA binding sites (h 118mG1G,) or into both GATA and the HNF-1 
binding sites (h118mG 1G2H) were not activated by GATA-4. These data demonstrate that the 
GATA binding sites are critical for the GATA-4-specific activation of the human LPH promoter. 
To test the importance ofGATA and HNF-1 binding sites in the human LPH promoter 
for the GA TA-4/HNF-1 a cooperative activation, transient co-transfection assays in HeLa cells 
were carried out using wild type and mutated h118 constructs co-transfected with GATA-4 and 
HNF-1a expression vectors together (Fig. 4B bottom panel). The hllSwt construct was 
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synergistically activated by a combination ofGATA-4 and HNF-la, as also shovm in Fig. 3, and 
as previously reported (1). The hl18mG 1G2 construct remained synergistically activated by 
GATA-4 and HNF-la together although this construct was activated less than that ofhl18wt. 
However, introduction of a mutation into the HNF-1 binding site alone or in combination with 
both GAIA sites, resulted in a complete loss of synergistic activation by GATA-4 and HNF-1 a. 
These data demonstrate that cooperative GATA-4/HNF-la activation of the human LPH 
promoter requires HNF-1 binding sites, similar to that previously shown for GATA-5/HNF-la 
cooperativity (I). 
To characterize critical domains in GATA-4 necessary for the GATA-4-specific and the 
GATA-4/HNF-la cooperative activation, mutations were introduced into GATA-4 that delete or 
disrupt specific structures (Fig. 5A). To test the capacity of wild type and mutated GATA-4 
proteins to bind DNA which is necessary for GATA-4-specific activation, EMSAs were carried 
out using in vitro synthesized proteins and a previously described probe that binds GATA factors 
(24). As shown in Fig. 5B, wild type GATA-4 forms a protein/DNA complex (lane 2) which, in 
tum, forms a supershift complex (SC) using a mouse antibody for GATA-4 (lane 3). GATA-4 
mut 1, which contains a deletion of the activation domains, binds DNA (lane 4), whereas, 
GATA-4 mut 2, which contains a mutation in the C-terrninal zinc fmger that dismpts the 
structure of this zinc finger (lane 5), is incapable of binding DNA as previously shown (36). 
These data confirm that the C-terrninal zinc finger ofGATA-4 is critical for DNA binding. 
To test the importance of specific domains in GATA-4 for the physical interaction with 
HNF-la, GST pull-down assays (Fig. 5C, top panel) were carried out using in vitro labeled wild 
type and mutated GATA-4 proteins. Wild type GATA-4 and GATA-4 mut I physically interact 
with HNF-la, but GATA-4 mut 2 does not (lanes 1-3, respectively). Wild type and mutated 
GATA-4 proteins were synthesized as shown by the direct loading of in vitro labeled proteins 
(Fig. SC, bottom panel). These data demonstrate that the C-terrninal zinc finger is critical not 
only for DNA binding, but also for direct protein-protein interaction with HNF-la, as previously 
shown for GATA-5 (I). 
A AD 1 Fig. 5: The C-terminal zinc finger of GATA-4 Wild type (wt)c=:::=!!'=A~D~I!:' JlE:':";1 ,:jn=!~l~:@:::*:':cT:D:M:-~:~:-:& mediates DNA binding and physical interaction 
mut 1 C2?0S with HNF-la. A. Schematic representation of wild 
mut 2 c::::::::J!!M::::::::J!IIIIIIIi4a.ur,211'*!Z-BaEOl,.,_;nmm;;;!!A+!TI:WE!,,illJI type and mutant GAT A-4 proteins. GAT A-4 contains 
B G4 Antibody 
G4 Protein: 
sc-
• 
, ' 
-' 
r&-, ~ ~ 
i~ 
two N-terminal activation domains (AD I and AD II), 
c GST.,:H1o ~ two zinc fingers (Zn I, N-terminal zinc finger; Zn II, 
GATA-4; -;:: ~ ~ 3 C-terminal zinc finger), and a basic region (B) near 
120- the C-tenninus (36). Both activation domains are 
84" deleted in mut 1. GATA-4 mut 2 is a cysteine-to-
52,~ ..,serine substitution in the C-tenninal zinc finger at 
36-' amino acid 290. B. The GATA-4 C-terminal zinc 
finger med1ates DNA bmdmg EMSAs \\ere earned 30
- 1 2 3 4 out using the previously described GAT A binding 
GATA-4: 3 
84-
52-~_, 
36-
30-"!"'~~ 
2 3 
site as a probe (1) and wild type and mutant GATA-4 
proteins as indicated across the top of the figure 
(lanes 2-5). A protein-DNA complex (black 
arrowhead, lane 2), forms a supershift complex (SC) 
with a mouse GATA-4 antibody (lane 3). GATA-4 
mut I (gray arrowhead) binds to DNA, whereas 
GATA-4 mut 2 does not bind to DNA. C. The 
GAT A-4 C-terminal zinc finger is required for the 
physical interaction with HNF-la. GST pull-down assays (upper panel) were carried out using GST-Hlo: incubated 
with labeled in vitro transcribed and translated wild type (lane 1) and mutant GATA-4 (lanes 2 and 3). GATA-4 
wild type (black arrowhead) and mut 1 (gray arrowhead) were pulled down by GST-Hlo: whereas GATA-4 mut 2 
was not. GATA-4 was not pulled down by GST alone (lane 4). All proteins used in GST pull-down assays were 
synthesized as shown by direct loading of TNT products (lower panel). 
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To test the importance of GATA-4 activation domains and the C-terminal zinc finger for 
the GATA-4-specific and GATA-4/HNF-la synergistic activation, transient co-transfection 
assays in HeLa cells (Fig. 6) were conducted using GATA-4 mutants. To test the importance of 
these domains for the GATA-4 specific activation, GATA-4 wild type and mut 1 were co-
transfected independently ofHNF-la (Fig. 6, top panel). Wild type GATA-4 was capable of 
activating hll8wt, whereas GATA-4 mut 1, which binds DNA, activates hll8wt 60% lower than 
that ofGATA-4 wild type. GATA-4 mut 2, which contains a mutation that disrupts the C-
terminal zinc finger, binds DNA, but does not activate hll8wt. These data demonstrate that the 
GATA-4-specific activation requires GATA-4 activation domains and an intact C-terminal zinc 
finger. 
To determine whether the activation domains and the C-terminal zinc finger are 
important for the GAIA -4/HNF -1 a synergistic activation of the human LPH promoter, transient 
co-transfection assays were carried out using HeLa cells. The hll8wt was co-transfected with 
wild type and mutated GATA-4 and HNF-la expression vectors (Fig. 6, bottom panel). The 
hll8wt construct was synergistically activated by the combination ofGATA-4 plus HNF-la 
together, as indicated by a transcriptional activity that was ~2 fold greater than the sum of the 
individual transcriptional activities of GATA-4 and HNF-la alone (indicated by the dotted line). 
GATA-4 mut 1 demonstrates synergistic activation ofhll8wt when co-transfected with HNF-
la, although reduced as compared for that ofhll8wt co-transfected with GATA-4 and HNF-la 
together. However, GATA-4 mut 2, which does not physically interact with HNF-la or bind 
with DNA, does not synergistically activate hll8wt construct with HNF-la. However, promoter 
mutation experiments (Fig. 4) reveal that GAIA binding to DNA is not necessary for functional 
synergy. 
- HNF-1et 
+ HNF-1a 
t ~ s -s 
'----,"""E"'__=.E --' GATA4 
Expression vectors 
Fig. 6: The GATA-4-specific activation requires GATA-4 activation 
domains but GAT A-4/HNF -1 a cooperative activation does not. 
Transient co-transfection assays were carried out in HeLa cells using 
hll8wt, and wild type and mutant expre..~sion vectors for GAT A-4 singly 
(top panel) as well as together with the HNF-la expression vector 
(bottom panel). pRC-CMV was used as a negative control. The dotted 
lines indicate the sum of the transcriptional activities of wild type or 
mutant GATA-4 and \Vild type HNF-la (data not shown) expression 
vectors individually co-transfected with h118wt for that specific 
combination of expression vectors. Transcriptional activities that follow 
above the dotted lines indicate synergistic activation of the hl18wt 
promoter. Data are means± SEM ofn = 5. 
Thus, failure to synergistically activate the LPH promoter by 
GATA-4 mut 2 must be due to its inability to physically 
associate with HNF-la, rather than its inability to bind 
DNA. These data demonstrate that the mechanism ofGATA-
4/HNF-la synergy requires the physical interaction with 
HNF-la mediated through an intact C-terminal zinc finger. 
Synergistic activation does not require GATA-4 activation domains, similarly to the previously 
described GATA-5/HNF-la synergistic activation ofhll8wt (1). 
To test whether distinct functions among the GA TA factors are mediated through binding 
affinity differences of GATA-4 and GATA-5 to GAIA elements in the human LPH promoter, 
competition EMSAs were carried out (Fig. 7 A). Specific (S), non-specific (NS) oligonucleotides, 
as well as oligonucleotides containing each of the GATA binding sites of the human LPH 
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promoter were used as competitors to characterize binding affinities among GAIA binding sites 
for GATA-4 and GATA-5. Since GATA-4 and GATA-5 proteins are of different sizes, it was 
possible to assay these GAIA proteins together and directly compare the differences in GATA 
binding sites. Supershift analyses demonstrate that the top band is GATA-4 and the bottom band 
is GATA-5. EMSAs using the unlabeled oligonucleotide version of the probe was used a specific 
competitor, and both unlabeled hG1 and hG2 oligonucleotides demonstrated that the specific 
oligonucleotide competed stronger for GAIA proteins than either hG1 and hG2 as previously 
shown (1), where the hG1 oligonucleotide competed GATA-4 and -5 stronger than the hG, 
oligonucleotide. These data suggest that the two GAIA binding elements of the human LPH 
promoter between -95 and -88 bp (hGt) and between -67 and -61 bp (hG,) have a differential 
affinities for GATA proteins. 
To characterize different binding affinities ben:veen hG1 and hG2 for GATA-4 and 
GATA-5, densitometry quantification of each band was carried out (Fig. 7 A.) A premixed 
amount of GATA-4 and GA TA-5 was used for all binding assays (lanes 2-14). The band density 
in all lanes was used to calculate the ratio between amount ofGATA-4 or GATA-5 that was 
bound to the probe. 
A 
Protai!'l: 
Competition/ 
Anti body: 
GATA-4 + GATA-5 
•• 
B 
1.5 
"' ~ 0.75 
" 
0 
!11ilXF-GATA 
t2lhGATA24 
lillhGATA24c 
Molar excess 
(competitors) 
Fig. 7: GATA binding site in the human LPH promoter have distinct affinities for GATA proteins. A. GATA 
binding element between -95 and -88 bp demonstrated higher affinity for GAT A factors than the GATA binding 
element between -67 and -61 bp of human LPH 5'flanking sequence. EMSAs were carried out using the previous 
xF ABP described GATA probe (Fig. 58) and a standardized premix of wild type GATA-4 and GAT A-5 proteins 
(lanes 2-14). GAT A-4 (filled arrowhead) and GATA-5 (open arrowhead) bind to DNA, are of different sizes (lane 
2), and form a supershift complex (SC) with GATA-4 (G4 Ab) and GATA-5 (G5 Ab) mouse antibodies, 
respectively (lanes 3 and 4). Competition EMSAs were carried out using unlabeled oligonucleotides from xiFABP 
(lanes 5-7), both GATA binding site in the 5' -flanking region of the human LPH gene (lanes 8-13), and a non-
specific (lane 14) as competitors (indicated on the top of the gel). 2x, 20x, and 200x molar excess were used for each 
competitor. B. Densitometry among GATA-4 and GATA-5 band density for both GATA binding elements revealed 
higher affinity for GAT A-4 over GATA-5. 
The GATA-4 and GATA-5 incubated with probe and no competitor (lane 2) was used to 
standardize loading differences bet\.veen GATA-4 and GATA-5. The 200 molar excess of 
unlabeled oligonucelotides competed the GATA proteins completely and were not considered for 
densitometry. Specific competitor (unlabeled probe) showed, as expected, that each band was 
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competed equally. However competition with the hG1 and hG2 oligonucleotides revealed 
differential competition demonstrated by a greater reduction in GATA-4 binding to the probe 
(Fig, 7B). These data demonstrate that the GATA binding elements in the human LPH promoter 
have a preference for GATA-4 compared to GATA-5, suggesting that the higher affinity of 
GA TA binding elements for GATA-4 might mediate, in part, the GATA-4-specific activation of 
transcription ofLPH in vivo. 
DISCUSSION 
The GATA-4, -5, and -6 subfamily of transcription factors are expressed together in the 
mammalian small intestine as early as E9.5 (10) and activate promoters of intestinal genes 
(1,9,22-24), but distinct functions among these factors in the regulation of intestinal gene 
expression have not been previously reported. In the present study, we show for the first time 
distinct functions among individual GATA factors in their ability to activate the human LPH 
promoter. GATA-5 activates the LPH promoter in the presence ofHNF-la but is incapable of 
activating this promoter in the absence ofHNF-1 a (24). In contrast, GATA-4, in addition to 
synergistic activation with HNF-1 a, is capable of activating the LPH promoter independently of 
HNF-la. The GATA-4-specific activation requires GATA-4 binding to DNA and the GATA-4 
activation domains. In the present report we have shown that the mechanism ofGATA-4/HNF-
1a cooperativity requires the physical interaction between GATA-4 and HNF-la and that this 
interaction is mediated through the C-terminal zinc finger of GATA-4. This GA TA-4/HNF-1 a 
mechanism is similar to the previously shown mechanism of the GATA-5/HNF-la cooperativity 
which is mediated through the C-terminal and basic region ofGATA-5 and the homeodomain of 
HNF-la. Further, both GATA-4/HNF-la and GATA-5/HNF-la cooperativity require HNF-la 
binding to DNA (1) and the HNF-la activation domains. These findings are in agreement with 
our previously reported model which states that the GATAJHNF-1a synergy is mediated by 
HNF-1a through its activation domains which are oriented for high levels of activation through a 
combination of binding to DNA and physical association with GATA factors(!). Although dual 
mechanisms for GATA-4 have been reported in the regulation of the MUllerian inhibiting 
substance gene (MIS) (21 ), this study is the first to demonstrate distinct regulatory mechanisms 
for activation of the human LPH promoter by two conserved GATA factors, suggesting that 
these factors play a critical role in the transcriptional regulation of intestinal genes in vivo. 
Zinc finger-homeodomain interactions may be an important mechanism for tissue-
specific gene regulation. We have previously shown that GATA factors physically interact with a 
member of the homeodomain transcription factor family, HNF-la, in vivo, which is required for 
the cooperative activation of intestine-specific genes, like LPH (1) and SI (25). The zinc 
finger/homeodomian interaction mechanism is also demonstrated for other tissue-specific genes 
(10,37) as well as in Drosophila (29,30). The redundant function ofGATA factors in the zinc 
finger -homeodomain synergy mechanism and the fact that this mechanism is found in other 
vertebrate tissue as well as in Drosophila suggest that zinc finger-homeodomain interactions are 
an efficient mechanism for synergistic activation of gene transcription that has been conserved 
throughout evolution in which conserved GATA factors play an important role. 
This study demonstrates for the first time different binding affinities of GATA elements 
in the promoter of an intestinal gene. We have demonstrated by competition EMSAs that the hG1 
( -95 to -88 bp) has a higher affinity for GATA proteins than the hG, ( -67 to -61 bp) (Fig 7 A). 
Additionally both GATA elements preferentially bind GATA-4 over GATA-5 (Fig. 7B). The 
alignment of the 5'-flanking sequence of the human, rat, mouse, and pig LPH gene, revealed that 
hG 1 (-95 to -88 bp) is evolutionarily conserved, suggesting that is element is important for 
GATA regulation of transcription. However, hG2 ( -67 to -61 bp) revealed differences in 
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sequence among mammals and may mediate species-specific GAIA regulation at LPH 
promoter, as previously described (24). 
Distinct functions among the GATA-4, -5, and -6 transcription factor family have not 
been reported for the regulation of intestinal-specific gene transcription and may, in part, be 
explained by the differential binding affinities between these GAIA factors for the cis-acting 
elements in promoters of target genes. We have demonstrated by densitometry that the human 
GATA elements preferentially bind GATA-4 over GATA-5 in vitro (Fig. 7B) which may, in 
part, explain the GATA-4-specific activation of the human LPH promoter. Consistent with these 
data are the affinity differences of GAIA factors for the GAIA element in the promoters of 
cardiac genes. GATA-4 has a higher affinity for the GAIA element in the a- and ~-myosin 
heavy-chain (a- and B-MHC) promoters than GATA-6, which explained, the higher 
transcriptional activation of these promoters by GATA-4 (38). Additionally, in the same report, it 
is suggested that the differential activation of the atrial natriuretic factor promoter by GATA-4 
and GATA-6 correlates well with their affinity differences for the GATA sites in this promoter. 
Further, in another report, it was demonstrated that GATA-5, and -6 activate the cardiac troponin 
I promoter better than GATA-4, which was suggested to be regulated by the cis-acting elements 
of the promoter (39). Finally, in a previous report, it is demonstrated that GATA-6 activates the 
mitogen-responsive phosphoprotein Dab2 promoter, but GATA-4 does not ( 40). In contrast to 
the recent and previous reports, Morrisey et al suggested that the GATA-6-specific activation is 
not regulated through the zinc finger regions, but rather through N-terminal or C-terminal 
domains. However, our recent data clearly demonstrates that the distinct functions between 
GATA-4 and GATA-5 correlates with the distinct affinities for the GATA elements. These data 
suggest that the GATA elements in intestine-specific promoters have different affinities for 
members of the GATA-4, -5, and -6 subfamily, which may explain, in part the distinct functions 
among these GATA factors for the transcriptional regulation of intestine-specific genes. 
Although the wide-ranging expression patterns ofGATA-4, -5, and -6 argue against these 
proteins as being master regulators of tissue- or cell-type-specific gene expression, the 
phenotypes of mice which contain targeted disruption ofGATA-4, -5, and -6 suggest distinct 
functions of these factors. In addition, the expression pattern ofGATA-4 mRNA along the 
horizontal gradient coincides with that ofLPH mRNA in adult small intestine, but not the 
GATA-5 mRNA expression pattern, suggesting that GATA-4 is a critical component for the 
transcription ofLPH along the horizontal gradient. Since Cdx-2, a caudel related homeodomian 
transcription factor, also physically interacts with GATA factors (25)and HNF-la (41) and we 
have previously shown that LPH is also synergistically activated by a combination of GATA, 
HNF-la, and Cdx-2 (24), it remains possible that these transcription factors bind and act in 
concert to regulate LPH gene transcription. Finally, both GATA-4 and GATA-5 with HNF-la 
are capable of cooperatively activating the human LPH promoter and GATA-5 is expressed in 
enterocytes of the intestine where LPH is not expressed, it is reasonable to hypothesize that these 
factors are important but not sufficient for the complex expression patterns ofLPH. Interaction 
with other tissue-restricted transcription factors and co-factors, such as SP-1 (37), FOG-2 
(42,43), Cdx-2 (41) and dimerization co-factor ofHNF-la (44) as well as other information 
further upstream in the LPH promoter ( 45,46) must be considered when characterizing specific 
expression of the LPH gene in vivo. 
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ABSTRACT 
Friend of GATA (FOG) is a family of multi-zinc finger co factors that modulate the 
GAIA activation of target genes. Two members have been identified thus far, FOG-I and FOG-
2. We have previously shown that the lactase-phlorizin hydrolase (LPH) promoter is activated by 
GAIA and HNF-1 a transcription factors, both individually and cooperatively (Am. J. Physiol. 
28l:G69-G84, 2001). The aim of this study was to define the role of FOG cofactors on the 
GAT A-specific and GATAIHNF-la cooperative activation of the LPH promoter. Both FOG-I 
and FOG-2 mRNAs were detected in RNA isolated from adult mouse jejunum by RT-PCR 
demonstrating that these two cofactors are expressed in mammalian small intestine. Both FOG-I 
and FOG-2 repressed the GATA-4-specific activation of the human LPH promoter to less than 
70% (FOG-1) or 10% (FOG-2) of its activated value. FOG-1 and FOG-2 had no effect on the 
HNF-la-stimulated activation, demonstrating that FOG repression is GAT A-specific. FOG 
cofactors also repressed the GATAJHNF-la cooperative activation of the LPH promoter. 
Introduction of critical amino acid substitutions in the N-terrninal zinc finger of GATA factors, 
which have been shown to disrupt physical interactions with FOG, result in the reduction of 
FOG-specific repression of the GATA/HNF-la cooperative activation, but not the GATA-4-
speci:fic activation. These data suggest that FOG co factors expressed in the intestine modulate 
LPH gene expression by repressing the GAT A-specific and GATA/HNF-la cooperative 
activation of the LPH promoter. This repression likely occurs via physical associations between 
GATA and FOG proteins that involve, in part, the N-terrninal zinc fingers of GATA factors. 
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INTRODUCTION 
Friend ofGATA (FOG) is a family of multi-zinc finger, transcriptional co-factors that 
modulate GAT A-specific activation of target genes during cellular differentiation. FOG-1 is 
highly expressed in parallel with GA TA-l in erythroid cell lines and in spleen, liver, and testis 
(25). As with GAT A-I, FOG-I plays a critical role in hematopoiesis. The targeted disruption of 
fog-1 in mice leads to embryonic lethality, with mice dying of severe anemia between embryonic 
day II and 12 (24), similar to that fonnd in gala- I null mice (8). FOG-2 is more widely 
expressed than FOG-I, generally paralleling that of the GATA-4, -5, -6 subfamily. In mice, 
FOG-2 mRNA is first detected in developing heart and septum transversum (E8.5) followed by 
expression in neural epithelium and the urogenital ridge (Ell.5) (21, 22). At E15.5, expression is 
detected in the developing lnng, kidney, and gut (22). In adult mice, FOG-2 is expressed highly 
in heart, brain, and testis, and at lower levels in lung, liver, and kidney (22). As with GATA-4, 
FOG-2 plays a critical role in cardiogenesis. Mice harboring a targeted mutation ofjog-2 die of 
congestive heart failure at E13 characterized by a thin ventricular myocardium, tricuspid atresia, 
and a defective vasculature (20, 23), similar to that found in gata-4 null mice (15, 17). Indeed, 
knock-in of a GATA-4 substitution that is incapable of physically associating with FOG-2 
exhibits a remarkably similar constellation of defects (3) suggesting that interactions between 
GATA-4 and FOG-2 are essential for normal heart development. FOG-I and FOG-2 are both 
expressed in fetal intestine (3, 16, 22, 25), but the expression and function of these two proteins 
in adult intestine have not been reported. 
FOG proteins have been shown to modulate the transcriptional activities of the GAIA 
proteins through interactions with theN-terminal zinc finger ofGATA factors (GAIA factors 
have a pair of zinc fingers). Depending on the context, FOG can act to further activate 
(synergize) or repress the GAT A-activation of target genes (I 0, 16, 24, 25). For example, theN-
terminal zinc finger of GATA-1 associates with FOG-1 resulting in synergistic activation of the 
erythroid-specific NF-E2 promoter (24, 25). However, FOG-I represses the GATA-1-activation 
of the Mla promoter (10). Similarly, the a-myosin heavy chain (a-MHC) promoter is activated 
by FOG-2 in COS cells, but repressed by FOG-2 in neonatal rat cardiomyocytes (16). FOG-! 
interacts with the transcriptional co-repressor CtBP2, which may be recruited by FOG-1 to 
repress gene expression (1 0), although knock-in of a FOG-1 substitution that does not interact 
with CtBP2 exhibits no phenotypic abnormalities (11 ). Although FOG-2 also contains the 
conserved CtBP2 binding site, PIDLS, the GATA-4-specific repression of cardiac promoters was 
recently localized to a novel N-terminal domain (aa 1-247) ofFOG-2 (19). This domain, which 
is also conserved in FOG-1, is both necessary and sufficient to repress GATA-4-dependent 
transcription. These data demonstrate a multifunctionality of FOG proteins that is dependent on 
the configuration of target promoters as well as the expression of other components within cells. 
GATA-4, -5, and -6 subfamily expressed in intestinal epithelium (1, 9), and activate the 
promoters of intestinal genes, including those of the intestinal fatty acid binding protein (9), 
sucrase-isomaltase (12), and lactase-phlorizin hydrolase (LPH) (5, 6, 12). We have further 
shown that GAIA factors physically associate with the homeobox transcription factor, 
hepatocyte nuclear factor-lu (HNF-lu), and synergistically activate the LPH promoter (27). 
Finally, GATA factors demonstrate independent functions characterized by the ability ofGATA-
4, and inability ofGATA-5, to activate the LPH promoter in the absence ofHNF-la (12, 26, 27). 
In the present study, we demonstrate that FOG-I and FOG-2 are expressed in the adult mouse 
small intestine and repress the GATA-4-specific and GATAIHNF-la cooperative activation by a 
mechanism that requires at least one intact GATA zinc finger. 
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METHODS 
RT-PCR-To characterize FOG expression in adult mouse small intestine, RT-PCR was 
conducted using RNA isolated from tissue of adult mice. RNA was isolated using Trizol 
Reagent™ (Gibco-BRL) according to the manufacturers instructions. After annealing the RNA 
to oligo dT, first strand eDNA was synthesized using Superscript II (Gibco-BRL) according to 
the manufacturers instructions. PCR was then conducted using a thermocycler (MJ Research) by 
melting at 94'C (30 sec), annealing at 55'C (30 sec) and extending at 72'C (1 min) for a total of 
30 cycles. The following oligonucleotides were used: FOG-1, 5'-
TGGTGCAGGGTTACCAAAGT-3', 5'-TTGATGACTGCGGTAGCAAG-3'; FOG-2, 5'-
AGTCTTCAGCGAAGCAGCTC-3', 5'-TGACCATGCCTCTGTTTTTG-3'; SI, 5'-
ACACGTTGCTGCCCTATTTC-3', 5'-CATAAAAGCTGGACCCACA-3'. Expected sizes of 
amplification products were: FOG-1, 194 bp; FOG-2, 299 bp; SI, 146 bp. 
Plasm ids- Previously characterized expression vectors for mouse FOG-1 (FOG-1-CMV) 
(25) (gift of S. Orkin) and FOG-2 (FOG-2-CMV) (21) (gift of J. Leiden) were obtained for these 
studies. Previously characterized expression vectors for mouse GATA-4 (G4-CMV) (15), 
GATA-5 (G5-CMV) (18) (gifts ofM. Pannacek, University of Pennsylvania) and HNF-la (14) 
(gift of G. Crabtree, Stanford University) were also obtained for these studies. Since the original 
HNF-la expression vector replicates inefficiently during bacterial amplification, the HNF-la 
coding region was PCR amplified and subcloned into the BamHI and EcoRI sites of pcDNAl 
(called Hla-CMV), as previously described (27). This plasmid was amplified efficiently in 
E. coli DH5a cells. 
To introduce a mutation into theN-terminal zinc finger of GATA-4 that has been 
previously shown to disrupt FOG-2 interactions (19), site-directed mutagenesis was carried out 
using the method of Kunkel et al (13) as previously described (27). This mutation, a glutamic 
acid-to-lysine substitution at amino acid 215 (E215K, mutl), was introduced using the 
mutagenic oligonucleotide, 5'-CACAATTGACACACTTTCTGCCTTCTGAG-3' (mutation 
underlined). 
For transfection studies, the human LPH promoter containing 118 bp of5'-flanking 
region was fused 5' to the human growth hormone reporter (called hllRwt) as previously 
described (12). This region contains previously characterized GATA and HNF-1 binding sites. 
An hll8 construct in which the GATA sites were mutated (called hll8mGlG2) was also used in 
these studies. Mutations introduced into these sites have been previously shown to disrupt 
specific protein-DNA interactions (12). pRC-C:rvt:V (Invitrogen) served as a negative control 
expression vector for all co-transfection experiments. 
Cell culture and transient co-transfection assays-All cells were grown in Dulbecco's 
modified Eagle's medium (Gibco-BRL) supplemented with 5 J.Lg of penicillin-streptomycin per 
ml and containing 10% fetal calf serum. Transient co-transfection assays were carried out in 
Caco-2 and HeLa cells. Caco-2 cells were used to define the function of FOG co factors in an 
intestinal cell line. HeLa cells were used because GAT A-specific and GATA/HNF-la 
cooperative activation can only be distinguished in cells that do not synthesize endogenous 
HNF-la, exempting Caco-2 cells because they make abundant amounts ofHNF-la. Cells at 80-
95% confluence were collected by trypsinization and plated onto 6-well plates the day before 
transfection. Cells were transfected using Effectene™ reagent (Qiagen) according to the 
protocol provided by the manufacturer. Optimal conditions for both cell lines were: 1 llg total 
DNA (0.4 ~Jg of promoter/reporter construct and 0.2 ~Jg of expression vector) and 4 ~-tl of 
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additional24 h, as previously described (27). All plates were confluent at the time of harvest. 
The amount of human grovvth hormone reporter secreted into the media over 24 h was measured 
using an [1251] radio/immunoassay kit (Allegro hGH, Nichols Institute). To control for 
transfection efficiency, all transcriptional activities were expressed relative to pXGH5, a 
constitutively active metallothionine-1 promoter fused to the human grovvth hormone gene. 
Statistics-The one-way analysis of variance was employed in all statistical analyses using 
InStat software (GraphPAD Software, Inc.). Multiple comparisons were carried out by the Tukey 
multiple comparison test. 
RESULTS AND DISCUSSION 
To determine if FOG cofactors are expressed in the adult mammalian small intestine, RT-
PCR was carried out on RNA isolated from the mid jejunum of a 10 week old mouse. As shown 
in Fig. 1, an amplification product of predicted size for FOG-I was clearly identified in adult 
mouse jejunum as well as in spleen and liver, as previously shown (25). 
Fig. 1. FOG~ 1 and FOG-2 are expressed in adult 
mouse small intestine. RT-PCR was carried out on RNA 
isolated from the mid jejunum of a 10 week old mouse 
using oligonucleotides specific for mouse FOG-I, FOG-2, 
and sucrase-isomaltase (Sl). Size markers are indicated on 
the left in bp. Expected sizes of amplified products: FOG-
!, 194 bp; FOG-2, 299 bp; Sl, 146 bp. 
A feint, but detectable amplification product of predicted size for FOG-2 was also identified in 
mouse jejunum. A FOG-2 amplification product was also detected in spleen and liver, as 
previously published for liver (22). On the right, is a positive sucrase-isomaltase control for 
intestinal RNA. This experiment demonstrates that FOG co factors are expressed in adult mouse 
JeJunum. 
GATA factors have been sho\\111 to activate certain intestinal gene promoters, including 
those of the intestinal fatty acid binding protein (9), sucrase-isornaltase (2, 12), and LPH (5, 6, 
12) genes. In non-intestinal systems, FOG cofactors have been shown to modulate the GATA 
activation of target genes (4, 7, 16, 19, 21, 25). To define the role of FOG cofactors on the 
GATA activation of intestinal genes, the effect of FOG cofactors on the GAIA activation of the 
LPH promoter was determined using transient co-transfection assays in the Caco-2 intestinal cell 
line. As shown in Fig. 2, both FOG-land FOG-2 repressed the GATA-4 and GATA-5 
activation of the LPH promoter, and FOG-2 repressed the GATA-6 activation of this promoter. 
.z-. 0·75 ;:J pRC-CMV 
:2: • FOG-1 ~ 050 .I c:h· ~ FOG·.L~2 ~l ~ \ ·~ 0.25 ~ 
~ 
2 
0.00· l 
pRC-CMV GATA-4 GATA-5 GATA-6 HNF-1a 
Expression vector 
Fig. 2. FOG~ I and FOG-2 repress the GAT A-activation 
of the human LPH promoter in the Caco-2 intestinal cell 
line. Transient co-transfection assays were carried out using 
h118 and expression vectors for pRC-CMV (empty vector 
control), GATA-4, GATA-5, GATA-6, orHNF-la. 
independently (open box) or along with expression vectors 
for FOG-1 (filled box) or FOG-2 (hashed box). 
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This repression was GAT A-specific because neither FOG-1 nor FOG-2 repressed the HNF-la 
activation. This study demonstrates that FOG cofactors are capable of modulating the GA TA 
activation intestinal gene promoters in an absorptive enterocyte-like cell line. 
GATA-4 is capable of activating the LPH promoter independently as well as 
cooperatively through physical interactions with HNF-la (26). To delineate the effect of FOG 
cofactors on the dual mechanisms ofGATA-4 activation, the effect of FOG cofactors on the 
GATA-4-independent and GATA-4/HNF-la cooperative activation were determined using 
transient co-transfection assays in HeLa cells. HeLa cells were used because they do not 
synthesize HNF-la (12), which is necessary to distinguish GATA-4-independent from GATA-
4/HNF-la cooperative activation. As shown in Fig. 3, FOG-1 reduced the GATA-4-specific 
activation by approximately 50%, whereas FOG-2 reduced it virtually to baseline. 
0 pRC-CMV 
II FOG-1 
!:SI FOG-2 
Expression vector 
Fig. 3. FOG-I and FOG-2 repress the GATA-4-specific and 
GATAIHNF-lu cooperative activation of the LPH promoter. 
Transient co-transfection assays were carried out in HeLa cells using 
hl18wt and expression vectors for pRC-CMV (control), GAT A-4, 
and HNF-la as indicated, without (open box) and with expression 
vectors for FOG-I (filled box) or FOG-2 (hashed box). *Significantly 
different than the non-FOG cotransfected control, P < 0.05. 
Again, the FOG effects were GAT A-specific because the FOG cofactors had no effect on HNF-
la activation of the LPH promoter. FOG cofactors also reduced the combined GATA-4/HNF-la 
activation approximately 40% by FOG-1 and 50% by FOG-2. This experiment demonstrates that 
FOG cofactors, especially FOG-2, repress GATA-4-mediated activation of the LPH promoter in 
HeLa cells. This experiment also suggests that FOG cofactors repress the GATA/HNF-la 
activation of the LPH promoter, although it is uncertain whether this repression is due to 
repression of cooperativity or to repression of the GATA-4-specific component of the combined 
activation. 
To test the hypothesis that FOG-2 represses the GATA/HNF-la cooperative activation of 
the LPH promoter specifically, tvvo models of cooperativity were employed. In the first model 
(Fig. 4A), GATA-5 was used since GATA-5 demonstrates high levels of synergy with HNF-la, 
but has no intrinsic activity of its o\Vll (12). As shown by the addition ofFOG-2 to the combined 
activation, synergistic activation was reduced approximately 70%. In the second model (Fig. 
4B), GATA-4 was used, but the GATA binding sites in the LPH promoter were mutated. As 
shown recently (26), GATA-4-specific activation requires intact GATA binding sites on the 
promoter, but GATA/HNF-la cooperative activation does not. Cooperative activation requires 
only an intact HNF-1 binding site. Thus, by mutating the GATA sites, the GAT A-specific 
component of cooperative activation is eliminated. As shown by the addition of FOG-2, 
synergistic activation is reduced approximately 50%. 
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Fig. 4. FOG-2 represses the GATAJHNF-lu 
cooperative activation of the LPH promoter. 
Transient cotransfection assays were carried out 
in HeLa cells using two models ofGATAIHNF-
la cooperativity. In the first model, A, GATA-5 
was used since GAT A-5 demonstrates high levels 
of synergy with HNF-lu in the activation of 
hl18wt, but has no intrinsic activity of its own 
(12). In the second model, B, GAT A-4 was used, 
but the LPH promoter in the promoter-reporter 
construct had GAT A binding sites that were 
mutated (indicated as hll8mG1G2). GATA-4-
specific activation requires intact GAT A binding 
sites on the promoter, but GATNHNF-lu 
cooperative activation does not. The transfected 
expression vectors are indicated along the bottom 
of each figure. The dotted line represents the sum 
of the individual GAT A and HNF-la transfections. 
This is parallel to the finding by Lu et al (16), who showed that the cooperative activation of the 
atrial natriuretic factor (ANF) promoter by GATA-4 and Nkx-2.5 is repressed by FOG-2. 
Together, these data are support the hypothesis that FOG-2 represses not only the GAT A-
specific activation, but also the GATAJHNF-la cooperative activation of the LPH promoter. 
It has been previously shown that FOG co factors physically associate with theN-terminal 
zinc finger ofGATA factors to modulate GAIA activation of target genes (16, 19, 25). To test 
the hypothesis that FOG cofactors mediate repression of the LPH gene through interactions with 
theN-terminal zinc finger ofGATA-4, a previously characterized amino acid substitution 
(E215K) that disrupts physical interactions with FOG-2 (19) was introduced into GATA-4 
(mutl). As shown in Fig. 5, GATA-4 mutl activates the LPH promoter similar to that of wild 
type GATA-4 shown in Fig. 3. 
D pRC-CMV 
II FOG-1 
ts FOG-2 
Expression vector 
Fig. 5. A mutation in theN-terminal zinc finger of GATA-4 disrupts 
GAT A-4/HNF -la cooperative, but not GAT A-4-specific activation of the 
LPH promoter. Transient co-transfection assays were carried out in HeLa cells 
using hll8wt and expression vectors for pRC-CMV (control) and GAT A-4 
mutl individually and in combination with HNF-la as indicated, without (open 
box) and with expression vectors for FOG-1 (filled box) or FOG-2 (hashed box). 
*Significantly different than the non-FOG cotransfected control, P < 0.05. 
As with wild-type GATA-4, GATA-4 mutl binds DNA (EMSA, 
not shown). In the absence ofHNF-la, GATA-4 mutl mediates 
FOG repression similarly to that of wild type GATA-4, but in the 
presence of co-transfected HNF-la, GATA-4 mutl is unable to 
mediate repression ofGATA/HNF-la cooperative activation (in 
contrast to wild type GATA-4). Based on these findings, it is 
hypothesized that in the absence ofHNF-la, GATA-4 mutl is capable ofbinding FOG cofactors 
through the intact C-terminal zinc finger, whereas in the presence ofHNF-la, which we have 
previously shovm binds to this zinc finger (27), is no longer capable of binding FOG cofactors 
and mediating FOG repression, perhaps because of competition with HNF-la. 
These data demonstrate that FOG cofactors are expressed in adult mouse small intestine 
and repress the GAT A-mediated activation of the LPH promoter. Although FOG-! and FOG-2 
are both expressed in fetal intestine (3, 16, 22, 25), this is the first report demonstrating 
138 Chapter 7 
expression and function of these two proteins in adult intestine. Previous studies have shown that 
depending on promoter and cell lines, FOG cofactors can act as either activators or repressors of 
the GAIA activation of target gene expression (10, 16, 24, 25). For example, the a-myosin 
heavy chain (a-MHC) promoter is activated by FOG-2 in COS cells, but repressed by FOG-2 in 
neonatal rat cardiomyocytes (16). In the present study, we found both FOG-1 and FOG-2 repress 
the GAT A-specific activation of the LPH promoter in intestinal Caco-2 cells as well as in non-
intestinal HeLa cells. Thus, FOG cofactors may regulate the specific expression of intestinal 
genes by repressing GAT A-activated gene transcription in vivo. This repression likely occurs via 
physical associations between GAIA and FOG proteins that involve, in part, theN-terminal zinc 
fingers of GATA factors. 
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Chapter 8 
HNF-la is a critical transcription factor for the regulation of LPH gene 
expression in vivo. 
(Manuscript in preparation) 
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INTRODUCTION 
These data are outside the scoop of this thesis. However, these experiments were carried 
out during the process of the thesis preparation and demonstrate a significant part of the 
hypothesis of this thesis and therefore were appropriate to mention. 
HNF -1 a is expressed in the intestine and activates the promoters of several intestine-
specific genes, including that of the intestinal differentiation marker gene, lactase-phlorizin 
hydrolase (LPH). LPH, an intestinal disaccharidase necessary for the digestion of milk lactose, is 
expressed only in absorptive enterocytes on villi [1-4], and thus is a model for tissue-, cell-type-, 
and differentiation-specific gene expression. In rats, LPH is first expressed at the time of villus 
formation [5, 4], and thus is a marker for this event in the developing gut. The LPH gene is 
expressed throughout the small intestine at birth and during suckling, but is reduced and also 
restricted to the jejunum and proximal ileum after weaning [2]. Together, these data demonstrate 
an intricate, highly regulated pattern of expression that coincides with critical mechanisms of 
gene regulation in the mammalian small intestine. Accordingly, the LPH gene is used as a model 
for defining the mechanisms of intestine-specific gene expression. 
Initial characterization ofLPH gene expression revealed that the developmental pattern 
oflactase activity in rats [6, 7, 2] and the genetic pattern in humans [8] are both coordinated with 
the abundance ofLPH mRNA. Using sophisticated pre-mRNA analyses and nuclear run-on 
assays, the PI then demonstrated that the horizontal and developmental patterns ofLPH gene 
expression are transcriptionally regulated [2]. Transcriptional control was further supported by in 
vivo studies by the PI [3] and others [9, 10] who showed using transgenic mice that the LPH 
promoter directs reporter expression to absorptive enterocytes on small intestinal villi. These 
studies revealed that information for tissue-, cell-type-, and differentiation-specific LPH gene 
expression is contained in its 5'-flanking region. 
Sequence analysis of the LPH 5'-flanking regions of the human, rat, mouse, and pig LPH 
genes [11-13] reveal binding sites for the transcription factors, Cdx-2, GATA, and HNF-1, all of 
which are expressed in the intestinal epithelium. The conserved position of these binding sites in 
the LPH promoter among different species, and the close proximity of these sites to the TAT A-
box and to each other have led to our hypothesis that the factors that bind these sites are 
important and act in concert to modulate LPH gene expression in vivo. Indeed, we have shown 
that HNF-1a independently and cooperatively (with GAIA factors) activates the LPH promoter, 
and that the HNF-1 binding site at -90 to -70 bp is critical for these activations [14]. 
These data have led us to hypothesize that HNF-1a. act as a linker for other proteins in 
order to act in concert with these proteins for the regulation ofLPH gene expression in adult 
mtce m vtvo. 
Methods 
Knock out mice-To test the hypothesis that HNF-1 a is required for LPH gene expression 
in vivo, we have obtained frozen tissues from adult hnf-1 a-1- and-/+ littermates (gift from Drs. 
T. Akiyama and F. Gonzalez, NIH). The hnf-1 anull mice were produced in the laboratory of Dr. 
F. Gonzalez (NIH, Bethesda, MD) using the Cre-/axP recombination system whereby mice 
homozygous for an hnf 1 a gene containing introduced loxP sites were bred with a homozygous 
ere transgenic mouse line, Ella-ere [5], which express Cre in all cells of early embryos. Lack of 
HNF-la: expression in the livers and kidneys of these mice has been verified [15, 16]. 
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Plasm ids- To construct plasmids templates for the synthesis of RNA probe for RNase 
protection assays. Single-stranded 32P-labeled antisense RNA probe for mouse LPH was 
synthesized and gel purified. To identifY endogenous mouse LPH mRNA, a template was 
derived from the 3.3-kb EcoRI (located at -823 in the 5'-flanking region)/Hind III (located at 
+584 in the coding region) fragment into the EcoRI/Hind III sites of pSP73 (Promega Biotec, 
Madison, WI). The template was linearized with Nco!, which is present in the first ex on(+ 398) 
of the rat LPH gene [17]. The antisense RNA probe was synthesized using T7 RNA polymerase. 
RNase protection assays-The quantitative pattern of GATA and HNF-la expression was 
compared to that ofLPH using RNase protection assays as previously described [2, 3]. Total 
RNA was isolated from mouse tissues using Trizol Reagent™ (Invitrogen), quantified by optical 
density at A260 nm, and checked on an agarose gel. C2P]-labeled probes were hybridized at 
68°C in 50% formamide overnight, digested with RNase A and Tl, and the protected fragments 
were separated on 6% denaturing polyacrylamide gels and revealed by autoradiography. 
RESULTS 
To characterize the effect of the absence ofHNF-la on LPH gene expression in vivo, 
LPH mRNA abundance was determined by RNase protection assays in RNA isolated from 
jejunum of adult mice. As shovm in Fig. 1, LPH rnRNA was reduced by 85% in the hnf-1 a-/-
mice as compared to the-/+ control, indicating that LPH gene expression requires HNF-la in 
VIVO. 
LPH 
LPHmRNA ~ W 
1 2 3 4 5 
Fig. l. LPH mRNA expression is reduced in adult mice homozygous for 
the hnf-1 a null allele. RNase protection assay using a probe specific for 
mouse LPH mRNA [3] was carried out on RNA isolated from the small 
intestine of mice homozygous(-/-, lanes 2) and heterozygous(-/+, lanes 3) for 
the hnf-1 a null allele. Mouse liver RNA (lanes 4) and tRNA (lanes 5) were 
used as negative controls. Intact ribosomal bands on ethidium bromide-stained 
gels indicated that the RNA was not degraded (not shown). LPH mRNA 
abundance was reduced by 85% in the small intestine of an hnf-1 a-/- mouse 
(lane 2) as compared to that of a hnf- I a -I+ mouse (lane 3) (determined by the 
cutting and counting of the protected fragment from dried gels). 
These data demonstrate that HNF-la is a critical component of the LPH gene expression in 
adult mice in vivo. 
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9.SUMMARY 
9.1 LPH and Sf are marker genes 
Here, I have defined the function ofCdx-2, HNF-la, and GATA-4, -5, and -6 
transcription factor family members in the transcriptional regulation of the intestinal marker 
genes, LPH and SI. Through a series of elegant experiments in the laboratory ofR. J. Grand, as 
well as experiments in other laboratories, lactase and sucrase were shown to be excellent markers 
of intestine-specific gene expression (chapter 1 ). These disaccharidases are absorptive enterocyte 
membrane anchored glycoproteins. Lactase digests lactose, the main carbohydrate in milk, 
whereas sucrase hydrolyzes sucrose, which is derived mainly from sugar cane and beet which are 
found in many solid foods. LPH and SI are both expressed in absorptive enterocytes on villi, and 
therefore display tissue-, cell type-, and differentiation specific patterns. The expression patterns 
along the horizontal and developmental gradients for LPH and SI are different from each other. 
LPH first appears at the time of villus formation, is highly expressed at birth, and remains high 
until weaning, when LPH expression is reduced and restricted to the mid jejunum and proximal 
ileum. During this period, the intestine undergoes a biochemical and morphological transition 
that prepares the intestine for solid food nutrients. At weaning, SI increases from low levels to 
adult levels and therefore is an excellent marker for this transition. The abundance of LPH and SI 
proteins coincides with the levels of their mRNAs, pre-mRNAs, and transcriptional rates, 
demonstrating that LPH and Sl protein abundances are regulated at the transcriptional level. 
Transgenic studies have revealed that a 2 kb promoter of the rat LPH gene directs specific 
expression along the vertical, horizontal, and developmental gradients. For SI, a short180 bp 
evolutionarily conserved region of the SI promoter is sufficient to direct its developmental and 
differentiation-dependent expression patterns. Together, these data establish that LPH and SI are 
excellent marker genes for intestine-specific-gene expression, and that these expression patterns 
coincide with important transitions in the intestine of developing mammals. Therefore, 
understanding the mechanisms ofLPH and SI expression during these important transitions 
should reveal critical processes in the regulation of intestinal differentiation and development. 
This thesis reveals fundamental control mechanisms for the transcriptional processes of the LPH 
and SI marker genes. 
9.2 Difj€:rential activation of rat and human LPH and human and mouse Sf promoter 
In chapter two, it is revealed that approximately the first 118 bp of the rat and human 
LPH promoters and 183 bp of the human SI promoter contain binding sites for three intestinal 
transcription factor families, Cdx-2, HNF-1 and GAT A. The effects of members of these 
transcription factor families on the transcription of rat and human LPH and human SI promoters 
linked to a human growth hormone reporter were studied using transient co-transfection assays 
in Caco-2 cells, which are derived from a human colon adenocarcinoma and are a model for 
absorptive enterocytes. GATA and HNF-la transcription factors were strong activators of the 
human LPH promoter, whereas Cdx-2 was a weak activator. In contradistinction to the LPH 
promoter, the Cdx-2 and HNF-1a transcription factors were strong activators of the human SI 
promoter, whereas GATA factors were weak activators. Cdx-2, HNF-la, and GATA factors co-
transfected together cooperatively activated both LPH and SI promoters. However, a key finding 
of this study was that LPH demonstrated maximal levels of functional synergy in response to a 
combination ofGATA-5 and HNF-la. Indeed, GATA-5 was inactive in cell lines that do not 
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make endogenous HNF-la, but demonstrated synergistic activation of the human LPH promoter 
when HNF-la was co-transfected together with GATA-5 in these cells. Functional synergy is 
defined as a higher activation by a combination of transcription factors than the additive 
activation of each transcription factor co-transfected individually. In the human LPH promoter, 
an intact HNF-1 site was required for functional synergy, but not intact GATA sites. In this 
chapter, it is demonstrated that: (1) LPH and SI promoters are differentially activated by multiple 
transcription factors co-transfected singly and in combination. (2) GATA-5 was unable to 
activate the human LPH promoter in the absence ofHNF-la. (3) GATA-5 and HNF-la 
cooperatively activate the human LPH promoter, which requires an intact HNF-1 binding site. 
Synergistic activation is a mechanism by which higher levels of tissue-specific-gene expression 
might be attained by overlapping expression of specific transcription factors. 
The SI gene is strongly induced in differentiated small intestinal villus epithelium during 
the suckling-weaning transition. In chapter two, we have demonstrated that specific cis-acting 
elements within a short evolutionarily conserved human SI promoter contain binding sites for 
HNF-la, GATA and Cdx-2 and that their cis-acting elements are necessary for the 
transcriptional activation of SL In the report that is described in chapter three, it is suggested that 
from the GATA-4, -5, and -6 subfamily, GATA-4 is more important for the mouse SI promoter. 
However, the nature and profile of expression and interactions among HNF-la, GATA-4, and 
Cdx-2 proteins had not been previously investigated before, during and after the weaning period, 
and this is the main focus of this report (chapter 3). In chapter three, we present data consistent 
with the hypothesis that HNF-la, GATA-4, and Cdx-2 are the main transcription factors in the 
adult mouse intestinal epithelium that interact with SIF3, GATA, and SIFl elements, 
respectively, and regulate the SI promoter. Immunohistochemistry revealed that HNF-1 a is 
weakly detected in rare epithelial cells on the villi of suckling mice and becomes progressively 
expressed in all epithelial cells along the entire villi during the weaning period, similar to the up-
regulation of SI during this transition. GATA-4 protein is expressed in differentiated epithelial 
cells on villi of the proximal small intestine, and its expression is decreased in the ileum and is 
undetectable in the colon. Cdx-2 proteins are detected on the entire villi and in colon at all ages. 
This pattern parallels that of the horizontal SI expression of adult mice. HNF-la, GATA-4 and 
Cdx-2 interact in vitro and it is hypothesized that they co-exist in a complex in vivo. In addition, 
these factors activate SI promoter activity in co-transfection assays where GATA-4 requires the 
presence ofboth HNF-la and Cdx-2 to influence this activity. These findings imply a 
combinatory role ofHNF-la, GATA-4, and Cdx-2 for the temporal and position-dependent 
regulation of SI transcription during intestinal development. 
9.3 Regulation ofLPH transcription 
9.3.1.1 Cdx-2 and NF-LPH1/R 
The last two chapters characterize the mechanisms of functional activation of the LPH 
and SI promoters by Cdx-2, HNF-la, and GATA-4, -5, and -6 transcription factors individually 
as well as cooperatively. In chapter four, we characterize the Cdx-2-mediated activation of the 
LPH promoter at CE-LPHla and the TAT A-box, and have identified a non-Cdx-2 repressor 
complex that binds CE-LPHla. Cdx-2 is capable of activating a short human LPH construct that 
contains the first 37 bp ofthe 5'-flanking region and does not contain CE-LPHla but just the 
TAT A-box. Using EMSAs, Cdx-2 was found to bind a Cdx-2 binding site overlying the TAT A-
box. A specific mutation introduced into the TAT A-box which binds TBP, necessary for 
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transcription (chapter 1 ), but does not bind Cdx-2, does not disrupt the Cd.x-2 activation of the 
LPH promoter, suggesting that Cdx-2 does not activate the LPH promoter through interaction at 
the TAT A-box, but might rather be regulated through direct physical interaction with proteins 
that are part of the transcription initiation complex, such as TBP (Fig. 1). Characterization ofCE-
LPHla using EMSAs confirmed Cdx-2 binding, but also revealed the presence of a novel, non-
Cdx-2 complex in multiple cell lines that has a slower mobility than that ofCdx-2. This complex 
binds to a site that is different from the Cdx-2 binding site. Mutational analysis in transient co-
transfection assays using Caco-2 cells revealed a repressor function for this protein (NF-
LPHl/R). Transfer of four copies of this element onto the active TK promoter revealed a -50% 
reduction of transcriptional activity as compared to TK alone, using NIH/3T3 cells, which do not 
produce Cdx-2, demonstrating that this repressor function is transferable to a heterologous 
promoter. Together, these data are consistent with the hypothesis that NF-LPHl/R represses LPH 
gene expression in non-Cdx-2-producing cells, and that this repression is overcome by Cdx-2 in 
cells that synthesize Cdx-2 such as those in the intestinal epithelium (Fig. 1). 
Non-intestinal repression by NF-
LPH1/R of the human LPH 
promoter 
-118 bp 
lntestinal-specific-Cdx-2 
activation of the human LPH 
promoter 
NF-LPH1/R 
Fig. 1. Model for CE-LPHla 
regulation of LPH by Cdx-2 and NF-
LPHl/R (Top panel). NF-LPHIIR 
binds at CE-LPHla independently of 
the Cdx-2 binding site. The line 
indicates the first 118 bp of5'-flanking 
region of the human LPH gene. The 
TAT A-box binds the transcription 
initiation complex, which is necessary 
/7'\\ for gene transcription. C, H, and G are 
U V ~the binding sites for Cdx-2, HNF-1, 
----_----.__ + and GATA transcription factors, 
rr-niti~llg~o respectively. 
Comple (Bottom panel) Cdx-2 is present in 
_118 ~ :--bp-o:o--an--ao-2C'n::j]@iJ:-_j intestinal epithelial cells and binds to 
the CE-LPHJa site. Since the binding 
sites for NF-LPHI/R and Cdx-2 overly 
each other, it is hypothesized that Cdx-
CS> 
NF-LPH1/R 
2 preferably binds CE-LPHla and replaces NF-LPHl/R in intestinal epithelial cells, which results in activating the 
human LPH promoter. 
As shown in Fig. 1, NF-LPHl/R represses the human LPH promoter in cells that do not 
contain Cdx-2 (i.e. non-intestinal cells). Since the binding sites for both proteins overlie each 
other the binding of Cdx-2 and NF-LPH!/R might be mutually exclusive. The presence of Cdx-2 
in intestinal epithelial cells may therefore block binding ofNF-LPHl/R and release its 
repressional function, allowing the transcription of the LPH promoter to be activated by Cdx-2 
(bottom panel). In addition, there is evidence that Cdx-2 might activate the human LPH promoter 
through direct physical interaction with the transcriptional initiation complex. Cdx-2 is expressed 
in mid jejunum where LPH is also expressed (chapter 3 for Cdx-2 expression). However, Cdx-2 
is also expressed in the colon where LPH is not, therefore Cdx-2 might be necessary but is not 
sufficient for the cell-specific transcriptional activation in vivo. 
9.3.1.2 Future directions 
Since these studies identified a potential critical repressor pathway that may mediate 
intestine-specific gene expression, it would be important in future studies to characterize this 
repressor protein. This could be done by isolating the complex and micro sequencing it. The 
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peptide analysis will facilitate searches in protein databases for matches. If the protein is cloned, 
expression vectors might be available or construction of expression vectors will be possible. 
Antibodies might be available or developed. Probes for in situ hybridization and RNase 
protection assays, and expression vectors, will than be available for future experiments. To 
define the expression ofNF-LPHl/R in cells as well as the expression along the vertical (in situ 
hybridisation) and horizontal (RNase protection assays) gradients, in situ hybridization and 
RNase protection assays should be carried out on intestinal tissues, using non-intestinal tissues as 
controls. To test affinity differences ofCE-LPHla for Cdx-2 and NF-LPHl/R EMSAs will be 
carried out, using nuclear extracts from cells that were co-transfected with different amounts of 
expression vectors for Cdx-2 and NF-LPH1/R and a CE-LPHla as a probe. To test for functional 
mutual exclusivity of these proteins, transient co-transfection assays need to be carried out using 
different amounts of expression vectors of these proteins and compare the transcriptional 
activities. To explore the expression ofNF-LPH1/R, immunohistochemistry experiments could 
be carried out. By defining the independent and overlapping expressions ofNF-LPH1/R and 
Cdx-2, these studies will provide insights into the function ofNF-LPHl/R for the down-
regulation of the human LPH gene resulting in the tissue-specific, vertical and horizontal 
expression patterns of LPH. 
9.3.2.1 Physical association between GATA and HNF-la transcription factors 
In chapter five, we characterized the mechanism ofGATA-5/HNF-la cooperativity in 
regulating the human LPH promoter. GATA-5 and HNF-la physically associate both in vivo and 
in vitro, which is necessary for GATA-5/HNF-1a cooperative activation (Fig. 2). Furthermore, 
physical association is mediated by the C-terminal zinc finger and basic region ofGATA-5 and 
the homeodomain ofHNF-la. Interruption ofHNF-1 binding sites in the human LPH promoter 
or a deletion of the HNF-la activation domains result in a complete loss of cooperativity, 
whereas an interruption ofGATA binding sties or a deletion ofGATA-5 activation domains 
results in a reduction, but not an elimination, of cooperativity. These results led to a model for 
GATAJHNF-la-cooperativity in which activation requires HNF-la bound to the DNA and is 
mediated by HNF-1 a through its activation domains which are oriented for high levels of 
activation through the physical association with GATA factors (Fig. 2). In addition, GATA-4 
also physically associates with HNF-1 a, and co-transfection of GA TA-4 and HNF-1 a together 
also results in cooperative activation of the human LPH promoter (Chapter 5). Parallel 
mechanisms in other tissue of vertebrates as well as in Drosophila suggest that zinc 
finger/homeodomain interactions are an efficient pathway of cooperative activation of gene 
transcription that has been conserved throughout evolution (chapter 1 ). These data suggest a 
paradigm whereby intestine-specific gene expression is regulated by unique interactions among 
tissue-restricted transcription factors co-expressed in the intestine. 
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9.3.2.2 Future directions 
Fig. 2. Upstream elements of the human LPH 
promoter direct independent as well as 
cooperative activation by HNF-1« and GATA-4, 
-5 transcription factors. A. HNF-la binds to the 
cis-acting element of the human LPH promoter as a 
dimer, and independently activates the human LPH 
promoter(++). C, H, and G are the binding sites 
for Cdx-2, HNF-1, and GATA transcription factors, 
respectively. DNA binding is regulated through its 
homeodomain (HD). The independent activation 
requires the HNF-1 a activation domains B. 
GATAIHNF-la cooperative activation 
(+++++++).Both GATA-4 and GATA-5 
demonstrate cooperative activation of the human 
LPH promoter with HNF -1 a. This mechanism 
requires HNF-lu binding to DNA, but not GATA 
binding. The physical interaction between GAT A 
and HNF-la is critical for the cooperative 
activation and is mediated through the 
homeodomain ofHNF-la and the C-terminal zinc 
finger and basic regions ofGATA proteins. 
LPH gene expression in adult mammals is hypothesized to be regulated by an HNF-1 a 
dependent mechanism. Cell culture and other in vitro experiments (chapters 2, 3, and 5) 
demonstrated that HNF-la is a critical transcription factor, which may interact with several 
intestinal transcription factors resulting in high levels of LPH transcription. These in vitro data 
are complemented by a critical finding (chapter 8) that demonstrates that HNF-1a is important 
for LPH expression of adult mice in vivo, using knockout studies. RNase protection assays 
revealed that in HNF-1a knockout mice, the level ofLPH mRNA was reduced by 80% from that 
of wild type mice. HNF-la is capable of recruiting histone-acetylase activity and other cofactors 
important for the general transcription machinery and is important for gene transcription in vivo 
(chapter 1). Thus, the goal of future experiments is to define the importance ofHNF-la and its 
binding site for the regulation of LPH and SI gene expression in vivo, and delineate the function 
ofHNF-1a-dependent recruitment of histone acetylase activity. To test these hypotheses, the 
chromosomal immunoprecipitation (CHIP) assay, an accepted technique for the study of protein-
DNA interaction in vivo, will be carried out. These experiments will demonstrate whether HNF-
la occupies the HNF-1 site in the human LPH promoter in vivo and the function ofHNF-1a for 
the recruitment of histone acetylase activity to activate the LPH and SI promoters. 
9.3.3.1 Differential activation between GATA-4 and GATA-5 
The horizontal expression ofGATA-4 mRNA coincided with that of the LPH rnRNA, 
suggesting an important role for GATA-4 in the transcriptional regulation ofLPH gene. 
Furthermore. similar to the GATA-5/HNF-la cooperativity. GATA-4 and HNF-la 
cooperatively activate the human LPH promoter as well. However, in contrast to GATA-5, 
which in the absence ofHNF-la does not appreciably activate the human LPH promoter (chapter 
2 and 5). GATA-4 activates the human LPH promoter independently ofHNF-la. To define the 
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dual mechanisms of GATA-4 activation of the human LPH promoter, the function of critical 
domains in GATA-4 was mapped by first introducing mutations that delete or disrupt specific 
structures, and then characterizing specific functions such as physical association with HNF-la 
(GST pull-down assays), binding to DNA (EMSAs), and transcriptional activation in HeLa cells 
(transient co-transfection assays). HeLa cells were used because GAT A-specific and 
GATAIHNF-la cooperative activation can be distinguished in cells that do not synthesize 
endogenous HNF-la. This study revealed that in contrast to GATA-5, GATA-4 activates the 
human LPH promoter independently ofHNF-la by a mechanism that requires the activation 
domains and the C-terminal zinc finger which is responsible for binding to DNA (Fig. 3). 
However, similar to GATA-5, GATA-4 physically associates with HNF-la and cooperatively 
activates the human LPH promoter by a mechanism that does not require the GATA-4 activation 
domains or GA TA-4 binding to DNA. Cooperative activation does require physical association 
between GATA-4 and HNF-la as well as an intact HNF-1 binding site on the promoter. Physical 
interaction involves the C-terminal zinc finger ofGATA-4. 
. . . Fig. 3. Distinct regulation of human LPH gene 
GATA-4-Independent activation transedption by GATA-4 and GATA-5. 
~ GATA-4 of the GATA-4, -5, and -6 transcription 
L__j ~~factor subfamily independently activates the 
AD ++ human LPHpromoter (++).DNA binding is 
GATA-4 ++ mediated through the C-terminal zinc finger 
~ ~ (Znii), and basic region (B) ofGATA proteins. 
Zntt IIJ. GATA-4-independent activation requires GATA-
4 binding to the human LPH promoter as well as 
-118 bp the GATA-4 activation domains. The mechanism 
for GATA-4/HNF-1 a. cooperativity is similar to 
that ofGATA-5/HNF-la. (see Fig. 2). 
Indeed, EMSAs revealed that the GAIA binding sites in the human LPH promoter have a 
higher affinity for GATA-4 than for GATA-5. The conclusions derived from these data are that 
GATA-4 demonstrates dual mechanisms of activation of the human LPH promoter that are 
characterized by: (1) HNF-la-independent activation (in contrast to GATA-5), in which the 
DNA binding and activation domains are required, and (2) HNF-la-dependent cooperative 
activation (similar to GATA-5), in which physical association is required but not the GATA-4 
activation domains or GATA-4/DNA binding. It is hypothesized that the distinct functions in 
transcriptional activation between members of the GATA-4, -5, and-6 subfamily in part is 
mediated through the specific affinity of promoters for the individual GATA factors. This study 
is the first to demonstrate distinct regulatory mechanisms for activation of an intestinal gene 
promoter by two conserved GATA factors. 
Although, LPH mRNA abundance is reduced in the absence ofHNF-la, as shown in 
chapter 8 by RNase protection assays, a residual amount ofLPH mRNA was present in adult 
HNF-la knockout mice. These data suggest that in adult mice the LPH expression is also 
regulated by a mechanism that is independent ofHNF-la. Since GATA-4 is expressed in the 
small intestine, its horizontal expression pattern coincides with that ofLPH and finally GATA-4 
independently activates the human LPH promoter, it is suggested that GATA-4 plays an 
important role in the expression ofLPH in the absence ofHNF-la as well as in cooperativity 
with HNF-la. As previously is shown in chapter 3, HNF-la is low detectable during the 
suckling period when LPH is abundantly expressed. However, GATA-4 is expressed in small 
intestine during suckling (chapter 3) and GATA-4 independently activates the human LPH 
promoter (chapter 8). These data has led to the hypotheses that during the pre-weaning period 
LPH transcription is regulated by a mechanism independently ofHNF-la in which GATA-4 
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potentially plays a critical role and during and after weaning LPH expression is regulated by a 
mechanism that depends on HNF-la, in which GATA factors play a role as cofactors. 
9.3.3.2 Future directions 
To characterize the role that GATA factors play in the expression ofLPH and SI genes 
independently as well as cooperatively with HNF-la in vivo, knockout studies need to be 
conducted. To complement the studies in this thesis, a critical technology that should be 
developed is tissue-specific knockouts. Fortuitously, HNF-la knockout mice survive providing 
an opportunity to study the effect of the absence ofHNF-la on intestinal differentiation and LPH 
anSI gene expression. GATA-5 knockout mice also survive, and thus the role ofGATA-5 for 
intestinal gene regulation can also be studied in vivo. In contrast, GATA-4 and GATA-6 
knockout mice die during early embryogenesis without a foregut. Therefore, the conventional 
whole animal knockout system does not provide any data for the importance of these 
transcription factors for intestinal differentiation and intestine gene expression. Using Cre-loxP 
recombination technology, it may be possible to ablate the expression of GATA-4, -5, and -6 
individually as well as in all combinations in limited tissues and provide in vivo data for their 
specific role in the intestinal development and intestinal genes expression. 
To define the mechanism of the independent GATA-4 activation, detailed 
characterization of the domains that mediate affinity differences among GATA factors need to be 
carried out. To define binding sites specificities, a methodological approach should be used that 
depends on randomized oligonucleotides as was carried out for GATA-1 and GATA-6. Amino 
acid sequence analysis of the C-terminal zinc finger and basic region, which mediate protein-
DNA binding, revealed only 10 residues that are not conserved among this subfamily (Fig. 4). 
: -----------------Zinc Finger 11-----------------: -------------------Basic Reg ion-------------------: 
GATA-1 GTVCSNCQTSTTTLWRRSPMGDPVCNACGL YYKLHQVNRPL TMRKDGIQTRNRKVSSKGKKR 
** * * * ** * * ** **** ** * 
GATA-4 GLSCANCQTTTTTLWRRNAEGEPVCNACGLYMKLHGVPRPLAMRKEGIQTRKRKPKNLNKSK 
GATA-5 GLCCSNCHTATTTLWRRNSEGEPVCNACGL YMKLHGVPRPLAMKKE SIQTRKRKPENPAKIK 
GATA-6 GLSCANCHTTTTTLWRRNAEGEPVCNACGL YMKLHGVPRPLAMKKE GIQTRKRKPKNINKSK 
A A 
Fig. 4. The -100 to -20 bp region of the human (h) (1), rat (r) (2), mouse (m), and pig (p) (3) LPH 5'-flanking 
sequence contains conserved binding sites for GAT A (A/TGAT AA/G), HNF-I (GTT AATNA TT AAC), and 
Cdx-2 (TTT AT/C) (underlined). TAT A-boxes are in boldface type. The mouse sequence was obtained from the 
genetic database of the Celera Discovery System (Rockville, MD) (Dr. M. Fleming, licensee, Dept. Pathology, 
Children's Hospital Boston). Cortesy of Stephen D. Krasinski 
To define the importance of these and other non-conserved amino acids, specific residues 
in GATA-5 will be changed into GA TA-4-like structures and tested for gain-of-affinity for the 
LPH GATA sites. Likewise for GATA-4 amino-acid, changes into GATA-5-like structures and 
tested for lost-of-affinity. This affinity differences for specific cis-acting elements might be a key 
regulatory pathway, by which proteins and cis-acting elements regulate promoter-specific and 
tissue-specific gene transcription. 
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9.3.4.1 Regulation of FOG on the LPH transcriptional activation 
FOG is a family of multi-zinc finger cofactors that modulate the GATA activation of 
target genes. Two members have been identified thus far, FOG-1 and FOG-2. The aim of the 
study presented in chapter 7 was to define the role of FOG cofactors on the GAT A-specific and 
GATA!HNF-la cooperative activation of the LPH promoter. To demonstrate expression of 
FOG-1 and FOG-2 in the intestine, RT-PCR was carried out. To characterize the function of 
FOG co factors, transient co-transfections were conducted in HeLa cells using a promoter-
reporter construct containing 118 bp of the human LPH 5'-flanking region fused to the human 
growth hormone gene. Both FOG-I and FOG-2 mRNAs were detected in RNA isolated from 
adult mouse jejunum using R T-PCR, demonstrating that these two co factors are expressed in 
adult mammalian small intestine. FOG-1 and FOG-2 repressed the GATA-4-specific activation 
of the human LPH promoter to less than 50% (FOG-I) or less than 5% (FOG-2) of its activated 
value. FOG-1 and FOG-2 had no effect on the HNF-la-stimulated activation, demonstrating that 
FOG repression is GAT A-specific. FOG-I and FOG-2 also had an effect on the GATA/HNF-la 
cooperative activation of the LPH promoter although to a lesser extent than the effect on GATA-
4 independent activation. Introduction of a critical amino acid substitution in theN-terminal zinc 
finger of GATA factors, which have been shown to disrupt physical interactions with FOG, 
results in the reduction of FOG-specific repression. FOG cofactors expressed in the intestine may 
modulate LPH gene expression by repressing the GAT A-specific and GATA/HNF-la 
cooperative activation of the LPH promoter (Fig 5). This repression likely occurs via physical 
associations between GATA and FOG proteins that involve theN-terminal zinc fingers of 
GATA factors. 
Repression by FOG-2 of the GATA-4-independent Fig. s. The mechanisms of FOG mediated 
activation repression of the human LPH promoter.FOG-1 
-118 bp 
9.3.4.2 Future directions 
+ 
and FOG-2 co-factors do not bind DNA, but 
physically interact specifically with GAT A 
proteins. This physical interaction is mediated by 
theN-terminal zinc finger of GAT A factors. 
GATA-4 independent activation is reduced for 90% 
by FOG-2 (top panel). The GATAIHNF-lu 
cooperative activation of the human LPH promoter 
is also reduced by FOG-2 but to a lesser extent than 
without presence ofFOG-2 (bottom panel). 
To delineate the mechanisms of FOG repression, the expression patterns need to be 
defined along the vertical, horizontal and developmental gradients using in situ hybridization, 
RNase protection assays, and immunohistochemistry. The hypothesis in these experiments is that 
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FOG-2, in the presence of intestinal GAT As, is a repressor ofLPH gene transcription, and 
therefore demonstrates an inverse relationship in its pattern of expression ofLPH in vivo. 
9.4 Mode/for LPH expression in adult mammals 
This thesis has described the important transcription factors for gene regulation of 
intestine-specific marker genes, LPH and SL Members of the Cdx-2, HNF-1, and GATA-4, -5, 
and -6 transcription factor families have been demonstrated to be important for LPH and SI gene 
transcription, both in vitro and in vivo. The proximal promoters of the LPH and SI genes 
demonstrate differences in number and arrangement of binding sites for these transcription 
factors. Based on the data demonstrated in this thesis, I propose the following model for the LPH 
expression in adult mammals, which is demonstrated by a schematic representation in Fig. 6. 
? 
-3.6 kb 
NF-LPHl!RCS> 
Fig. 6. Schematic representation of LPH specific gene expression. Straight and dotted lines indicate influences 
by upstream elements on the transcription process. The presence ofCdx-2 in intestinal cells relieves the repression 
ofNF-LPHJ/R that binds to CE-LPH!a in non-intestinal cells. Cdx-2 may then physically interact with the 
transcriptional initiation complex to stabilize the transcription initiation complex. An HNF-la dimer binds to the 
DNA and links GAT A factors for synergistic up-regulation ofLPH gene expression, as well as proteins that have 
histone acetylase activity. GATA-4 is activates LPH promoter in absence ofHNF-la, which requires DNA binding 
as well as cooperatively activate with HNF -1 a, which requires physical interaction with HNF -1 a. FOG represses 
both GAT A independent as well as GATAJHNF-la cooperativity, which requires physical interaction with GATA 
transcription factors but not with DNA. All these elements are required for the appropriate LPH expression along the 
vertical, horizontal, and developmental gradients. 
Cdx-2 binds to CE-LPHla and blocks NF-LPHl!R from binding CE-LPHla. Cdx-2 individually 
is capable of minimally activating the LPH promoter and may physically interact directly with 
the transcriptional initiation complex and stabilize this complex. HNF-la binds as a dimer to its 
cis-acting element and activates transcription. HNF-1 a may act as a linker protein that physically 
interacts with a multitude of proteins, such as GATA and Cdx-2 transcription factors. These 
physical interactions result in high levels ofLPH expression, as well as recruitment of histone 
acetylase activity that facilitates LPH gene transcription. Since the expression patterns ofGATA-
4 and LPH coincide along the horizontal axis in adult small intestine, GAT AA is suggested to 
play an important role in the GAT A/HNF-1 a cooperative activation of the LPH gene. Since Cdx-
2 physically interacts with HNF-la (4) and GATA-4 (chapter 3) it remains possible that these 
three transcription factors all form one complex that stabilizes the transcriptional initiation 
complex and recruits histone acetylase activity. Since, the transcription factors all are activating 
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LPH and SI transcription, repressors might play a role in the down-regulation ofLPH and SI 
gene transcription. FOG co factors are repressors ofGATA-4 independent as well as the 
GATA/HNF-la cooperative activation and might play a role in the regulation of the specific 
LPH expression patterns. 
LPH is a marker gene which has a distinct expression pattern along the vertical, 
horizontal and developmental gradient. Members of the transcription factor families described in 
this thesis have independent and overlapping expression patterns. These expression patterns do 
not always coincide with that of the LPH and SI expression patterns, meaning that Cdx-2, HNF-
1 a and GATA might be expressed together in regions were LPH is not expressed. Therefore, 
upstream elements must contain more regulatory elements that cooperate with the proximal 
elements to direct the appropriate LPH expression pattern which is suggested in previous reports 
(5). Although, the upstream elements play a role in directing the specific vertical, horizontal and 
developmental expression patterns ofLPH, the Cdx-2, HNF-la and GATA-4,-5 transcription 
factors, which are characterized in this thesis, activate in concert the transcription ofLPH and SI 
genes and turn on the transcription machinery for the LPH and SI intestine-specific-gene 
expression in vivo. 
9. 5 Significance 
The studies presented in this thesis provide insight into the regulatory mechanisms that 
control LPH and SI protein expression in the intestine, and also elucidate some of the mechanism 
governing the complex processes of cell-specific gene expression, cellular differentiation, and 
intestinal development. As these mechanisms are defined, and general as well as gene-specific 
regulatory pathways are characterized, it may become possible to stimulate the expression of 
individual genes or panels of genes in specific regions of intestine resulting in restoration of lost 
or deficient intestinal function. 
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10. SAMENVATTING 
10.1 LPH en SI zijn marker genen 
In dit proefschrift wordt de functie van Cdx-2, HNF-la, en GATA-4, -5, en -6 
transcriptie factoren gedefinieerd voor wat betreft de transcriptie regulatie van de intestinale 
marker genen, lactase-phlorizin hydrolase (LPH) en sucrase-isomaltase (SI). Door middel van 
een aantal elegante experimenten, is gebleken dat lactase en sucrase zeer goede markers zijn 
voor bet intestinale differentiatieproces (Hoofdstuk 1 ). Deze disaccharidases zijn suiker-eiwitten 
die verankerd zijn in bet membraanoppervlak van enterocyten (absorptieve cellen). Lactase 
splitst lactose, het belangrijkste koolhydraat in melk. Sucrase hydrolyseert sucrose. Sucrose 
wordt hoofdzakelijk gevonden in suikerriet dat voorkomt in vele soorten voeding. LPH en SI 
worden allebei tot expressie gebracht in enterocyten op villi (darmvlokken) en Iaten een 
weefsel-, eel, en differentiatie-specifiek verticale (crypt-villus) expressie patroon zien. De 
expressie patron en van LPH en SI langs de horizontale (proximaal-distaal) en ontwikkelings 
gradienten verschillen van elkaar. DeLPH expressie begint al gedurende de uitrijping en 
differentiatie van de foetale darm, op het moment dat de eerste rudimentaire darmvlokken 
worden aangelegd. LPH gen expressie wordt aldus vlak voor de geboorte aangezet en komt vlak 
voor en direct na de geboorte maximaal tot expressie en blijft constant tot de peri ode van het 
spenen; daarna vindt er uitdoving plaats aan beide uiteinden van de dunne darm zodat na het 
spenen slechts in het midden-gedeelte van de dunne darm (jejunum) LPH wordt gevonden. 
Spenen is de peri ode waarin de dann van een zoogdier zich voorbereidt op de overgang van een 
dieet met aileen borstvoeding naar een dieet met ook vast voedsel. Daarentegen, SI wordt op een 
heellaag niveau tot expressie gebracht vanafhet stadium van de rudimentaire darmvlokken en 
dit blijft zo tot de peri ode van het spenen. Tijdens deze peri ode bereikt de SI expressie snel het 
niveau van het volwassen gen-expressie niveau. Het feit dat de expressie patronen van LPH en SI 
eiwitten parallel I open aan die van hun messenger RNA, pre-rnRNA en hun transcriptie 
activaties, wijst erop dat het niveau van de eiwitten voornamelijk wordt gereguleerd op het 
niveau van de transcriptie van deze respectievelijke genen. Experimenten met trans gene muizen 
hebben aangetoond dat een 2 kb promoter regio van de rat LPH promoter een expressiepatroon 
dirigeert met een adequaat verticale, horizontale en ontwikkelings gradient. Een evolutionair 
geconserveerd 180 base paren (bp) tell en de SI promoter is genoeg om een goed expressiepatroon 
te dirigeren langs de verticale en ontwikkelings gradienten. AI deze onderzoeksresultaten hebben 
er toe geleid dat LPH en SI heden ten dage als goede markers van intestinaal-specifieke-
genexpressie kunnen worden beschouwd. Deze specifieke expressiepatronen I open parallel met 
andere belangrijke veranderingen in de ontvirikkeling van zoogdieren. Daarom kan een beter 
begrip van de mechanismen betrokken bij LPH en SI genexpressie gedurende deze belangrijke 
stadia van ontwikkeling lei den tot een beter inzicht in de intestinale differentiatie en 
ontwikkeling. Dit proefschrift karakteriseert enkele fundamentele controle mechanismen van de 
transcriptie van LPH and SL 
10.2 Differentiele activatie van het LPH gen bij de rat en de mens en van het SI gen bij de mens 
en de muis. 
Zoals is beschreven in Hoofdstuk 2, blijkt dat de eerste 118 bp van de LPH promoter bij 
de rat en de mens en 183 bp van de SI promoter bij de mens bindingsplaatsen bevatten voor 
leden van drie intestinale transcriptiefactor families te weten Cdx-2, HNF-1 en GATA. De 
effecten van I eden van deze transcriptiefactor families op de transcriptie van de LPH promoter 
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bij rat en mens en de SI promoter bij de mens zijn bestudeerd door middel van tijdelijke co-
transfectie experimenten in Caco-2 cellen. Dit zijn cellen die zijn geisoleerd uit een humaan 
colon adenocarcinoom en zij vormen een model voor enterocyten. GAT A en HNF-1a 
transcriptiefactoren zijn sterke activatoren van de LPH promoter van de mens, in tegenstelling tot 
Cdx-2 dat een zwakke activator is. In tegenstelling tot de LPH promoter wordt de humane SI 
promoter, sterker geactiveerd door Cdx-2 en HNF-1a transcriptiefactoren en zijn GATA factoren 
de zwakste activatoren. Aile drie de transcriptiefactoren samen activeren de LPH and SI 
promoteren synergistisch. Een van de hoofdpunten van dit hoofdstuk is dat LPH de maximale 
synergistische activatie ondervond door een combinatie van GATA-5 en HNF-la 
transcriptiefactoren. Het bleek dat GATA-5 individueel niet in staat was om LPH te activeren in 
cellen die geen endogene HNF-1a produceren, en dat oak in deze cellen LPH synergistisch 
geactiveerd werd, wanneer HNF-la tegelijk met GATA-5 werd getransfecteerd. Functionele 
synergie wordt gedefinieerd als een sterkere activatie door een combinatie van 
transcriptiefactoren dan de sam van de activaties van iedere transcriptiefactor apart. Voor de 
GAT A-5/HNF-la. synergie van de LPH promoter is een intacte HNF-1 bindingsplaats nodig, 
maar hoeven er geen intacte GATA bindingsplaatsen te zijn. Met andere woorden is in dit 
hoofdstuk aangetoond dat: (1) LPH en SI promoters verschillend worden geactiveerd door 
meerdere transcriptiefactoren, zowel individueel als oak in combinatie. (2) GATA-5 is niet in 
staat om de LPH promoter in afurezigheid van HNF-1 ate activeren. (3) GAT A-5 and HNF-la 
zorgen voor een cooperatieve activatie (synergie) van de LPH promoter, waarvoor een intakte 
HNF-1 bindingsplaats noodzakelijk is. Synergie is een mechanisme om hoge niveaus van 
weefsel-specifieke-gen expressie te verkrijgen door gebruik te maken van overlappende 
expressie van transcriptiefactoren. 
Tijdens de periode van bet spenen wordt de SI gen expressie sterk geinduceerd in de 
epitheellaag van de villi in de dunne darm. Zoals in Hoofdstuk 2 is aangetoond blijkt dat een 
korte, evolutionair constante, SI promoter, bindingsplaatsen bevat die HNF-1a, GATA en Cdx-2 
binden en dat deze bindingsplaatsen nodig zijn voor de transcriptie van de SI promoter van de 
muis. De experimenten zoals beschreven in Hoofdstuk 3, suggereren dat van de GATA-4,-5 en -
6 familie GATA-4 het belangrijkst is voor de muis SI promoter. Buiten deze initiele constatering 
zijn de expressie profielen en de interactie tussen HNF-1a, GATA-4 en Cdx-2 nag niet eerder 
onderzocht. In Hoofdstuk 3 worden er gegevens gepresenteerd die consistent zijn met de 
hypothese dat in bet intestinale epitheel van volwassen muizen, HNF-la, GATA-4 en Cdx-2 de 
belangrijkste transcriptiefactoren zijn die binden aan SIF3, GATA en SIF1 elementen, 
respectievelijk, en zo de transcriptie van de SI promoter reguleren. Immunohistochemische 
experimenten hebben aangetoond dat HNF-la slechts gering aanwezig is in epitheelcellen van 
intestinale villi gedurende de lactatie-periode (v66r spenen), maar steeds meer tot expressie komt 
tijdens de peri ode van bet spenen om uiteindelijk, aan bet einde van de peri ode van bet spenen, 
in aile enterocyten in de dunne dann tot expressie te komen. Deze op-regulatie komt overeen met 
de op-regulatie van SI expressie tijdens dezelfde periode. GATA-4 wordt gevonden in 
gedifferentieerde epitheelcellen van villi in de proximale dunne dann, maar de expressie neemt 
langzaam in hoeveelheid af in de richting van bet ileum, om uiteindelijk volledig afurezig te zijn 
in bet colon. In volwassen muizen loopt bet horizon tale expressiepatroon (proximal-distal) van 
GA TA-4 synchroon met die van SI. HNF-1 a, GATA-4 en Cdx-2 hebben een interactie in vivo 
and in vitro eperimenten en de hypothese is dat deze dire factoren gezamelijk een complex 
vonnen. Verder blijkt dat deze factoren de transcriptie van SI activeren, met dien verstande dat 
GATA-4 de andere tvvee factoren (HNF-1a en Cdx-2) nodig heeft. Deze resultaten suggereren 
een gecombineerde rol voor HNF-1 a, GATA-4 en Cdx-2 in een positie afhankelijke regulatie 
van SI expressie tijdens de ontwikkeling van de dunne darm. 
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10.3 Regulatie van LPH transcriptie 
10.3.1.1 Cdx-2 en NF-LPHIIR 
In de vorige twee hoofdstukken werd het mechanisme besproken waarmee functionele 
activatie plaatsvindt van de LPH en SI promoters door Cdx-2, HNF-la en GATA-4, -5, en -6 
transcriptiefactoren (individueel als ook in combinatie). In het volgende hoofdstuk (Hoofdstuk 4) 
wordt de Cdx-2 gemedieerde activatie aan CE-LPHla en de TAT A-box van de LPH promoter 
beschreven. Ook wordt er een niet-Cdx-2 repressor complex geidentificeerd dat aan CE-LPHla 
bindt. Cdx-2 kan een korte LPH promoter van de mens (37 bp) activeren die aileen een TAT A-
box en geen andere bindings elementen bevat. EMSAs (gel-shift experimenten) hebben 
aangetoond dat Cdx-2 aan een Cdx-2 bindingplaats bindt, die gedeeltelijk over de TATA-box 
sequentie heen ligt. Een specifieke mutatie die geintroduceerd werd in de TATA-box, die wel 
TBP bindt, wat nodig is voor transcriptie (Hoofdstuk 1), maar niet meer Cdx-2, verandert de 
Cdx-2 transcriptie activatie niet. Deze resultaten suggereren dat Cdx-2 niet door binding met de 
TAT A-box, de LPH transcriptie reguleert, maar eerder door direkt eiwit-eiwit contact met 
eiwitten van het transcriptie initiatie complex, zoals TBP (Fig. 1). CE-LPHla werd onderzocht 
door gebruik te maken van gel-shift experimenten. Deze experimenten bevestigde de binding van 
Cdx-2 aan CE-LPHla, maar lieten ook binding van een nieuw niet-Cdx-2 complex zien. Dit 
complex was in intestinale asl ook in niet intestinale cellen te vinden. Dit complex beweegt zich 
langzamer door de gel dan Cdx-2. Dit complex bindt aan een bindingsplaats die verschillend is 
van die van Cdx-2. Analyse met behulp van constructies met mutaties in de CE-LPHla in 
transcriptie experimenten, als ook transriptie experimenten met constructies met meerdere 
copieen van CE-LPHla gebonden aan de actieve TK promoter, hebben aangetoond dat dit 
complex een repressor functie heeft (NF-LPHl/R). Alles bij elkaar genomen komen deze 
resultaten overeen met de hypothese, dat NF-LPHl/R, de expressie van de LPH promoter van de 
mens onderdrukt in cellen, die geen Cdx-2 produceren, zoals niet-intestinale cellen, maar dat 
deze onderdrukking wordt opgeheven in cellen, die wel Cdx-2 synthetiseren zoals intestinale 
cellen (Fig. 1). Omdat de bindingsplaatsen van respectievelijk Cdx-2 en NF-LPHl/R elkaar 
overlappen, wordt er verondersteld dat ze niet tegelijk kunnen binden aan CE-LPHla. De 
aanwezigheid van Cdx-2 in intestinale cellen zou de binding van NF-LPHl/R aan CE-LPHla 
dan kunnen blokkeren en de onderdrukking van NF-LPHl/R opheffen en zo de transcriptie van 
LPH activeren (Fig.l onderste gedeelte ). 
NF-LPH1/R represses the human 
LPH promoter in non-intestinal cells 
-118bp 
lntestine-specific-Cdx-2 activation 
of the human LPH promoter 
-118 bp 
~ 
NF-LPH1/R 
Fig. 1. Model van de LPH transcriptie 
regulatie door Cdx-2 en NF-LPHI/R via 
CE-LPHla (bovendste). A) NF-LPHJIR 
bindt aan CE-LPHla onajhankelijk van de 
Cdx-2 bindingsplaats. De doorgetrokken 
streep geeft de eerste 118 bp of 5 '-flanking 
regie (gedeelte van de promoter) van het 
LPH gen van de mens weer. De TAT A-
box bindt het transcriptie-initiatie 
/7\\ complex, wat nodig is voor de algemene 
U V ~ gen transcriptie. C, Hen G zijn de 
bindingsplaatsen respectievelijk voor de 
+ Cdx-2, HNF-1 en GATA transcriptie 
factor families.(Onderste) Cdx-2 is 
aanwezig in intestinale epitheelcellen en 
bindt aan CE-LPHla. Omdat de 
bindingsplaatsen voor NF-LPHl/R en 
Cdx-2 gedeeltelijk over elkaar heen liggen, 
NF-LPH1/R is de hypothese dat Cdx-2 de binding van 
NF-LPHl/R aan CE-LPHla verbreekt en zelf de LPH transcriptie stimuleert. 
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Verder zijn er aanwijzingen dat Cdx-2 de LPH transcriptie activeert door middel van direkte 
eiwit-eiwit binding met gedeeltes van het transcriptie-initiatie complex. Deze eiwit-eiwit 
interactie zou het initiation complex kunnen helpen stabiliseren. Cdx-2 is aanwezig in het 
middelste gedeelte van dunne darm (jejunum) waar LPH ook tot expressie komt (zie Hoofdstuk 3 
voor de Cdx-2 expressie). Echter, Cdx-2 is bijvoorbeeld ook aanwezig in het colon waar LPH 
niet tot expressie komt. De conclusie is dat Cdx-2 wel noodzakelijk is voor de transcriptie 
regulatie van LPH maar niet effectief is voor de expressiepatroon-specifieke transcriptie van 
LPH in vivo. 
10.3.1.2. Toekomstbee/d 
Vanwege de identificatie van een potentieel belangrijk repressor mechanisme, dat 
specifiek intestinale gen expressie zou kunnen reguleren, is het belangrijk om in toekomstige 
studies dit repressor eiwit te karakteriseren. Dit kan gedaan worden door dit eiwit te isoleren en 
de aminozuur sequentie te identificeren. Deze peptide analyse zal het mogelijk maken om een 
match te zoeken in de eiwit-databases. Als het eiwit gecloond is, kunnen expressievectoren 
gemaakt worden. Antilichamen tegen dit eiwit zullen ontwikkeld kunnen worden. Probes zullen 
gebruikt kunnen worden in in-situ hybridisatie en RNase protection experimenten en 
expressievectoren zijn te gebruiken in tijdelijke transfectie experimenten. Om de expressie van 
NF-LPHl/R in de verschillende weefsels en langs de horizontale en ontwikkelings gradienten te 
definieren, dienen RNase protectie en in situ hybridisatie experimenten te worden uitgevoerd op 
intestinale en niet intestinale weefsels. Om affiniteitsverschillen te meten kunnen gel-shift 
experimenten worden uitgevoerd, waarbij kern extracten worden gebruikt die zijn geco-
transfecteerd met verschillende hoeveelheden expressievectoren voor Cdx-2 en NF-LPHl/R. De 
transcriptie activatie van deze co-transfectie experimenten met verschillende hoeveelheden 
expressievectoren van Cdx-2 en NF-LPHl/R kunnen worden uitgevoerd, waardoor de 
exclusiviteit waarmee deze eiwitten kunnen binden aan CE-LPHla kunnen worden 
gekarakteriseerd. Om de expressie van NF-LPHl/R te onderzoeken moeten 
immunohistochemische experimenten worden uitgevoerd. Door de overlappende 
expressiepatronen van Cdx-2, NF-LPHl/R en LPH te bepalen zal er inzicht ontstaan over de 
eventuele functie van NF-LPHl/R in de regulatie ven de specifieke expressie patronen van het 
LPHgen. 
10.3.2.1 Fysieke associatie tussen GATA en HNF-la transcriptiefactoren 
Het mechanisme van de GATA-5/HNF-la cooperatieve activatie van het humane LPH 
gen wordt besproken in Hoofdstuk 5. GATA-5 en HNF-la zijn fysiek met elkaar verbonden, 
zowel in-vitro als in-vivo. Deze fysieke interactie is nodig voor de GATA-5/HNF-la synergie 
(Fig. 2). Verder wordt de fysieke interactie gemedieerd door de C-terminale zink vinger en 
basische regio van GATA factoren en bet homeodomein van HNF-la. Het verbreken van HNF-
la binding met het DNA of een ven.vijdering van de activatie domeinen in bet HNF-la eiwit 
resulteren in een volledige verdwijning van de synergie, maar een verbreken van de GATA 
binding aan de bindingsplaatsen of een ven.vijdering van de activatie domeinen in de GATA-5 
eiwitten doen de synergie wei afnemen maar niet verbreken. Deze resultaten hebben tot bet 
volgende model geleid voor de GATNHNF-la synergie: de synergistische activatie komt tot 
stand doordat de binding van HNF-la aan zijn bindingsplaats en de activatie domeinen, welke zo 
is georienteerd, door de fysieke interactie met GATA factoren, dat hoge niveaus van LPH gen 
expressie kunnen worden bereikt (Fig. 2). Daarbij komt nog dat GATA-4 ook fysiek met HNF-
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la kan verbinden en dat in tijdelijke co-transfectie experimenten GATA-4 en HNF-la samen 
ook bet LPH gen van de mens synergistisch kunnen activeren. Overeenkomende mechanismen in 
zowel andere weefsels als ook in Drosophila suggereren dat dit geconserveerde zink 
vinger!homeodomein interactie een efficient mechanisme is om synergistische gen activatie te 
verkrijgen. Op basis van deze data wordt er een paradigma voorgesteld waarin intestinaal-
specifieke gen expressie is gereguleerd door een unieke interactie tussen t\vee weefsel gebonden 
transcriptiefactoren in de dunne darm. 
A. HNF-1 a-independent activation 
~~ 
AD AD ++ 
Transcription 
Initiation 
HD HD Comple 
-118 bp 
-118 bp 
10.3.2.2 Toekomstbee/d 
Fig. 2. Elementen in de 5'-flanking sequentie 
van bet LPH gen van de mens sturen zowel 
onafltankelijke als ook cooperative activatie 
door HNF-la en GATA-4, -5 transcriptie 
factoren. A. HNF-la vormt een dimeer en bindt 
zo aan zijn bindingsplaats in de LPH promoter 
van de mens, om zo onajhankelijk the LPH 
promoter te stimuleren (++). C, Hen G zijn de 
bindingsplaatsen voor respectievelijk Cdx-2, 
HNF -l en GAT A transcriptiefactoren. B. 
GATAIHNF-la synergistische activatie 
(+++++++). Beide GATA-4 en GATA-5 
kulmen sam en met HNF -1 a de LPH promoter 
synergistisch activeren. Dit mechanisme heeft 
debinding van HNF-la aan het DNA nodig, maar 
niet dat van de GAT A fact oren. De fysieke 
interactie tussen GATA en HNF-la is belangrijk 
voor de synergistische activatie en deze interactie 
wordt gemedieerd door de homeodomein van 
HNF-la en de C-terminale zink vinger en 
basische regie van GAT A eiwitten. 
Het wordt verondersteld dat de LPH genexpressie in volwassen zoogdieren wordt 
gereguleerd door een mechanisme dat afhankelijk is van HNF-la. Celkv.reek en andere in vitro 
experimenten (Hoofdstukken 2, 3 en 5) laten zien dat HNF-la een belangrijke transcriptiefactor 
is, die met verschillende intestinale transcriptiefactoren associeert het geen resulteert in een 
verhoogde transcriptie activatie van LPH. Deze in vitro resultaten worden aangevuld door een 
bevinding (Hoofdstuk 8) waarin met behulp van HNF-la knock-out muizen wordt aangetoond 
dat HNF-la ook belangrijk is voor LPH expressie in vivo. RNase potectie experimenten laten 
zien dat in volwassen HNF-la knock-out muizen de transriptie van LPH mRNA met 80% 
gereduceerd is in vergelijking met de transcriptie van LPH mRNA in wild type muizen. HNF-la 
is belangrijk voor de gentranscriptie in vivo, omdat HNF-la zowel histone acetylatie activiteit 
kan recruteren als ook andere cofactoren, die belangrijk zijn voor het transcriptie initiatie 
complex (Hoofdstuk 1). Volgende experimenten zijn noodzakelijk om het belang van HNF-la en 
zijn bindingsplaats voor de LPH en SI gen expressie in vivo aan te tonen als ook om de functie 
van het recruteren van histone acetylatie activiteit door HNF-la voor de LPH en SI gen expressie 
aan te tonen. Deze hypothese kan worden getest door middel van immunoprecipitatie (CHIP) 
experimenten. Dit is een geaccepteerde techniek voor het aantonen van eiwit-DNA interactie in 
vivo. Deze experimenten zullen aantonen ofHNF-la de HNF-1 bindingsplaats in de LPH en SI 
promoters van de mens bindt in vivo en ze zullen de functie van HNF-la in het recruteren van 
histone acetylase activiteit voor de activatie van LPH en SI promoters aantonen. 
Samenvatting 163 
10.3.3.1 Differentiele activatie tussen GATA-4 en GATA-5 
Het horizontale expressie patroon van GATA-4 mRNA loopt synchroon met bet 
expressiepatroon van LPH mRNA. Dit suggereert dat GATA-4 een rol speelt in de transcriptie 
regulatie van bet LPH gen (Hoofdstuk 6). Gel-shift experimenten die gebruik maakten van 
nucleaire extracten van dunne darm epitheelcellen uit volwassen muizen, laten zien dat GATA-4 
preferentieel aan de GATA bindingsplaatsen bind! in de LPH promoter van de mens (hoofstuk 6) 
en SI (hoofdstuk 3) promoter van de muis. Tenslotte kan GATA-4 ook met HNF-la de LPH 
promoter synergistisch activeren wat overeenkomt met de GATA-5/HNF-la synergie 
(Hoofdstuk 5). In tegenstelling tot GATA-5, dat de LPH promoter niet kan activeren zonder 
HNF-la (Hoofdstuk 2), kan GATA-4 de LPH promoter wel individueel activeren (Hoofdstuk 6). 
Voor het karakteriseren van dit tweeledige mechanisme van de GATA-4 activatie aan de LPH 
promoter van de mens, werd de rol van de GAIA bindingsplaatsen als eerste getest door middel 
van gemuteerde LPH promoters. Daarna werden de functies van kritieke domeinen in GATA-4 
in kaart gebracht door ten eerste mutaties die specifieke domeinen verwijderen of dysfunctioneel 
mak.en te introduceren in GATA-4. Hiema werden de gemuteerde eiwitten getest op specifieke 
functies zoals; bindingsmogelijkbeid aan DNA (gel-shift experimenten), de mogelijkbeid om 
fysiek HNF-la te binden (GST-pull down experimenten) en de mogelijke transcriptie activatie te 
meten in Hela cellen (tijdelijke co-transfectie experimenten). Hela cellen werden bier gebruikt 
omdat ze niet in staat zijn endogenen HNF-la. te produceren, zodat onderscheid gemaakt kan 
worden tussen de GATA-specifeke en de GATA!HNF-la synergistische activatie. De studies 
besproken in Hoofdstuk 6laten zien dat GATA-4, in tegenstelling tot GATA-5, de LPH 
promoter van de mens wel onafhankelijk activeert, via een mechanisme waarvoor intacte GATA 
bindingsplaatsen, de GATA-4 activiteits domeinen noodzakelijk zijn. De C-terminale zink vinger 
van GATA-4 reguleren de binding met het DNA (Fig. 3). Daarentegen kan GATA-4, gelijk aan 
GAT A-5, sam en met HNF -1 a de LPH promoter van de mens synergistisch activeren. Deze 
activatie gaat via een mechanisme, waarbij GAIA bindingsplaatsen of de GATA-4 activatie 
domeinen niet noodzakelijk zijn. De fysieke interactie tussen GATA-4 en HNF-la als ook een 
intacte HNF-1 bindingsplaats zijn noodzakelijk voor de GATA-4/HNF-la synergie. DeC-
terminale zink vinger van GATA-4 medieert de fysieke interactie met HNF-1 a. 
Fig. 3. GAT A-4 en GAT A-5 reguleren het 
humane LPH gen verschillend. De GATA-4 van 
de GATA-4, -5 en -6 transcriptiefactor familie 
kan de LPH promoter van de mens onajhankelijk 
activeren (++).Binding op het DNA wordt 
gemedieerd door de C-terminale zink vinger 
(Znii), en de basische regia (B) van de GATA 
eiwitten. Voor de onafhankelijke activatie moet 
GATA-4 methet DNA binden en heeft hetzijn 
-118 bp activatie domeinen nodig. Het mechanisme van 
de GATA-4/HNF-la synergie vertoont gelijkenissen met het mechanisme van de GATA-5/HNF-lu synergie (zie 
Fig. 2). 
Gel-shift experimenten hebben aangetoond dat de GATA bindingsplaatsen in de LPH 
promoter van de mens een hogere affiniteit hebben voor GATA-4 dan voor GATA-5. De 
conclusies gebasseerd op deze resultaten zijn, dat GATA-4 gebruik maakt van een tweeledig 
mechanisme om de humane LPH promoter transcriptie te activeren. Dit mechanisme wordt 
gekarakteriseerd door: (1) activatie die onafhankelijk is van HNF-la (in tegenstelling tot GATA-
5), waarbij binding aan bet DNA en de GATA-4 activatie domeinen nodig zijn en (2) een 
activatie in samenwerking met HNF-la (gelijk aan GATA-5), waarbij de fysieke associatie met 
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HNF-la noodzakelijk is, maar intacte GATA bindingsplaatsen en de GATA-4 activatie 
domeinen niet noodzakelijk zijn. De veronderstelde verschillen in activatie door de GATA-4, -5 
ranscriptie factoren voor een deel worden bepaald door de verschillende affiniteiten van de 
GATA bindingsplaatsen voor de GATA factoren. Dit is de eerste studie die heeft aangetoond dat 
er een verschil is in het transcriptie regulatie mechanisme van een intestinale gen door twee 
verschillende GAT A factoren. 
Alhoewel LPH mRNA is gereduceerd in de a:f\vezigheid van HNF-la zeals is beschreven 
in Hoofdstuk 8, wordt er een kleine hoeveelheid LPH rnRNA geproduceerd in de volwassen 
knock-out muizen. Dit suggereert dat gedurende de lactatie-periode er een transcriptie regulatie 
mechanisme is dat onafhankelijk van HNF-la de transcriptie van het humane LPH gen in vivo 
kan activeren. Vanwege de GATA-4 expressie in de dunne dann en het feit dat het horizontale 
expressiepatroon van GATA-4 parallel loop! aan die van LPH en omdat GATA-4 de LPH 
promoter van de mens individueel kan activeren, wordt er verondersteld dat GATA-4 een 
belangrijke rol speelt in de transcriptie van LPH zowel zonder als met HNF-la. Zoals in 
Hoofdstuk 3 is beschreven wordt HNF-la nauwelijks in de dunne darm aangetroffen gedurende 
de lactatie-periode, terwijl in deze periode LPH op de villi overal in de dunne darm kan worden 
aangetoond. Met behulp van de resultaten bij de knock-out muizen die in Hoofdstuk 8 
beschreven zijn kan worden verondersteld dat het mechanisme van de LPH transcriptie in vivo 
tijdens de lactatie-periode onafhankelijk is van HNF-la. Echter, GATA-4 eiwitten worden wel 
gevonden in de villi van de dunne darm gedurende deze periode (Hoofdstuk 3). Dit alles heeft tot 
de volgende hypothese geleid: (1) Tijdens de lactatie-periode word! de LPH transcriptie gestuurd 
door een mechanisme dat onafhankelijk is van HNF-la maar waarin GATA-4 potentieel een 
belangrijke rol zou kunnen spelen. (2) Gedurende de periode van het spenen en in de peri ode 
daama verandert het mechanisme van HNF-la onafhankelijk naar een HNF-la afhankelijk 
mechanisme waarin samen met GATA factoren de LPH transcripite wordt gereguleerd. 
10.3.3.2 Toekomstbeeld 
Om de rol die GATA factoren zowel individueel als in samenwerking met HNF-la bij de 
in vivo expressie van LPH en SI genen spelen duidelijk te maken, moeten knock-out 
experimenten worden uitgevoerd. Ter aanvulling van de onderzoeksresultaten in dit proefschrift 
moet er een belangrijke techniek worden ontwikkeld waarin weefsel specifieke knock-outs 
worden gecreeerd. Gelukk:ig overleven HNF -1 a knock -out muizen waardoor de effecten van de 
afwezigheid van HNF-la op de intestinale differentiatie en de LPH en SI gen expressie kunnen 
worden bestudeerd. In tegenstelling tot de GATA-5 knock-out muizen, die overleven en waarin 
de rol van GATA-5 kan worden bestudeerd voor de intestinale gen regulatie in vivo, gaan de 
GATA-4 en GATA-6 knock-out muizen dood zonder voor-darm te ontwikkelen. De 
conventionele knockout studies waarin de factor uit het hele dier wordt verwijderd, leveren dus 
geen informatie op over intestinale processen. Gelukk:ig is er een vrij nieuwe techniek 
ontwikkeld waarin gebruik gemaakt wordt van een Cre-loxP recombinatie technologie. Deze 
techniek maakt het mogelijk om de expressie van GATA-4, -5 en -6 zowel individueel als ook in 
combinatie specifiek uit de dunne darm te verwijderen. Dit model zal in vivo informatie 
opleveren over de rol die GATA-4, -5 en -6 spelen in de intestinale ontwikkeling en gen 
expressie. 
Om het mechanisme van de onafhankelijke activatie van GA TA-4 te bestuderen moet er 
een gedetailleerde karakterisatie worden uitgevoerd van de GATA bindingsplaatsen op de 
verschillende promoters en van de domeinen in de GATA eiwitten die de DNA binding 
reguleren. Een aanpak om de bindingsplaats karakteristieken te definieren is het gebruik van 
gerandomiseerde GATA bindingsplaatsen als oligonucleotiden in gel-shift experimenten. Dit is 
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al eerder gedaan voor GATA-1 (2). Aminozuur sequentie analyses van de C-terminale zink 
vinger en basische regio, die DNA binding reguleren, hebben aangetoond dater ongeveer 10 
aminozuren zijn die niet zijn geconserveerd tussen de GATA-4, -5 en -6 factoren (Fig.4). 
: -----------------Zinc Finger 11-----------------:-------------------Basic Region-------------------: 
GAT A-1 GTVCSNCQTSTTTLWRRSPMGDPVCNACGL YYKLHQVNRPL TMRKDGIQTRNRKVSSKGKKR 
** * * * ** * * ** **** ** * 
GATA-4 GLSCANCQTTTTTLWRRNAEGEPVCNACGLYMKLHGVPRPLAMRKEGIQTRKRKPKNLNKSK 
GAT A-5 GLCCSNCHTA TTTLWRRNSEGEPVCNACGL YMKLHGVPRPLAMKKE SIQTRKRKPENPAKIK 
GATA-6 GLSCANCHTTTTTLWRRNAEGEPVCNACGLYMKLHGVPRPLAMKKE GIQTRKRKPKNINKSK 
A A 
Fig. 4. Aminozuur sequentie van de C-terminale zink vinger en basische regio van GATA-1, -4,-5 en -6. Niet 
geconserveerde aminozuren tussen GAT A-4, -5 en -6 zijn in dik gedrukte hoofdletters aangegeven. Een astriks (*) 
houdt potentiele contact punten met de DNA in voor GATA-1 (2). Een zwarte driehoek geeft niet geconserveerde 
arninozuren in de hele GATA familie aan die tegelijkertijd contact punten zijn met de DNA. 
Om het belang van deze en andere niet geconserveerde aminozuren te bestuderen, kunnen 
specifieke aminozuren in GATA-5 worden veranderd in die van GATA-4 en worden getest voor 
een verhoogde bindingsaffiniteit. Natuurlijk zal het omgekeerde ook kunnen worden getest 
waarin GATA-4 structuren worden veranderd in die van GATA-5 en wordt er gekeken naar 
verlies van bindingsaffiniteit. Deze verschillen in bindingsaffiniteit voor specifieke bindings 
plaatsen zouden een belangrijk mechanisme kunnen zijn waarmee bindingsplaatsen op promoters 
voor eiwitten een weefsel specifieke gen transcriptie kunnen regelen. 
10.3.4.1 FOG reguleert de transcriptie van het LPH gen van de mens. 
FOG bet geen een afkorting is van (Friend of GATA) zijn multipele zink vinger 
cofactoren die specifiek de GATA activatie van de door GATA gereguleerde transcriptie van 
genen beinvloeden. Twee leden zijn tot nu toe geidentificeerd, FOG-1 en FOG-2. Het doel van 
de studies beschreven in Hoofdstuk 7 is om de rol te definieren van FOG cofactoren op de 
GATA-specifieke en GATA/HNF-la synergistiscbe activatie van de LPH promoter. De FOG-I 
en FOG-2 rnRNA expressie in de dunne darm werd bestudeerd door middel van reverse 
transcriptase-PCR (RT-PCR) experimenten. Om de functie van FOG cofactoren te 
karakteriseren, werden transfectie experimenten gedaan in Hela cellen met een construct dat 118 
bp van de LPH promoter van de mens bezit en aan de humane groeihormoon reporter was 
gekoppeld. Beide FOG-1 en FOG-2 rnRNA werden gevonden in RNA dat was geisoleerd uit 
jejunum van volwassen muizen hetgeen suggereert dat beide cofactoren in de dunnen darm 
worden produceerd. FOG-1 onderdrukte de GATA-4 specifieke activatie van bet LPH gen tot 
ongeveer een niveau van 50% en FOG-2 onderdrukte de activatie tot ongeveer 5% van de 
GATA-4 activatie. Daamaast hebben FOG-! en FOG-2 geen effect of de HNF-la activatie, 
waarmee wordt aangetoond dat het effect inderdaad GATA specifiek is. Ook hebben beide FOG-
I en FOG-2 een effect op de GATA/HNF-1a synergie van de LPH promoter, alhoewel bet effect 
minder drastisch is dan op de GATA-4 specifieke activatie. Een substitutie van een belangrijk 
arninozuur in de N-terminale zink vinger van GATA factoren, dat voorheen de fysieke interactie 
met FOG cofactoren onderbrak, resulteert in een reductie van de FOG-specifieke repressie maar 
niet een verlies van de repressie op de GATA-4-specifieke activatie. Deze mutatie voorkomt 
volledig de FOG-repressie op de GATA!HNF-1a synergie. FOG cofactoren die in de darm 
worden gevonden zouden een rol kunnen spelen in de expressie van het LPH gen door rniddel 
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van de onderdrukking van GATA-specifieke en GATAIHNF-la synergistische activatie op de 
LPH promoter. Bij deze onderdrukking wordt gebruik gemaakt van onder andere de N-terminale 
zink vinger van GAIA factoren. 
Repression by FOG-2 of the GATA-4-independent 
activation 
+ 
10.3.4.2 Toekomstbeeld 
Fig. 5. Het mechanisme waarmee FOG 
cofactoren de LPH promoter van de mens 
onderdrukken. FOG-1 en FOG-2 cofactoren 
binden niet aan het DNA, maar associeren specifiek 
met GA TA eiwitten. Deze tysieke associatie vindt 
plaats door middel van de N-terrninale zink vinge:r 
van de GATA factoren. De onatbankelijke GAT A-
4 activatie wordt ongeveer met 95% gereduceerd 
(bovendste plaatje) De synergistische activatie van 
de LPH promotertussen GATA en HNF-la wordt 
ook gereduceerd maar minder sterk dan de reductie 
op de GATA-specifieke onderdrukking. 
Om het mechanisme van de FOG onderdrukking te karakteriseren, moeten de expressie 
patronen van deze cofactoren langs verticale, horizon tale en ont\.vikkelings gradienten worden 
onderzocht. Deze patronen kunnen worden gekarakteriseerd met behulp van RN ase protectie 
experimenten, in situ hybridisatie en immunohistochemische experimenten. De hypothese voor 
deze experimenten is dat FOG-2, in de aanwezigheid van GATA factoren, een repressor is van 
de LPH gen expressie, en dat bet patroon van FOG expressie in de dunne darm een omgekeerd 
evenredig patroon laat zien ten opzichte van LPH. 
10.4 Model voor de LPH expression in volwassen zoogdieren 
In dit proefschrift worden belangrijke transcriptie factoren beschreven die de transcriptie 
van intestinaal-specifieke genen zoals LPH en SI reguleren. Het is aangetoond dat leden van de 
Cdx-2, HNF-1 en GATA-4, -5 en -6 transcriptie factor families belangrijk zijn voor de LPH en 
SI gen transcriptie, zowel in vivo als in vitro. De proximale promoters van LPH en SI genen 
verschillen in het aantal en configuratie van de bindingsplaatsen voor deze transcriptie factoren. 
Gebaseerd op alle onderzoeksgegevens beschreven in dit proefschrift kan een model van de LPH 
gen expressie worden voorgesteld, zoals afgebeeld in Fig. 6. 
Cdx-2 bind! op CE-LPH!a en blokkeert zo de binding van NF-LPHI/R. Cdx-2 op 
zichzelf activeert de LPH promoter marginaal maar zou met onderdelen van de transcriptie 
initiation complex een directe eiwit-eiwit contact aan kunnen gaan. Deze fysieke interactie zou 
het initiation complex kunnen stabiliseren en dus het uit elkaar vallen van het transcription 
initiation complex tegengaan en zo bet transcriptie proces kunnen stimuleren. HNF-la bindt als 
een dimeer aan het DNA en activeert de transcriptie van de LPH promoter. 
Samenvatting 167 
? 
-3.6 kb 
NF-LPHl/R <Sl 
Fig. 6. Schematische weergave van de specifieke LPH gen expressie. De aanwezigbeid van Cdx-2 in intestinale 
cellen verbreekt de onderdrukking van NF-LPHl/R dat anders wei bindt op CE-LPH!a (zoals in niet intestinale 
cellen). Cdx-2 zou ook een fysieke interactie kunnen aangaan met onderdelen van de transcriptie initiation. Een 
dimeer van HNF-1 a bindt op bet DNA en recrutreert zo GAT A fact oren als ook histone acytelatie activiteit, dat 
zorgt voor de op-regulatie van de LPH gen expressie. GATA-4 activeert individueel de LPH promoter in 
afwezigbeid van HNF-lu, wat binding op bet DNA nodig heeft. Maar GATA-4 zorgt ook met HNF-la voor een 
synergistiscbe activatie van de LPH transcriptie, wat de fysieke interactie tussen deze factoren nodigt heeft maar niet 
de binding van GATA factoren op bet DNA. De doorgetrokken en gestippelde lijnen geven de invloeden weer die de 
upstream elementen bebben op bet transcriptie proces in bet specifieke expressie patroon van bet LPH gen van de 
mens. AI deze factoren belpen in bet transcriptie proces van de intestinale genen. 
HNF-la werkt als verbindings-eiwit die fysieke verbindingen aan kan gaan met vele eiwitten, 
waaronder GAIA en Cdx-2. Deze fysieke interactie resulteert in hoge transcriptie activiteit van 
de LPH promoter en het zou ook de histone acetylatie activiteit kunnen aantrekken (hoofdstuk 
1), hetgeen de LPH transcriptie faciliteert. Vanwege het parallellopen van de horizontale 
expressie patronen van GATA-4 en LPH in de dunne darm van volwassen muizen en het feit dat 
de GAIA bindings plaatsen in de proximale LPH promoter over het algemeen een voorkeur voor 
GATA-4 hebben. is de suggestie dat GATA-4 een belangrijke rol speelt in de horizontale LPH 
gen expressie. Daarenboven kan GAIA binden met HNF-la. (Hoofdstukken 3, 5 en 6) en Cdx-2 
(Hoofdstuk 3) en HNF-la en Cdx-2 kunnen op hun beurt ook weer met elkaar binden (I). Deze 
interacties sugereren dat deze eiwitten een groot complex kunnen vormen, dat de transcriptional 
initiation complex kan helpen vormen en stabiliseren, maar ook histone acetylatie activiteit kan 
aantrekken. Het feit dat leden van deze trasncriptie factor families ook samen worden gevonden 
in cellen waar LPH niet aanwezig is moeten er ook repressoren een rol spelen in de regulatie van 
de LPH en SI transcriptie. FOG cofactoren zijn repressoren van de GAIA-specifieke en 
GATA/HNF-la. synergistische activatie en zouden een rol kunnen spelen in de specifieke 
expressie patronen van LPH en SI genen. 
LPH is een marker gen dat een specifiek expressiepatroon heeft volgens verticale, 
horizontale en ontv.rikkelings gradienten. Leden van de transcriptie families die in dit proefschrift 
zijn besproken hebben onafhankelijke maar ook gedeeltelijk overlappende expressie patronen. 
Alhoewel over het algemeen deze facoren een positief effect hebben op de transcriptie van het 
LPH gen, lopen deze expressie patronen niet altijd parallel aan die van LPH en SL Daarom zijn 
deze eiwitten wel belangrijk maar waarschijnlijk niet voldoende om de LPH en SI 
expressiepatronen te verklaren. Dus spe1en de "upstream elementen" in samenwerking met de 
proximale elementen spelen een belangrijke rol in het tot expressie komen van LPH. Hoewel de 
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"upstream elementen" naar aile waarschijnlijkheid een belangrijke rol spelen zijn de "down-
sream" elementen uiterst belangrijk voor de stabilisatie van bet transcriptie initiation complex en 
het faciliteren van de LPH transcriptie. 
10.5. Significantie 
De studies die bier zijn beschreven hebben nieuwe inzichten gegeven in bet regulatie 
proces voor de transcriptie van LPH en SI genen. Deze regulatie mechanismen dirigeren de 
verschillende expressie patronen in de dunne darm. Zij hebben ook een bijdrage geleverd aan de 
opheldering van een aantal aspecten van de complexe processen van cel-specifieke genexpressie, 
intestinale-cellulaire differentiatie, en intestinale ontwikkeling. Wanneer deze mechanismen 
steeds meer bekend worden en zowel algemene als ook gen-specifieke regulatie mechanismen 
worden gekarakteriseerd, zal betook mogelijk worden om de expressie van een individueel gen 
specifiek te kunnen stimuleren, hetgeen resulteert in de herstel van de expressie van bet verloren 
of insufficiente functie van intestinale genen in de tractus digestivus. 
REFERENTIES 
1. Mitchelmore C, Troelsen JT, Spodsberg N, Sjostrom Hand Noren 0. Interaction between 
the homeodomain proteins Cdx2 and HNFlalpha mediates expression of the lactase-phlorizin 
hydrolase gene. Biochem J 346: 529-535, 2000. 
2. Omichinski JG, Clore GM, Schaad 0, Felsenfeld G, Trainor C, Appella E, Stahl SJ and 
Gronenborn AM. NMR structure of a specific DNA complex of Zn-containing DNA binding 
domain ofGATA-1. Science 261:438-446, 1993. 
Acknowledgements-Dankwoord 
AMSTERDAM-BOSTON-AMSTERDAM 
A continuing story: Lactase research in the Grand lab started around 1982 with some scribbling 
notes and drawing graphs on a paper napkin in a restaurant in Boston, where Prof. dr. Hans BUller en 
Prof. Richard J. Grand formed the lactase research collaboration. Edmond Rings in 1988 and many 
others have followed this initiative. From characterizing the lactase enzyme to describing the expression 
patterns of lactase in the intestine, I was honored when it was my tum to help continuing the project in 
1999. 
Through Mark Benninga, who helped me to contact Hans BUller, I was offered the opportunity to 
start with a clinical rotation at the New England Medical Center, Boston for three months in 1998. I 
gratefully took the opportunity that was offered to me the year after to do a research elective in Richard 
Grand's laboratory for six months. What started as a 6 month clerkship soon became a PhD-project. 
Three and a half years, some blood, sweat and tears later this thesis is the result of one of the best 
experiences I have had in my life so far! Now it is my turn to express my feelings and appreciation to 
the people who have had a hand in this experience. 
The "Big Dig" project on I-93 in Boston that, if one has visited Boston in the last seven years, 
made an impression in one way (waiting forever to pass the construction scene) or the other (hotel taxes 
raised in order to finance this project). The project consists of digging a 8 lane highway underneath 
Boston (I-93) while the old highway directly above the construction stays open for regular traffic. As 
former project director Peter Zuk stated: "It's like performing open heart surgery on a patient who 
continues to work and play tennis". This project is a symbol for the work that is done in the laboratory. 
Some facts: Largest underground and under water urban highway project ever ( 18 years, construction 
started 1991); The project so far has cost$ 15 billion (the estimated cost in 1983 was$ 2.5 billion); 14 
million cubic yards were dug, enough to fill a professional sports stadium .... 14 times; The control artery 
project will use up to 3.8 million cubic yards of concrete, enough to build a sidewalk 3 feet wide and 4 
inches thick from Boston to San Francisco and back ... 3 times!; During peak periods of construction 
(1998-2000) about $3 million of work is completed each day. 
Richard J. Grand, Dick, is projected in the money (Cdx-2), for obvious reasons. As head of the 
Pediatric Gastroenterology you are guiding this project. In 1999 it was you who helped to plan my 
career and helped me decide to do my PhD before my clinical rotations. Your enthusiasm is very 
contagious and you're an example to me how one should deal with clinic, research, teaching and being 
just a very nice person. Thank you very much for the opportunity to learn from you. I'm proud to have 
you as one of my Promoters. 
Stephen. D. Krasinski, Steve, is projected in the digging machine (TATA), since you're the 
engine of the research project. I do not know where to start thanking you for everything you are. Your 
enthusiasm, hard work, digging deeper to find out the outcome of experiments, stickler for controls, 
wonderful teacher, fishing, hiking and just a friend in everything, has been very important for me. I just 
hope that some day in the future I can give back to you what you have given to me. Until we'll meet 
again! 
"Herbie's angels" 
Dit is een term die ik niet zelfheb bedacht, maar als ik zie wat we met elkaar gedaan hebben en 
bet feit dat ik zonder jullie hulp nooit dit proefschrift had kunnen maken, dan kan ik een beetje trots en 
ontzag voor deze term niet onderdrukken. 
Courtesy of Marcelo Lavallen 
f Marcelo Lavallen Courtesy o 
Martijn, balancerend op een balk, het is natuurlijk gek te beginnen met jou, als "angel", maar jij 
kwam als eerste, via Dick's clinic naar het lab toe. Je verveelde je en had nog een maandje over, dus 
waarom ook niet. Je deed 1 "key"-experiment en je was weer we g. Mij achterlatend met mijn eerste 
publicatie (chapter 2). Dank voor je werk en ik hoop nog veel over je te horen in de toekomst. 
Inge, hangend aan een kraan, jij bent dan eigenlijk de eerste "echte" angel. Jij was de eerste die 6 
maanden bleefen wie ik mocht begeleiden (samen met Steve) in de beginselen van basic 
research ............. .ik heb enonn veel vanje geleerd! Jouw onuitputbare energie en lach hebben mij 
doen beseffen dat het leven toch wei mooi was. Ik dankje voor je werk (chapter 5) en je lieve woorden. 
Nu ga je zelf onderzoek (PhD) doen en ik hoop nog veel over jete horen en volg je van dichtbij. Dank! 
Sanne, "princess" elegant zittend op een graafmachine, wat hebben we gelachen. Ik zal nooit 
vergeten de eerste keer dat ik je "probes" leerde "labelen" ................ en de rest van bet lab ook. Maar 
zoals je bent pakte je bet snel open was je al gauw een expert (zie chapter 5). We hebben samen met 
Inge veelleuke dingen ondemomen. Succes met je weg naar dokter worden en hartelijk dank voor al je 
werk en gezeligheid. 
Naomi, ("kleine zus") lieflachend een beetje op de achtergrond,je kwam inje eentje en was de 
jongste van allen. In het begin een beetje wennen, ook zonder vriendje weg, en tussen aldie nieuwe 
mensen. Ik ben trots op hoe je je staande hebt weten te houden en hoe je uiteindelijk dingen mee ging 
organiseren. Je hebt keihard gewerkt enje vele experimenten eigen gemaakt (Chapter 7). Ik dankje voor 
al je inzet en plezier dat we hadden. Heel veel succes verder inje loopbaan. 
Maartje en Eef, samen kvvamen jullie en samen gingen jullie weer weg. Wij hebben een hele rare 
tijd meegemaakt. 11 September 2001 was een aparte tijd en al onze geprekk:en hebben dat nog specialer 
gemaakt. Maartje, ik zalje marrier van werken niet vergeten (boor de klep van de microcentrifuge nog 
klapperen) ik herkende mezelf daar af en toe in. Eef, jij was de koele van bet stel en zorgde voor 
hilariteit in het lab, je hebt heel veel voor me betekend. Samen hebben we vele leuke dingen gedaan en 
mede door jullie enthousiasme en gekke uitjes (Roxy) hebben jullie die periode in Boston voor mijn 
onvergetelijk gemaakt. Dank jullie wel. 
Marieke, drilboor in de handen, je kvvam een beetje met een gereserveerd gevoel naar Boston, 
maar dat was je snel kwijt en je hebt eruit gehaald wat erin zat. Je bent een mooi mens die niet in een 
stoffig lab hoort. Jouw ambities liggen vooral in het creatieve (zie pagina 6). Ik ben benieuwd hoe jij de 
toekomst gaat invullen. Je hebt drie maanden lang experimenten gedaan die niet of nauwelijks lukte en 
daardoor getwijfelt aan alles van wat en wie je was, maar hebt met keihard werken een fantastisch 
project gedaan en in zes maanden "in vivo" bewezen waar ik drie jaar en nog wat over heb gedaan. 
Dankje voor je enthousiasme en standvastigheid en lieve briefjes en gedichtjes. 
Tjalling, harde werker en voortzetter van het onderzoek. We hebben veel gesproken en ik denk 
dat je aile ingredienten hebt om er een fantastische tijd van te maken. In korte tijd heb je veel geleerd en 
benje opweg naar een mooi onderzoekers toekomst. Je bent een mooi mens die met gevoel te werk gaat. 
Jou bezig zien in het lab herken ik veel van mezelf. Ik ben benieuwd naar je resultaten en ik volg je op 
de voet. Heel vee I succes en maak ze gek daar in Boston. 
Prof. dr. H. BUller (Hans), ik ben zo gelukkig datje me deze kans hebt gegeven en datjij ook een 
van mijn promotoren bent. Je begeleiding is super en ik kan me geen betere voorstellen. Ik hoop ook dat 
ik je nog vaak zal gaan tegenkomen want ik kan nog heel veel van je leren. De opmerking " ..... keep 
going" is daar een mooi voorbeeld van. Dank voor nu. 
Robert Montgomery, Bob, it was a pleasure to have worked with you and have your expertise 
around. Special thanks for your help on the first chapter. 
Denesh Chitkara you became a true friend and I wish we would have hanged out sooner in and 
outside the lab. I wish you good luck in your career and I know our roads will cross again at some point. 
Lauren Dowling, thank you for your excellent help with my experiments. Your never-ending 
enthusiasm was great to see. I wish you a very nice career in the Medical area; I know you will do great! 
Vicky Houle, thank you for your advice in and around the lab. Your nice little cakes were great 
and I hope to see many papers with your name on it. 
Jean Shanley, thank you for your help in getting my visa and nice conversations. Wei, Douglas 
and Shelley Jefferson, Leah and Willem, thank you for your help and criticisms. You have helped 
launching my career in the lab. 
Susan Ivey, thanks for your professional help in getting students visa's and other paper work. 
Denise, Tucker Co liens, Mark Fleming, Dean, Tara and Jen thank you for your great help in getting 
things up and running, but also for your advice and criticisms. The way you have helped our lab settling 
in was beyond what we had expected and is one of the reasons it has been a great experience. 
Francois Boudreau, it was a great joy working with you and meeting you in your lab in 
Philadelphia. Chapters 3 and 5 in this thesis are an honor for me. It represents our intensive 
collaboration and I hope in the future to be able to meet you again. 
Edmond Rings, ik wil je graag bedanken voor je begeleiding in het lab en daarom heen. 
Hoofdstuk 3 en 5 zijn het directe bewijs van onze samenwerking. Ik ben er erg trots op! Maar ookje 
opvang buiten het lab en je waarde voor vriendschap met Steve heeft veel voor me betekend. Ik hoop je 
nog vaak tegen te komen in het Nederlandse leven (onderzoek en misschien wei als collega's). 
Hankje en Edward, dankje wel om van het laatste jaar zo'n gezellig jaar te maken. Ik en de 
andere studenten kwamen graag bij jullie over de vloer. Hankje, jij speciale dank voor je hulp bij de 
Nederlandse vertaling en het maken van mijn boekje. Ik hoop dat wij elkaar nog vaak gaan tegenkomen 
in Nederland. 
Sandrijn en Gary, allereerst Sandrijn dank voor je hulp en uitleg in het lab en wat te moeten doen 
voor het schrijven van een thesis, ik had dat wel nodig. Verder ben je een bijzonder mens en ik hoop dat 
we elkaar nog ergens in de wereld gaan tegenkomen. Gary thank you very much you and Sandrijn have 
meant a lot. The dinners and beer tasting in your house were always very pleasant get-togethers. You 
create a very welcoming atmosphere. I hope to be able to meet you again. 
Marcelo, I cannot tell you what meeting you has meant to me. A simple thank you doesn't even 
begin to describe that feeling. May be in your words if there are angels in this world you would be one 
ofthem. We will stay in contact forever. Thank you for your beautiful drawing. Only you could have 
done it this way. Thanks! 
Nicolas, Roomy, \Vhat to do with out you ........... We were the stable factor in 50 Brainerd road. 
Although we have changed every time we had different people over. Thank you for putting up with that 
crazy way oflife. I wish you good luck in the future with your PhD and thereafter. Of course you know 
there is always a door open for you ...... . 
Colleen, you have been a true friend and always there for me. Your never ending enthusiasm and 
happiness have been a bless for me. You and your family are very special to me. To the Driscoll's thank 
you for the Thanksgivings, Christmas evenings, and Eastern. 
"Gwennie" I would be a liar if didn't say that if it wasn't for you, I probably wouldn't have done 
this. Thank you for that. Mr. and Mrs. Zale and the rest of the family, thank you for helping me with my 
start in Boston. 
Mathew Babbich, thanks for being my roommate for a year and a half. 
Colette, coaching you on and off the field has been a great pleasure. We have had some crazy 
times but most of all fun. Family Gaudet, thank you very much for a wonderful time at the "Cape" 
I'm very happy to have met you, and got to know you better. 
Pepijn, we hebben een trouwe vriendschap opgebouwd en ondanks aile afstanden en tijden is 
deze niet veranderd. "Het is als of ik je gisteren nog zag", zei je vaak, na een jaar lang elkaar niet te 
hebben gezien. Ik kan je reactie nog zo voor de geest halen toen ik als verrassing op je afstudeerborrel 
verscheen. Je eerste reactie was inderdaad als of we gisteren nog aan de bar hadden gestaan. Ik ben er 
dan ook erg trots dat je als "para-nimf' naast me wil staan. 
Ferko, dat jij en Pep bij mij waren de eerste zomer was een groat genoegen en hard nodig. Ik ben 
blij datje ook nog even op de valreep 50 Brainerd Road hebt gezien. We hebben niet heel veel contact 
gehad, maar het gevoel is er niet minder op. Ik ben blij dat je zo'n goede vriend bent en hopelijk zal 
blijven. 
Gijs van den Brink, onze scientific breakfasts waren een groat plezier en omjou enthousiast te 
zien in research werkte erg aanstekelijk. Ik denk dat IFOP een goed voorbeeld is. Ik hoop in de toekomst 
nog veel met jete mogen samenwerken. 
Dr. J.H. van Wering, Pa, natuurlijk had ik dit zonder jou nooit kunnen doen. Dat hoefik niemand 
uit te leggen. Je was eigenlijk tegen mijn verblijfin de USA en datje me dan toch nog zoveel gesteund 
en gestuurd hebt is voor mij van Ievens be lang geweest. Onze vakantie met Esther was erg mooi, waarin 
we toch weer dichterbij elkaar zijn gekomen. Ik kan me nog de avond in een rare bar op "Times Square" 
voorstellen. Jou als para-nimfte hebben is dan ook niet aileen een traditie maar ook een teken als groat 
respect voor jou. 
Mamma, onze band is speciaal en zal ook altijd zo blijven. Ik denk dat we het daar wei eens over 
zijn. lk dankje voor de broodnodige, van levensbelang gebleken ondersteuning die je me hebt gegeven 
enje onuitputbare lieve woorden. 
Diew, zusje, ik dankje voor je leuke ideeen en hulp bij het maken van de voorkant. Ik beschouw 
het als een eer dat je dat hebt willen doen. Je bent erg lief en ik ben trots op je. 
Es, ook zusje, ik was onwijs blij datje met Ma en Diew bent meegekomen als verrassing naar 
50 Brainerd road. Daar kon je zien wat ik allemaal deed. Je hebt me een keer verteld dat bet met een 
lage frequentie van contact hebben met mij niet voorkwam uit een minder gevoel voor mij. Ik weet dat 
precies. Ik ben trots op je! 
Maarten Beuningh, "brother", ik ben gelukkig dat we elkaar met zoveel respect behandelen en 
dat onze vriendschap altijd sterk is geweest. Ik hoop dat het zo zal blijven, dank voor je 
ondersteuningen. 
Opa en Oma Neven, jullie telefoontjes elke maand betekende heel veel voor me. Ik ben trots op 
jullie actieve rol in het geheel. Iedereen in Boston wist wie die man was die om "his grandson Herbert" 
vroeg. Heel vee! respect en liefde voor jullie, dank. 
Natuurlijk kan ik nog meer mensen bedenken die erg belangrijk zijn geweest voor me en waarvan 
sommigen ook langs zijn geweest in de 3 jaar en nog wat maanden in Boston maar ............ het papier is 
op. Voor iedereen die ik heb vergeten, mijn dank is groot. 
Het is goed zo .............. . 
CURRICULUM VITAE 
The author of this thesis was born on March 30, 1972 in Rotterdam, The Netherlands. He 
graduated from Het Nieuwe Lyceum, Hilversum, The Netherlands in 1992, and started 
medical school the same year at the Catholic University of Leaven, Belgium. In 1994 he 
received the First medical degree at the Free University of Brussels, Belgium, however in 
the same year he started medical school at the Free University of Amsterdam, The 
Netherlands. As a medical student, he performed from May, 1998 through August, 1998, 
a clinical research elective at the Floating Hospital for Children at New England Medical 
Center, Tufts University under Dr. R.J. Grand his supervision. This research involved 
statistical analysis of two data sets. One was a comparison of growth and nutritional 
status in two cohorts of children, a group diagnosed with IBD in 1979-1983, and another 
in 1984-1996. From 1999 to 2001, he was trained in basic research in the laboratory of 
Pediatric Gastroenterology and Nutrition (trained by Dr. S.D. Krasinski, Dr. R.K. 
Montgomery, and Prof. R.J. Grand) New England Medical Center, Tufts University 
School of Medicine, Boston MA, USA and worked on intestine specific gene expression. 
He received the American Digestive Health Foundation Student Research Fellowship 
Award for his work on lactase gene transcription. In 1999 he received the degree of 
Master of Science from the Free University of Amsterdam, The Netherlands. He 
continued and finished his thesis work, from 2001 till2002 in the same laboratory at the 
Pediatric Gastroenterology and Nutrition Department at the Children's Hospital, Harvard 
Medical School, Boston MA, USA. In August 2002, Herbert van Wering started his 
clinical rotations in order to obtain his Medical Doctor degree from the Free University of 
Amsterdam, The Netherlands in 2004. 
REFERENCES 
Original manuscripts 
I. Integlia M, Weisselberg B, van Wering HM, Polk DB, Grand RJ, Mobassaleh M. 
Features of inflammatory bowel disease in children less than 5 years of age: comparison 
with older children. (in review) 
2. Saeed S, van Wering HM, Bandini L, Must A, Motil KJ, Grand RJ. Changing 
prevalence of growth failure in pediatric inflanunatory bowel disease. (in review) 
3. Stephen D. Krasinski, Herbert M. van Wering, Martijn R. Tannemaat, and Richard 
J. Grand. Diffemtial activation of intestinal gene promoters: functional interactions 
between GATA-5 and HNF-la. Am. J Physiol. Gastrointest. Liver Physio/28!: G69-
G84, 2001. 
4. Herbert M. van Wering, Inge L. Huibregtse, Sanne M. van der zwan, Maartje S. de 
Bie, Lauren N. Dowling, Franyois Boudreau, Edmond H.H.M. Rings, Gary P. Swain, 
Richard J. Grand, Stephen D. Krasinski. Physical interaction between GATA-5 and HNF-
1n results in synergistic activation of the human lactase-phlorizin hydrolase promoter. 
J. Bioi. Chem. 2002 August. 
5. Franyois Boudreau, Edmond H.H.M. Rings, Herbert M. van Wering, Richard K. 
Kim, Gary P. Swain, Stephen D. Krasinski, Jennifer Moffett, Richard J.Grand, Eun Ran 
Suh and Peter G. Traber. Hepatocyte-nuclear-factor-1a1pha (HNF-1o:), GATA-4 and 
caudal-related homeodomain protein Cdx2 functionally interact to modulate intestinal 
gene transcription: Implication for the developmental regulation of the Sucrase-
Isomaltase gene. J. Bioi. Chern. 2002 September. 
6. Herbert M. van Wering, Leah Moyer, Richard J. Grand, Stephen D. Krasinski. Cdx-
2 activation of the lactase-phlorizin hydrolase promoter: Identification of a non-Cdx-2 
repressor complex at CE-LPHla. (in review) 
7. Herbert M. van Wering, Evelien de Jong, Tjalling Bosse, Francois Boudreau, Gary 
P. Swain, Richard J. Grand, Stephen D. Krasinski. Dual mechanisms for the GATA-4 
activation of the human lactase-phlorizin hydrolase promoter. (in review) 
8. Stephen D. Krasinski, Herbert M. van Wering, Lauren N. Dowling, Naomi de Jong, 
Richard J. Grand. Friend ofGATA (FOG) cofactors mediate repression of the GATA 
activation of the lactase-phlorizin hydrolase gene promoter. (in review) 
Abstracts 
1. van Wering HM, Moyer L, Krasinski SD. Differential activation of the lactase-
phlorizin hydrolase and sucrase-isomaltase promoters by GATA 4/5/6, HNFla and p, and 
Cdx-2: demonstration ofCdx-2 activation at the TAT A-box. (presented as a poster at the 
annual meeting of the American Gastroenterological Association, 2000) 
Gastroenterology 118: A593, 2000. 
2. Herbert M. van Wering, Inge L. Huibregtse, Sanne M. van der Zwan, Richard J. 
Grand, Stephen D. Krasinski. Physical interaction between GATA-5 and HNF-la results 
in synergistic activation of the human lactase-phlorizin hydrolase promoter. (presented 
orally at the annual meeting of the American Gastroenterological Association, 2001) 
Gastroenterology 120: A123, 2001. 
3. Herbert M. van Wering, Evelien de Jong, Richard J. Grand, Francois Boudreau, 
Edmond H.H.M. Rings, Gary P. Swain, Stephen D. Krasinski. Dual mechanisms for the 
GATA-4 activation of the human lactase-phlorizin hydrolase promoter. (presented orally 
at the annual meeting of the American Gastroenterological Association, 2002) 
Gastroenterology 122: A717, 2002. 
4. Stephen D.Krasinski, Herbert M. van Wering, Naomi de Jong, Lauren Dowling, 
Richard J. Grand. Friend ofGATA (FOG) cofactors modulate the GATA activation of 
the human lactase-phlorizin hydrolase (LPH) promoter. (presented orally by S.D. 
Krasinski at the annual meeting of the American Gastroenterological Association, 2002) 
Gastroenterology 122: A264, 2002. 
5. Franyois Boudreau, Edmond H.H.M. Rings, Herbert M. Van Wering, Gary P. 
Swain, Stephen D. Krasinski, EunRan Suh, Richard J. Grand, and Peter G. Traber. A 
distinct transcriptional activator complex mediates sucrase-isomaltase gene expression. 
(presented orally by F. Boudreau at the annual meeting of the American 
Gastroenterological Association, 2002) Gastroenterology 122: Al61, 2002. 
